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Abstract 
 
Organosilica nanoparticles have attracted a lot of research interest in a variety of 
areas such as drug delivery and catalysis because of their properties which include high 
surface area as well as tunable particle and pore size. In particular, nanoparticles with 
large pore sizes are of great interest because of their potential to host large guest 
molecules such as proteins and as catalysts. The focus of the work in the thesis was to 
develop phosphonate functionalized organosilica nanoparticles for biomedical and 
catalytic applications. Raspberry textured phosphonatesilica nanoparticles denoted, 
RNPPME(2.5) (where the number in the brackets represents the moles of 
organophosphonate per gram), with large pore size (11–17 nm), uniform particle size (70 
– 90 nm) and high surface area were produced through the use of template directed base 
catalysed synthesis, using tetraethylorthosilicate (TEOS) and 
dimethylphosphonatoethyltrimethoxysilane (DMPTMS) as the silica sources. The role of 
the reaction conditions such as temperature, surfactant concentration, pH, organosilane 
concentration and type were investigated and a mechanism for the raspberry nanoparticle 
formation was proposed. The particles were characterized using electron microscopy 
(SEM and TEM), Dynamic light scattering (DLS), silicon and phosphorus solid state 
NMR, and solution phase proton NMR of base digested particles, FT–IR, nitrogen 
adsorption porosimetry and thermal analysis (TGA).   
The ability of the particles to host protein molecules of the model protein, bovine 
serum albumin (BSA) was investigated and the particle–protein composite was 
characterized using circular dichroism (CD). Raspberry textured nanoparticles were 
found to host large quantities (26 wt%) of protein. Studies on other (small pore (3 nm) 
phosphonate functionalized nanoparticles NP_PME(0.2) and NP_PME(1.0)) and (3 nm 
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pore) unfunctionalized mesoporous silica nanoparticles (MSN) revealed that phosphonate 
loading and the pore size influenced the protein uptake In addition to high protein uptake, 
the RNP_PME(2.5) particles also absorbed protein molecules rapidly (~ 20 minutes to 
maximum load). CD studies determined that the particle bound protein structure was not 
affected at physiological pH (7.40). The vast majority of the previously reported studies 
involving protein immobilization involved the use of bulk silica materials, which cannot 
be dispersed and hence those materials were unsuitable for in vivo protein delivery 
applications. The BSA@RNP_PME(2.5) particles showed good protein load and 
dispersion properties and hence are excellent protein delivery agents. 
Dispersions of nanoparticle composite BSA#@RNP*_PME(2.5) (where BSA# 
represents fluorescein isothiocyanate labelled BSA and RNP*_PME(2.5) represents 
rhodamine B isothiocyanate labelled RNP_PME(2.5)) was used to successfully deliver 
membrane impermeable protein BSA into HeLa cells. Intracellular protein delivery has 
attracted great interest due to its potential therapeutic applications and research tool value 
(e.g. for studying various cellular pathways). The toxicity of the guest free particles 
RNP*_PME(2.5) and the protein loaded particles BSA#@RNP*_PME(2.5) was studied 
using MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay. The 
particles and the protein-particle composite were found to be non-toxic. The mechanism 
of the particle uptake by the cells was also studied. The unloaded (protein free) particles 
were found to be taken up by caveolar endocytosis pathway and the protein loaded 
particles were taken up by folic acid mediated pathway. The results indicated that the 
particles can successfully deliver membrane impermeable protein across the cell 
membrane. This result suggested that the particles can potentially be used for intracellular 
protein delivery applications. 
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Raspberry textured nanoparticles RNP_PME(2.5) were also used to host the 
enzyme lipase. It was demonstrated that immobilization increased the maximum velocity 
and Michaelis constant of the enzyme and also that the particles offered protection against 
the denaturing agent, urea. Finally, in a chemical catalysis application, the 
RNP_PME(2.5) particles were used to synthesize the platform chemical HMF, through 
Brönsted acid catalysed dehydration of fructose. High yields of HMF (87 %) were 
achieved when 10 wt% fructose was used. The particles demonstrated good recyclability 
and also the ability to convert up to 50 wt% fructose into HMF (80 % yield). The particles 
therefore acted as protective agents for enzymes and can therefore be used as enzyme 
immobilizing agents. Additionally, they also acted as excellent Brönsted acid catalysts. 
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entry; a) protein carrier uptake through caveolar receptors, b) encapsulation in early 
endosome coated with caveolin, c) endosomal escape and carrier release, d) controlled 
release of encapsulated protein, e) protein action inside the cell, f) conversion of early 
endosomes to late endosomes, g) transfer to golgi apparatus. 
Scheme 4.4: Folic acid receptor mediated uptake a) folic acid receptor coating, b) 
encapsulation within endosomes, c) endosomal escape, d) controlled release of 
encapsulated protein, e) protein action inside the cell 
 
Figure 4.1: TEM images of RNP*_PME(2.5) (Scale A) 200 nm ; B) 100 nm) 
Figure 4.2: Nitrogen sorption porosimetry of RNP_PME(2.5) A) Sorption isotherm; B) 
BJH pore size distribution 
Figure 4.3: Adsorption of BSA# to RNP*_PME(2.5) particles (n = 2 ± Std. dev.) 
Figure 4.4: DLS data of the BSA loaded and unloaded particles in DMEM media 
Figure 4.5: Effect of RNP*_PME(2.5) particle concentration on HeLa cell survival. (n = 
3 ± Std. dev.) 
Figure 4.6: Effect of BSA# load in nanoparticles BSA#@ RNP*_PME(2.5) on cell 
survival (n = 3 ± Std. dev.) 
Figure 4.7: RNP*_PME(2.5) nanoparticle uptake versus time (n = 20 ± SEM (standard 
error of mean)) 
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Figure 4.8: Time dependent uptake of RNP*_PME(2.5) nanoparticles by HeLa cells 
(Scale 20 µm). The red spots indicate the presence of Rhodamine B isothiocyanate 
functionalized nanoparticles RNP*_PME(2.5) 
Figure 4.9 : Distribution of RNP*_PME(2.5) nanoparticles in HeLa cells at different 
exposure times (Scale bar 10 µm in all images); A ) 1 hour; B) 2 hours; C) 4 hours and 
D) 6 hours 
Figure 4.10: TEM images of HeLa cells 6 hours after RNP*_PME(2.5) particle uptake. 
A) HeLa cell (Scale 5 µm); B) Particles in cytoplasm (black arrows) (Scale 500 nm); C) 
Particles within vesicles (black arrow) (Scale 500 nm) (Inset 2X magnification of the 
region containing the particles, indicated by black arrows); D) Caveolae on the cell 
surface (black arrow) (Scale 500 nm) (Inset 2X magnification of the region containing 
the particles, indicated by black arrows); E) Nucleus (Scale 500 nm) 
Figure 4.11: BSA#@ RNP*_PME(2.5) uptake versus time  (n = 20 ± SEM) 
Figure 4.12: Time dependent uptake of BSA#@RNP*_PME(2.5)nanoparticles by HeLa 
cells (Scale 20 µm). The red spots indicate the presence of Rhodamine B isothiocyanate 
functionalized nanoparticles RNP*_PME(2.5) and the presence of protein molecules was 
determined by identifying fluorescein isothiocyanate functionalized BSA, green spots. 
Figure 4.13 : Distribution of BSA#@RNP*_PME(2.5)nanoparticles in HeLa cells at 
different exposure times; A ) 1 hour(Scale bar 5 µm); B) 2 hours (Scale bar 7 µm); C) 4 
hours (Scale bar 10 µm) and D) 6 hours (Scale bar 5 µm) 
Figure 4.14: TEM images A) HeLa cell (Scale 5000 nm); B) Protein loaded nanoparticle  
BSA#@ RNP*_PME(2.5)localisation (black arrows) within the cytoplasm (Scale 1000 
nm) (Inset 2X magnification of the region containing the particles, indicated by black 
arrows); C) Localization of nanoparticles within mitochondria (Scale 500 nm); D) 
Nucleus , note that particles were not observed (Scale 1000 nm) (Inset 2X magnification 
of the region containing the particles, indicated by black arrows); E) Particles within 
endosomes (indicated by black arrows) (Scale 1000 nm) (Inset 2X magnification of the 
region containing the particles, indicated by black arrows) 
Figure 4.15: BSA#@ RNP*_PME(2.5) Particle uptake versus protein load. (n = 20 ± 
SEM.) 
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Figure 4.16: Effect of protein load in BSA#@ RNP*_PME(2.5) particles on particle 
uptake (Scale bar 20 µm). The red spots indicate the presence of Rhodamine B 
isothiocyanate functionalized nanoparticles RNP*_PME(2.5) and the presence of protein 
molecules was determined by identifying fluorescein isothiocyanate functionalized BSA, 
green spots. 
Figure 4.17: Distribution of BSA#@RNP*_PME(2.5)nanoparticles in HeLa cells at 
different protein load; A ) 111.1 mg/g (Scale bar 5 µm); B) 166.7 mg/g  (Scale bar 5 µm); 
C) 223.0 mg/g (Scale bar 10 µm) 
Figure 4.18: Effect of RNP*_PME(2.5) particle numbers on incubation in particle free 
media  (n = 20 ± SEM) 
Figure 4.19: Effect of incubation in particle free media on RNP*_PME(2.5) particle 
loaded cells (Scale 20 µm). The red spots indicate the presence of Rhodamine B 
isothiocyanate functionalized nanoparticles RNP*_PME(2.5).  
Figure 4.20: Distribution of RNP*_PME(2.5)nanoparticles in HeLa cells at different 
incubation times in particle free media; A ) 0 hours (Scale bar 10 µm); B) 1.5 hours (Scale 
bar 10 µm); C) 2.5 hours (Scale bar 10 µm) and D) 3 hours (Scale bar 10 µm) 
Figure 4.21: TEM images of RNP*_PME(2.5) particle loaded cells after 3 hours of 
incubation in cell free media. A) Complete HeLa cell (Scale 5000 nm); B) Localization 
of the particles in cytoplasm (Scale 500 nm) (Inset 2X magnification of the region 
containing the particles, indicated by black arrows); C) Particle exocytosis (indicated by 
black arrows) (Scale 200 nm) 
Figure 4.22: Effect of BSA#@RNP*_PME(2.5) particle numbers on incubation in cell 
free media (n = 20 ± SEM) 
Figure 4.23: Effect of incubation in cell free media on BSA#@RNP*_PME(2.5) particle 
loaded cells (Scale 20 µm). The red spots indicate the presence of Rhodamine B 
isothiocyanate functionalized nanoparticles RNP*_PME(2.5) and the presence of protein 
molecules was determined by identifying fluorescein isothiocyanate functionalized BSA, 
green spots. 
Figure 4.24: Distribution of BSA#@RNP*_PME(2.5) nanoparticles in HeLa cells at 
different incubation times in particle free media; A ) 0 hours (Scale bar 5 µm); B) 1.5 
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hours (Scale bar 10 µm); C) 2.5 hours (Scale bar 10 µm) and D) 3 hours (Scale bar 10 
µm) 
Figure 4.25: TEM images of BSA#@RNP*_PME(2.5) particle loaded cells after 3 hours 
of incubation in cell free media. A) Complete HeLa cell (Scale 5000 nm); B) Localization 
of the particles in cytoplasm (Scale 1000 nm) (Inset 2X magnification of the region 
containing the particles, indicated by black arrows); C) Nucleus, note the absence of 
particles (Scale 1000 nm) 
Figure 4.26: Receptor mediated uptake of RNP*_PME(2.5) particles (n = 20 ± SEM.). 
Statistical significance was measured at p-value of 0.01 using Wilcoxon ranked sum test. 
Statistical significance was determined by comparing against the uptake when surface 
receptors were not blocked (Sample: None). Statistical significance is denoted by ** and 
non-significant results by *.  
Figure 4.27: Confocal microscope images depicting the effects of blocking surface 
receptors on RNP*_PME(2.5) particle uptake. (Scale 20 µm). The red spots indicate the 
presence of Rhodamine B isothiocyanate functionalized nanoparticles RNP*_PME(2.5).  
Figure 4.28: Distribution of RNP*_PME(2.5)nanoparticles in HeLa cells in presence of 
various cell surface receptor inhibitors; A ) No inhibitor (Scale bar 10 µm); B) Clathrin 
(Sucrose) (Scale bar 10 µm); C) Folate receptor (Folic acid) (Scale bar 10 µm) and D) 
Caveolae (Nystatin) (Scale bar 10 µm) 
Figure 4.29: Receptor mediated uptake of BSA#@ RNP*_PME(2.5) particles  (n = 20 ± 
Rel. std. dev.) Statistical significance was measured at p-value of 0.01 using Wilcoxon 
ranked sum test. Statistically significance was  determined by comparing against the 
uptake when surface receptors were not blocked (Sample: None). Statistical significance 
is denoted by ** and non-significant results by * 
Figure 4.30: Confocal microscope images depicting the effects of blocking surface 
receptors on RNP*_PME(2.5) particle uptake. (Scale 20 µm). The red spots indicate the 
presence of Rhodamine B isothiocyanate functionalized nanoparticles RNP*_PME(2.5) 
and the presence of protein molecules was determined by identifying fluorescein 
isothiocyanate functionalized BSA, green spots. 
Figure 4.31: Distribution of BSA#@RNP*_PME(2.5) nanoparticles in HeLa cells at in 
presence of various cell surface receptor inhibitors; A ) No inhibitor (Scale bar 10 µm); 
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B) Clathrin (Sucrose) (Scale bar 10 µm); C) Folate receptor (Folic acid) (Scale bar 10 
µm) and D) Caveolae (Nystatin) (Scale bar 10 µm) 
 
Table 4.1: Morphological properties of RNP_PME(2.5) 
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Chapter 5 
Scheme 5.1: HMF 
Scheme 5.2: HMF derivatives 
Scheme 5.3: Acyclic pathway for HMF synthesis 
Scheme 5.4: Cyclic pathway for the synthesis of HMF 
Scheme 5.5: Conversion of phosphonate monoester particles to phosphonic acid 
particles under the reaction conditions 
Scheme 5.6: Preparation of emulsions 
Scheme 5.7: HMF synthesis and phase transfer 
Scheme 5.8: Coomassie blue colour changes 
 
Figure 5.1: SEM images of RNP_PME(2.5) nanoparticles. Scale bar A) 1000 nm; B) 
500 nm 
Figure 5.2 Nitrogen adsorption isotherm of RNP_PME(2.5) nanoparticles 
Figure 5.3: Optical microscope images of oil–in–water emulsion A) At 20X 
magnification (Scale bar 50 µm) and B) At 50X magnification (Scale bar 20 µm) 
Figure 5.4: Optical microscope images of water–in–oil emulsion A) At 20X 
magnification (Scale bar 50 µm) and B) At 50X magnification (Scale bar 20 µm) 
Figure 5.5: Cryo–SEM image of O/W emulsion (Scale bar figures A and B – 5000 nm) 
Figure 5.6: High magnification Cryo–SEM image of O/W emulsion (Scale bar figures A 
and B – 2000 nm) 
Figure 5.7: Cryo–SEM image of W/O emulsion (Scale bars, A – 10 µm and B – 5 µm) 
Figure 5.8: Catalyst recycle study (n = 2 ± std. dev.) 
Figure 5.9: Effect of Fructose concentration on HMF yield (n = 2 ± std. dev.) 
Figure 5.10: HMF yield versus time 
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Figure 5.11: Relative change in the monoester concentration during the course of the 
reaction 
Figure 5.12: 31P NMR spectra of the particles dissolved in NaOD/D2O showing 
phosphonate monoester peak at δ31P 32.3 ppm 
Figure 5.13: 31P NMR spectra of the particles dissolved in NaOD/D2O showing 
phosphonate monoester (sodium salt) peak at δ31P 32.2 ppm and phosphonate diacid 
(sodium salt) at 24.38 
Figure 5.14: Lipase adsorption versus time (n = 2 ± std. dev.) 
Figure 5.15: C. rugosa lipase uptake versus concentration study (n = 3 ± std. dev.) 
Figure 5.16: Hydrodynamic radius of nanoparticles. 
Figure 5.17: Rate of catalysis (q) versus substrate concentration (S) (n = 8 ± std. dev.) 
Figure 5.18: Lineweaver–Burke plot of free and immobilized lipase 
Figure 5.19: Effect of urea on enzyme activity (n = 3 ± Std. dev.) 
 
Table 5.1 Morphological properties of RNP_PME(2.5) nanoparticles 
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Chapter 1: Silica Nanoparticles:Development and 
Applications 
 
1.1 Silica Nanoparticles 
In the early 20th century Paul Ehrlich coined the term “Magic Bullet” to describe 
chemical agents that would selectively target disease causing pathogens and leave the 
host unharmed.1 The discovery of the therapeutic potential of nanoparticles in medicine 
aligns well with Ehrlich’s vision of targeted drugs. Several reviews described the 
properties of an ideal drug delivery system and as collated from these reports an ideal 
drug delivery platform would have a number of properties including for example a) small 
size (below 200 nm) , stable , biocompatible composition and excellent dispersion 
properties that would allow the particles to remain dispersed in the blood stream; b) ability 
to host a variety of guest molecules like drugs, proteins; DNA etc.; c) zero premature 
release; d) the ability to accommodate different functionalities that would allow it to target 
specific receptors and finally, e) controlled release at the target site.2 Colloidal 
mesoporous silica nanoparticles (CMSNs) stand out as potential drug delivery candidates 
because of their properties such as high surface area, large pore volume, uniform and 
tunable pore size, facile functionalization and the ability to accommodate multiple 
functional groups. Because of these properties they have attracted a lot of research interest 
in fields such as biomedical research (including drug delivery, biomarkers and biological 
sensors) and catalysis. These applications and relevant literature are covered in section 
1.3.  
CMSNs are typically synthesized using base catalysed sol-gel processing. The 
general procedure utilizes alkoxysilane precursors (such as TEOS 
(tetraethylorthosilicate), TMOS (tetramethylorthosilicate) and VTMS 
(vinyltrimethoxysilane)) dissolved in a solvent and to this mixture base is added to initiate 
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base catalysed hydrolysis and condensation of the alkoxysilanes. The mechanism of the 
hydrolysis and condensation is shown below (Schemes 1.1 and 1.2): 
Scheme 1.1: Base catalysed hydrolysis3 
 
 
Scheme 1.2: Base catalysed condensation3 
Hydrolysis (Scheme 1.1) involves nucleophilic attack at the silicon atom resulting 
in the formation of silanol. Condensation (Scheme 1.2) is a polymerization reaction to 
form siloxane bonds with the liberation of either alcohol or water. The consequence of 
these reactions is the formation of a new phase known as a sol. Commonly used 
alkoxysilanes such TEOS, TMOS and VTMS are not soluble in water and either need a 
mutual solvent such as alcohol or a surfactant to disperse them. The first demonstration 
of silica nanoparticle synthesis was performed by Stöber et al. in 1968.4 
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1.1.1 Stöber Process 
The very first demonstration of silica nanoparticle synthesis was carried out by 
Stöber et al. in 1968 (Figure 1.1). This method involved base (ammonia) catalysed 
hydrolysis and condensation of the silica precursor, TEOS, in ethanol to form spherical 
silica particles in the nanometer and micrometer range.4 Further refinements such as the 
use of non-ionic surfactants as well as controlling the precursor and base concentrations 
lead to improvements in the monodispersity and sphericity of the particles and some of 
these examples are shown in Figures 1.2 and 1.3. This facile synthesis of nanoparticles 
lends itself to industrial production.  
 
Figure 1.1: Silica particles (Scale 1 µm) synthesized by method of Stöber et al. 4 
 
Figure 1.2: Effect of water concentration (10M LHS and 20M RHS) on the particle size 
(reaction carried out in ethanol) (scale 0.1 µm) 6 
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Figure 1.3: Effect of base (ammonia) concentration (2M LHS and 1.75 M RHS) on the 
particle size (reaction carried out in methanol) (scale 0.1 µm) 6 
The mechanism of particle formation was reported by Van Blaadren et al. and 
proceeded through two steps where the first step involved the formation of “seed 
particles” or pre-polymers by the base catalysed hydrolysis and condensation of the 
alkoxysilane. These seed particles then aggregated and underwent interparticle 
condensation to form nanoparticles (Scheme 1.3). Control of the particle morphology was 
achieved by carefully controlling the number of seed particles and their subsequent 
aggregation.5 This can be achieved by controlling various reaction parameters like 
temperature, base concentration, polarity of the solvent6 and the type of the silane 
precursor7 used in the particle synthesis. 
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Scheme 1.3: Mechanism of Stöber particle formation 
 Many modifications to the Stöber method have been reported.8 An important 
example involved the use of basic amino acids. Amino acids are the building blocks of 
proteins and basic amino acids such as lysine and arginine have been demonstrated as 
efficient catalysts for the synthesis of silica nanoparticles. In addition to their role as bases 
the amino acids also acted as capping agents limiting particle growth and aggregation and 
played a structure directing role in assisting the particles to arrange in a uniform lattice 
(Figure 1.4).9 This strategy has been demonstrated to be scalable. 
 
Figure 1.4: Silica nanoparticles synthesized using arginine as catalyst (TEM 
LHS and SEM RHS ) (bar = 100 nm)9 
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The main drawback of the Stöber process is that the particles produced are non-
porous and have low surface area. Due to the absence of a template the seed particles 
show non-directional aggregation.10 Following the aggregation of the seed particles 
further particle growth takes place through monomer addition, this prevents the formation 
of pores. This limits the ability of Stöber particles to host guest molecules or perform drug 
delivery applications. However, they have been used as sensors and cell markers.11 
1.1.2 Colloidal Mesoporous Silica Nanoparticles  
Kresge et al. developed the mesoporous silica MCM-41 in 1992 using base catalysed 
hydrolysis-condensation on the alkoxysilane TEOS and using CTAB (cetyltrimethyl 
ammonium bromide) as the surfactant template. This method resulted in the production 
of mesoporous silica material with ordered mesopore arrangement (pore size 3 nm).12 
This method later formed the basis for the production of CMSNs. Much of the initial 
focus was aimed at using these materials for catalysis applications.  Between 1999 and 
2001 several papers were published exploring the possible use of these materials for 
controlled release of biomedically relevant molecules (such as proteins and drugs).13,14 
These materials offered several advantages over conventional drug delivery systems as 
outlined below: 
1. Ordered pore network: Homogenous pore network to facilitate the control of 
drug upload and release.  
2. Large pore volume and surface area: This helps host a large quantity of 
biologically relevant molecules. 
3. Free silanol groups on the surface: The surface silanols can be used to 
functionalize the surface with organic molecules to better control the interactions 
with the guest molecules.15 
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The challenge, however, was the control of particle morphology. Initial synthetic 
procedures for MCM-41 and similar silicas such as SBA-15 and MCM-48 resulted in the 
formation of particles with irregular particle size, hence their application as potential drug 
delivery agents was severely limited despite their excellent controlled release properties. 
This problem was solved in the early 2000s when several groups independently 
synthesized silica nanoparticles using soft template approaches. In addition to the pore 
size and surface area, the nanoparticles have additional advantages such as fast mass 
transport, effective adhesion of substrates and good dispersability in solutions.16 The 
particle synthesis was the result of specific interactions between the surfactant, 
alkoxysilane precursor, base and co-solvent. The following sections discuss some of the 
key strategies used in controlling the particle morphology. 
1.1.2.1 Role of surfactant templates 
The interactions between silica and the surfactant head groups play a major role 
in determining the final pore morphology of the particles. Cationic surfactants such as 
quaternary ammonium surfactants are commonly used in the synthesis of CMSNs. 
Particle synthesis is typically carried out under basic conditions, resulting in the formation 
of negatively charged silica back bone (isoelectric point at pH ≈ 2). The negatively 
charged silica interacts with cationic surfactant through S+I- interactions (where S 
represents the surfactant and I the inorganic species) (Scheme 1.4). Non-ionic surfactants 
such as block co-polymers are sometimes used in the synthesis of mesoporous silica 
nanoparticles. In this case the inorganic silica species interact with the surfactant through 
hydrogen bonding (S0I0 interaction). 17 
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Scheme 1.4: Interactions between positively charged surfactants and negatively charged 
silica S+I- (under basic conditions) 
The early reports on silica nanoparticles used the cationic surfactant CTAB. Mann 
et al. in 2001 used base catalysed synthesis to prepare silica nanoparticles. CTAB was 
used as the surfactant. The particle morphology was controlled by dilution using a large 
amount of water followed by neutralization by adding HCl. The particle morphology 
varied depending on the acid quenching time. When the particles were quenched after 60 
seconds, the particle size was 23 ± 4 nm with a pore size of 6.64 nm. Quenching after 220 
seconds of reaction resulted in the formation of larger particles (100 ± 26 nm) with 
slightly smaller pores (4.64 nm) see (Figure 1.5).18 Cai et al. in the same year reported a 
low surfactant strategy for the synthesis of silica nanoparticles and variations of this 
method are widely used to produce CMSNs. In addition morphology control of silica 
nanoparticles was achieved simply by changing the base from ammonia to sodium 
hydroxide (Figure 1.6).19 
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Figure 1.5: CMSNs synthesized by quenching the reaction after A) 60s and B) 220s 
(Scale bar 100 nm).18 
 
Figure 1.6: Particles synthesized using A) ammonia as catalyst (Scale 500 nm) B) 
NaOH as catalyst (Scale 50 nm).19 
Template directed synthesis of silica nanoparticles involves the use of a surfactant 
template to guide the particle growth. Surfactants play a dual role in this process. First, 
the surfactants help evenly disperse the alkoxysilane precursor in water by forming an oil 
in water emulsion. The second role of the surfactants is to act as templates to guide the 
formation of the nanoparticles. The mechanism behind the silica nanoparticle formation 
was determined by Cai et al.19 and Nooney et al.10 The mechanism for the particle 
formation was determined from silica nanoparticles synthesized using the cationic 
surfactant CTAB as template. CTAB micelles undergo three phase transitions as the 
surfactant concentration is increased. First, the critical micelle concentration (CMC) of 
CTAB is 1 mM20a, which increases to 24 mM under basic conditions (pH ~ 12.5)20b and 
CTAB forms spherical micelles that are about 3 nm in diameter. Then as the concentration 
is increased it undergoes a second critical micelle concentration (CMC2) at 0.3 M at 
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neutral pH wherein the micelles now assume a rod shape with similar pore diameter. 
Further increase in the concentration leads to the formation of hexagonal liquid crystals 
at 1.1 M at neutral pH.20c,21 Colloidal mesoporous silica nanoparticles with ordered 
mesopore structure have the same pore diameter as the diameter of CTAB rod shaped 
micelles (CMC2), however, the concentration of CTAB typically used in this type of silica 
nanoparticle formation is at least two orders of magnitude lower (~ 1.7 mM) than the 
concentration needed for spherical micelle to rod micelle transition. This suggests that 
the structure directing effect of the surfactant phase is probably due to a transient 
surfactant-silica template (which we will subsequently refer to as SST). Thus an SST 
phase (rather than pure surfactant micelles) formed after interaction between the 
surfactant and silica oligomers is likely to be structure directing. Under the reaction 
conditions (pH > 11) the silica oligomers attain a negative charge due to the deprotonation 
of the silanol groups.22 These oligomers would interact with the positively charged 
surfactant through very strong multidentate linkages (Scheme 1.5). Frasch et al. 
demonstrated that the silica oligomers are formed prior to the formation of the silica-
surfactant template (SST).23 This is the first step in the formation of CMSNs (Scheme 
1.5). 
The second step is seed particle growth and aggregation. In this step, the particle 
growth takes place by the same two mechanisms that influence the particle growth in 
Stöber silica nanoparticles.  Seed particle growth takes place through slow addition of the 
silane monomers to the silica-surfactant composite.  Aggregation of these seed particles 
leads to the final nanoparticle.24 The evidence for this comes from the work of Cai et al.19 
and Nooney et al.10 Cai et al. grew nanoparticles at very low concentration of TEOS and 
the resultant particles had an urchin like structure, indicating the formation, aggregation 
and precipitation of rod shaped micelles. However, instead of the random aggregation of 
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the silica seed particles of the Stöber synthesis, the aggregation of the particles was 
directed along the crystal planes. This resulted in the formation of mesoporous silica 
nanoparticles.10,19 (Scheme 1.5). 
Scheme 1.5: Mechanism of CMSN formation 
Surfactant charge has a great effect on the silica nanoparticle formation and 
neutral surfactants like n-dodecylamine and block co-polymers like pluronic P-123 and 
F-127 do not form charged species in solution and they interact with the silica species 
through hydrogen bonds (S0I0). Block co-polymers have been used in the production of 
large pore mesoporous silica materials such as SBA-15. However, controlling the particle 
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size was very difficult under the acidic conditions needed to prepare these materials 
probably because siloxane chain growth is favoured under acidic conditions and small 
particle formation is favoured under basic conditions.16b. Zhang et al. used block co-
polymer Pluronic P123 to prepare mesoporous silica which was a mixture of amorphous 
silica and ordered mesoporous particles with relatively uniform particle size of around 
300 nm. (Figure 1.7).25 
 
Figure 1.7: Mesoporous silica nanoparticles synthesized using pluronic P123 as 
surfactant at different magnifications.25 
The use of surfactant template offers other advantages, for example, if the micelle 
size can be increased then the resultant pore size can be increased as well. This can be 
achieved by using pore enlargement agents and mixed micelles. Pore size enlargement is 
very important as this will help accommodate large, medically relevant molecules such 
as proteins and DNA. Lin et al. first demonstrated this using mesitylene as the pore 
enlargement agent. Particles with 6 nm ordered pores were obtained and these materials 
were used to encapsulate and deliver the membrane impermeable protein cytochrome C 
into HeLa cells.26 Kao et al. used alkane/ethanol mixtures to expand the pore size of 
mesoporous silica nanoparticles. Under these conditions the pore diameter of the silica 
nanoparticles increased from 2.5 nm (no alkane) to 5.6 nm when dodecane was used as 
the pore enlargement agent. In this mechanism of particle formation the pore enlargement 
agent, a hydrophobic molecule, resides within and thus enlarges the surfactant micelles. 
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27 This strategy, however had a major drawback, the particle size uniformity was severely 
affected by this process. For example the particle size reported by Lin et al. was between 
300-600 nm26 and this wide range in particle size makes these materials unsuitable for 
drug delivery applications. 
Several other groups reported on an alternative strategy to increase the pore size 
of the silica nanoparticles. In this process, mixed micelles containing two different 
surfactants were used to increase the pore size and limit the particle growth. One of the 
earliest reports by Gao et al. used mixed micelles of mesitylene, non-ionic surfactant F-
127 and fluorinated surfactant FC-4 as pore enlargement and particle growth limiting 
agents. In the proposed mechanism the silica species interacts with the block co-polymer 
surfactant under mildly acidic conditions and is converted into a partially ordered 
mesophase with face centred cubic symmetry. The fluorocarbon surfactant FC-4 interacts 
with the silica-surfactant mesophase and limits the particle growth. The reaction was 
carried out under mildly acidic conditions which facilitated slow hydrolysis and 
condensation of silica precursor TEOS and assisted in co-assembling silica oligomers and 
surfactant molecules. The resultant silica nanoparticles had an average pore size of 20 
nm.28 In a related type of study He et al. used dodecanethiol as a co-template to enlarge 
the pore size of silica nanoparticles to 16 ± 8 nm when coupled with high stirring rate 
(2600 rpm) nm.29 
While surfactant templates have a profound effect on generation of nanoparticle 
morphology, the post synthesis method for removal of template is critical for ensuring 
retention of critical properties. The most common method used in removing surfactants 
from mesoporous silica nanoparticles is calcination,30 however calcination caused 
interparticle siloxane bond formation between the surface silanol groups and caused 
irreversible aggregation between the particles and thus affected the particle 
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dispersability.33 Therefore solution based methods are preferred. The most common 
solution based method is the overnight reflux of particles suspended in acidic methanol 
or ethanol.31 Bein et al. developed different methods for removing surfactants from 
CMSNs. For example, ammonium nitrate/ethanol solution proved effective for rapid 
removal of surfactants.32 Another strategy involved, treating the nanoparticles for about 
3 hours in hydrogen peroxide to oxidize the surfactant templates. This process however 
lacks specificity and is incompatible with organosilanes, since the organic groups may 
also be oxidised by hydrogen peroxide.33 Urata et al. developed a dialysis strategy to 
remove surfactants from CMSNs that are smaller than 30 nm, as these particles cannot be 
centrifuged. Dialysis was demonstrated to protect the particle morphology, while 
completely removing the surfactant.34 
 
1.1.2.2 Role of Co-Solvent 
Co-solvents such as ethanol are used in the synthesis of mesoporous silica 
nanoparticles to evenly disperse the alkoxysilane precursors. However, the presence of 
co-solvents has a strong influence on the formation of silica nanoparticles. Polar protic 
solvents, with intermediate dielectric constant, such as small chain alcohols, are 
solubilized near the interface of the SST and water,35 thus reducing the interactions 
between the silica oligomers and the surfactant head groups. Small chain alcohols also 
influence the hydrolysis and condensation of the silane monomers under basic conditions 
by hydrogen bonding with the hydroxyl groups.36  
1.1.2.2.1 Ethanol  
Ethanol is the most common co-solvent used in the synthesis of CMSNs. It was 
demonstrated by Grün et al. that the presence of ethanol resulted in the formation of 
spherical particles.37 Spherical particles are of great biomedical significance (section 1.3). 
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The presence of ethanol had a strong influence on the final morphology of the silica 
nanoparticles. Nooney et al. observed that use of ethanol resulted in a reduction of 0.5 
nm in the pore diameter. They reasoned that this was due to the reduction in the template 
size by 0.4 nm, due to the influence of ethanol.10 In addition to this, the presence of ethanol 
also lowers the hydrolysis rate and condensation of the silane precursors.38 Higher 
concentrations of alcohol resulted in a disordered pore structure in CMSNs and increased 
the particle size. All these factors defined conditions for the formation of monodisperse 
CMSNs and resulted in the formation of spherical particles.39 
 
1.1.2.2.2 Ethylene glycol 
Ethylene glycol was also reported as a co-solvent and strongly interacted with the 
CTAB thereby limiting the interactions between silica oligomers and the surfactant. This 
helped achieve a monodisperse particle size distribution (Figure 8).40 
 
Figure 1.8: Nanoparticles synthesized using A) ethylene glycol (Scale 1000 nm)40 B) 
Formaldehyde (Scale 500 nm)41 as co-solvents.  
 
1.1.2.2.3 Formaldehyde: 
Formaldehyde polymerizes under the particle synthesis reaction conditions to 
form a polymer layer (of paraformaldehyde) around the silica nanoparticles. This strategy 
was used by Gu et al. to limit the growth of the silica nanoparticles to 30 nm. The authors 
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observed that increasing the formaldehyde concentration led to an increase in the pore 
volume, however it had no effect on the pore diameter or the particle size (Figure 1.8).41 
 
1.1.2.2.4 Ethers: 
Chen et al. studied the effects of two ethers, diethyl ether and 2-ethoxyethanol on 
the morphology of silica nanoparticles. 2-Ethoxyethanol (bp 135°C), produced particles 
with 3 nm pore channels. The authors observed that an increase in concentration of 2-
ethoxyethanol lead to an increase in the particle size.42 This observation was similar to 
that observed by Tan et al.43 The results also indicated that the behaviour of 2-
ethoxyethanol in water was similar to that of methanol, in that increasing concentration 
resulted in an increase in the particle size.  
In the same study, the effect of diethyl ether (bp 34.6 °C) on the particle 
morphology was studied. Diethyl ether has very low solubility in water. It was therefore 
expected to reside deep in the core of the surfactant template.42 However, due to its low 
boiling point it vaporized during the course of the nanoparticle formation and this resulted 
in the formation of particles with a thin outer shell and empty core, nanocapsule 
morphology.42 
 
1.1.2.3 Role of Base 
Silica nanoparticle formation is strongly influenced by the catalyst used in the 
reaction. Cai et al. demonstrated that final particle morphology is strongly influenced by 
the base used.19 They found that the use of strong bases such as sodium hydroxide lead 
to the formation of small particles (100 nm diameter), while the use of a weak base such 
as ammonia lead to the formation of large particles. In order to explain these results the 
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authors suggested that the particle size was dependent on the length of the silica-surfactant 
composite micelles. The silica oligomers interact with the micelles in two ways, under 
the basic reaction conditions the silanol groups dissociate to form negatively charged Si-
O- groups that interact with the positively charged surfactant. In addition to the 
hydrophilic silanol groups, the oligomers contain hydrophobic siloxane linkages. The 
results from the experiment showed a strong increase in the particle size when sodium 
hydroxide was replaced with ammonia as the catalyst. It was suggested that the length of 
the silica-surfactant micelle was dependent on the interactions between the oligomers and 
the hydrophobic region of the surfactant. Weak bases like ammonia promoted these 
interactions while strong bases disrupted them, thus resulting in particles of smaller size.19 
The interactions between the surfactants and the base have been used to achieve 
some interesting morphological changes, as demonstrated by Zhang et al. They used two 
surfactants; a surfactant with a hard head group –bromide ion, cetyltrimethylammonium 
bromide and a surfactant with a soft head group – tosylate ion, cetyltrimethylammonium 
tosylate. The reactions were carried out under two reaction conditions, low base (pH 7.2 
to 7.4) and high base (pH 10). All the particles synthesized at pH 10 had wormhole pore 
structure (wormhole pore structure consists of irregular but interconnected pores) and 
smaller particle size, irrespective of the surfactant used. However, the particles 
synthesized at low base conditions resulted in a diversity of particle morphologies, 
depending on the surfactant and the organic amine used. When the particles were 
synthesized using CTAB as template and triethanolamine as the base, the particles with 
raspberry texture were observed. However, when cetyltrimethylammonium tosylate 
(CTAT) was used as the template, the particles formed with stellate morphology. The 
pore size of the particles varied from 54 nm (trimethylamine) to 16 nm (triethanolamine) 
and 17 nm (2-amino-2-(hydroxymethyl)propane-1,3-diol). The authors suggested that the 
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morphology changes were due to the interactions between the counterions and 
surfactants; bromide ions strongly dissociate from the CTAB while tosylate ions 
dissociate to a smaller extent, thus there is increased competition between the surfactant 
and silica oligomers. This could explain the differences in morphology for different 
surfactants (Figure 1.9).44 
 
 
Figure 1.9: Particles formed by different amine catalysts (A and B triethylamine) (C and 
D 2-amino-2-(hydroxymethyl)propane-1,3-diol) at different magnifications44 and using 
CTAT (E) as surfactant template. 
Bein et al. developed a novel method to synthesize CMSNs, where 
triethanolamine was used as both catalyst and particle size control agent. Interactions 
between triethanolamine and alkoxysilanes were exploited to control the particle 
morphology. Triethanolamine when heated with alkoxysilanes resulted in formation of 
silatranes. These silantranes slowly dissociated in water to produce silica oligomers. The 
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oligomers condensed around the micelles to form silica nanoparticles. Using this process, 
mesoporous silica nanoparticles with uniform pore and particle size were produced.32 
Similarly Okuyama et al. used the basic amino acid lysine as the catalyst and particle size 
control agent. Lysine acquired a positive charge under basic conditions and interacted 
with the negatively charged silane monomers to restrict their growth. The mechanism 
used by the basic amino acid to control the particle size is similar to the one described 
earlier in section 1.1.1.45 
 
1.2 Organosilica nanoparticles 
Despite their interesting morphological properties such as monodisperse particle 
size, tunable pore size, high surface area and pore volume, the applications of silica 
nanoparticles would be greatly limited without organic functionalization. Organic 
functional groups aid dispersion and promote particle stability and are crucial for various 
applications of these particles46 (see section 1.3). Organo-functionalization of silica 
nanoparticles can be achieved by grafting or co-condensation methods. 
1.2.1 Grafting: 
Grafting involves treatment of CMSNs with organoalkoxysilanes or 
organotrichlorosilanes in a non-polar anhydrous solvent. This is to ensure the 
functionalization of the particles and prevent condensation between the 
organoalkoxysilanes which is difficult to control. Grafting is not the favoured method for 
synthesizing organosilica nanoparticles because it results in inhomogeneous distribution 
of the organic groups on the particle surface. This is because the external surface and the 
outer pore walls of the CMSNs have greater kinetic accessibility compared to the inner 
surfaces.43 
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Several groups have developed strategies to improve the functionalization 
efficiency of grafting. Tsai et al. synthesized mercaptopropyl functionalized silica 
nanoparticles by grafting the mercaptopropyl silane onto as synthesized CMSNs with 
surfactant in their pores.48 The presence of the surfactant in the pores restricts the access 
of the organosilane and helps limit the organic group functionalization to the surface. 
Other groups such as Yang et al. partially cleaved the surfactant pluronic P123 to expose 
the micropores and functionalize them.49 
Despite these results grafting is severely restrictive in terms of the number of 
groups that can be attached to CMSNs. For example, the presence of organic groups at 
the pore entrances limits the diffusion of the additional organosilanes.50 Therefore the co-
condensation strategy is favoured to synthesize organically functionalized CMSNs 
(OCMSNs) with uniform distribution of organic groups. 
 
1.2.2 Co-condensation 
Bein et al. developed a novel strategy to selectively functionalize the outer and 
inner surfaces of the CMSNs by carefully timing the addition of organosilane 3-
aminopropyltriethoxysilane (APTES) and TEOS mixtures. The reaction was carried out 
under basic conditions with triethanolamine as the base and cetyltrimethylammonium 
chloride (CTAC) as the surfactant. At the start of the reaction only TEOS was used as the 
silica source. TEOS and APTES mixtures were then carefully added after 5, 10 and 30 
minute time intervals to functionalize the core, middle and the outer surface of the 
nanoparticles. (Figure 1.10)51 
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Figure 1.10: Selective functionalization strategy based on addition of organosilane at 
different time points (Figure from ref. 51). 
The presence of the amine groups on the particles was confirmed by FTIR. The 
location of the amine was determined by measuring the zetapotential of the particles. The 
zeta potential of the unfunctionalized CMSs and particle functionalized after 5 minutes 
(APCMS 7) had similar zetapotential. However, the particles functionalized after 30 
minutes (APCMS 9) showed a positive surface charge, indicating surface 
functionalization by the amines. Additional confirmation of the location of the amines 
was obtained by complexing iridium to the amine groups and determining its location by 
Z-scanning using scanning transmission electron microscopy (STEM). The STEM results 
showed that the amines in the sample examined after 30 minutes were almost completely 
located on the outer surface, while the sample examined after 10 minutes (APCMS 8) had 
amines located on the inner surface (Figure 11).51 
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Figure 1.11: STEM images of iridium immobilized particles A) represents APCMS-9 
(30 min); B) represents APCMS-8 (10 min).51 
They extended this strategy to achieve functionalization of the inner and outer 
surfaces of the nanoparticles by adding different silanes at different times during the 
reaction. 52 A similar strategy was adopted by Zink et al. to attach phosphonate groups on 
the surface of silica nanoparticles.53 
 
1.2.3 Morphology control of OCMSNs: 
The studies performed by Bein et al. were carried out in the presence of a very 
small amount of organosilane (~2 mol %). At that quantity, the organosilane has very 
little influence on the particle morphology. However, for catalytic and drug delivery 
applications large quantities of organosilanes are required (> 10 mol %). At large 
concentrations, the interactions between the organosilanes and the monomers start to have 
a strong effect on the particle formation.47 Lin et al. demonstrated that the surfactant 
organosilica interactions depended on the polarity of the organic groups. Non-polar 
organic groups helped stabilize the SST, while polar organic groups destabilized the SST. 
Stabilization of the template involved favourable interactions between the siloxane 
backbone and the hydrophobic surfactant tail. This resulted in an increase in the SST size 
and resulted in the formation of long cylindrical surfactant silica composite. The presence 
of non-polar groups thus resulted in the formation of rod particles. Polar molecules on the 
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other hand did not favourably interact with the hydrocarbon tail of the surfactants. Thus, 
the SST growth was limited and short spherical surfactant silica composites were 
produced.54 In their study Lin et al. demonstrated that particles produced using 
hydrophilic groups such as N-(2-aminoethylamino)ethylaminopropyltrimethoxysilane 
(AEPTMS) and  ureidopropyltrimethoxysilane (UDPTMS) resulted in the formation of 
spherical particles and when silanes with non-polar groups such as 
cyanopropyltriethoxysilane (CPTES) or allyltrimethoxysilane (ALTMS) were used, the 
resulting particles had rod shape (Figures 1.12 and 1.13). The authors also demonstrated 
that increasing the concentration of hydrophilic silane (AEPTMS) resulted in rod to 
sphere transition in nanoparticle shape.54 
 
 
Figure 1.12: Organosilica particle synthesis using polar organic groups A) AEPTMS 
and B) UDPTMS (Scale 3000 nm).54 
 
Figure 1.13: Organosilica particle synthesis using non-polar organic groups A) CPTES 
and B) ALTMS (Scale 3000 nm).54 
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In addition to this, when mixtures of hydrophilic and hydrophobic groups were 
used, then the final particle morphology of the particles was determined by the silane that 
apparently had the stronger structure directing effect. When, AEPTMS was mixed with 
CPTES, the resulting particles all had spherical particle morphology. Varying the ratios 
of the organosilanes did not have an effect on the shape of the particles, indicating that 
AEPTMS had the stronger structure directing effect of the two. The porosity of the 
particles, however was affected. Particles made from non-polar silanes had a regular 
honeycomb pore structure.55 An increase in the concentration of the polar groups resulted 
in the formation of the particles with greater distortion in pore structure.  
 
1.3 Applications of CMSNs 
Mesoporous silica nanoparticles have numerous applications ranging from drug 
delivery to catalysis. The following section describes some of the recent applications of 
these materials. Scheme 1.6 illustrates the timeline of the development of biomedical 
applications of silica nanoparticles. 
 
Scheme 1.6: Schematic representation of development of CMSNs for biomedical 
applications (adapted from ref 56) 
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1.3.1 Drug delivery 
Until the early 2000s much of the focus involving systems for controlled delivery 
of drug molecules was focussed on polymers. These systems however, have many 
disadvantages. Most polymeric nanoparticles involved in controlled release applications, 
use hydrolysis induced erosion of the polymeric structure, and this could lead to 
premature release of the guest molecules.52 Polyesters such as PLGA (poly lactic co-
glycolic acid) are widely used for drug delivery applications.56b Nano/microparticles 
made from these polymers release acid molecules upon degradation, which can denature 
the protein molecules.56c In contrast, silica nanoparticles represent a robust drug delivery 
system. CMSNs, have a biocompatible silica framework.52 The silica framework is stable 
under physiological conditions and does not have an antigenic effect. The particle 
properties such as particle size, pore size, pore volume and surface functionality can be 
optimised for different drug delivery applications.  
Section 1.1.2 listed a few properties of silica materials that make them excellent 
materials for drug delivery applications. The following section discusses some of the 
properties of drug delivery platforms and how the properties of CMSNs can be modified 
to improve their properties as drug delivery systems.  
1. Stable and bio compatible framework: Silica nanoparticles have a 
biocompatible framework.56a The main challenge involved in the use of CMSNs 
for in vivo drug delivery applications is their poor dispersibility and stability in 
biological media. Bein et al. demonstrated that silica nanoparticles dispersed in 
SBF (simulated body fluid) undergo morphological changes.57 Lin et al. 
developed dual functionalized mesoporous silica nanoparticles with hydrophobic 
groups (methyl from trimethyl chlorosilane (TMS) or trifluoropropyl from 3,3,3-
trifluoropropyldimethylchlorosilane (TFS)) and hydrophilic groups (poly 
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ethyleneglycol (PEG) from PEG-silane) as surface modifiers to improve the long 
term dispersion stability of the nanoparticles. The attachment of hydrophilic silane 
helped improve the dispersion stability of the particles and the presence of the 
hydrophobic silane reduced the silica dissolution.58 Dispersions of the dual 
functionalized nanoparticles were stable in PBS (phosphate buffer saline), SBF 
(simulated body fluid) and DMEM (Dulbecco’s Modified Eagle Medium) for 15 
days (Figure 1.14). 
 
Figure 1.14: Hydrodynamic radius versus time in A)PBS and B) Various media (sample 
MS25@PEG/TMS-hy-c), of surface functionalized nanoparticles (hy stands for 
hydrothermal treatment).58 
2. Drug uptake: Commonly used drug delivery systems such as polymers typically 
have low surface areas and this limits their ability to take up large quantities of 
drug molecules.59 Liu et al. recently developed a mesoporous silica nanosphere 
based drug delivery system, whose surface area can be varied by varying the ratio 
of surfactants (FC4 and Pluronic F127) used in the synthesis. FC4 is a 
fluorocarbon surfactant and is known to form vesicles, while pluronic F127 is a 
block co-polymer surfactant, consisting of polyethylene glycol and polypropylene 
glycol. They demonstrated that the particle surface area had a high impact on the 
uptake of the hydrophobic drug ibuprofen. Drug loads up to 448 mg g-1 were 
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achieved and the particles were shown to release the drug for 24 hours under 
physiological conditions.60 The process of loading drugs in polymers often 
requires the use of organic solvents.59 This limits the application of polymer 
particles solely for the delivery of small organic molecules. Biomolecules such as 
proteins and DNA undergo denaturation in presence of organic solvents. CMSNs 
can take up molecules from both aqueous and organic solvents and therefore 
represent a robust drug delivery platform. 
3. Controlled drug release: Drug release from many polymers (such as polylactic 
glycolic acid (PLGA)) has typically involved erosion of the polymer matrix and 
this causes difficulties in controlling the rate of drug release and also in premature 
release of the drug molecules.59 The rate at which the guest molecules are released 
from CMSNs depends on the pore size of the nanoparticles. By adjusting the pore 
size of the nanoparticles the rate of drug delivery can be altered.61 Gao et al. 
synthesized mesoporous silica nanoparticles with varying pore size (3.6, 7.2 and 
12.6 nm) (Figure 1.15) and used these nanoparticles to deliver doxorubicin, a 
hydrophobic anticancer drug, to MCF-7 breast cancer cells. The study showed 
that the large pore particles (12.6 nm) demonstrated enhanced cell uptake (Figure 
1.16a) and higher cell mortality compared to small pore nanoparticles or treatment 
with free doxorubicin (Figure 1.16).62 The authors suggested that the higher rate 
of cancer cell mortality was due to increased particle uptake and higher rate of 
drug delivery by large pore size particles (Scheme 1.7). In addition to controlling 
drug release by tuning the pore sizes of the particles, drug release can be controlled 
by using a variety of methods such as use of rotaxane nanovalves63, or 
nanoparticle 64 and enzyme responsive caps.65 
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Figure 1.15: Mesoporous silica nanoparticles with different pore sizes (A) Schematic 
representation of particle morphology (B) Particles with 3.2 nm pores (HMSN-1) (C) 
Particles with 6.4 nm pores (HMSN-2) (D) Particles with 12.6 nm pores (HMSN-3) 
(Scale 200 nm).62 
 
 
Figure 1.16: Variation in the uptake of nanoparticles by MCF-7 cells. Free dox = free 
doxorubicin; DMSNs1 = 3.2 nm pore sized particle; DMSNs2 = 6.4 nm pore sized 
particle and DMSNs3 = 12.6 nm. (A) Measurement of nanoparticle uptake by the cells 
(using Fluorescence-activated cell sorting (FACS)) and cell viability after doxorubicin 
treatment (using MTT assay).62 
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Scheme 1.7: Effect of pore size on the delivery of doxorubicin (Scheme modified from 
ref 62). 
4. Targeted drug release: The surface of the silica nanoparticles can be modified 
by reacting the surface silanols with a variety of organosilanes. This helps in 
changing the surface properties of the mesoporous nanoparticles. It can be used to 
attach groups to achieve targeted delivery to cancer cells. He et al. synthesized 
carboxylic acid functionalized mesoporous silica nanoparticles (COOH_MSNs) 
(Figure 1.17) to carry the anti-cancer drug doxorubicin to the leukaemia cell line, 
CEM (Scheme 1.8). In order to specifically target the cancer cells an aptamer 
Sgc8c, that binds to the protein tyrosine kinase 7 (PTK7) which is highly 
expressed in CEM cells,66a was attached to the particle surface by the EDC/NH2 
coupling method. (Note: aptamers are oligonucleotide or small peptide molecules 
that bind to specific target molecules on the cell surface and Sgc8c is a DNA 
aptamer). This study demonstrated that the nanoparticles specifically inhibited the 
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growth of the CEM cell line, while another cell line, Ramos, for which the aptamer 
has no affinity, was not inhibited.66b 
 
Figure 1.17: (A) TEM image of COOH_MSNs; (B) Cell viability studies performed on 
CEM cells and Ramos cell line, showing strong reduction in viability of CEM cells.66a 
 
 
Scheme 1.8: Synthesis and targeted delivery of Sgc8c tagged particles.66a 
 
1.3.2 Biosensors and biomarkers: 
 In addition to the applications in the area of drug delivery, mesoporous silica 
nanoparticles can be used for detection of small molecules and also for tracking cells. 
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Detection of analytes such as hydrogen peroxide often involve the use of enzymes.67 
However, enzymes are prone to denaturation and this limits their applications.52 
Mesoporous silica nanoparticles have a stable framework that is stable in presence of 
aqueous and organic solvents and it is therefore advantageous to use them.52 Additionally, 
the particles have a large surface area and pore size which can be used to immobilize large 
quantities of sensing molecules, improving the sensitivity of the system. Mesoporous 
silica materials are optically transparent and this enables detection of analytes through the 
layers of material.52 
 Lin et al. synthesised o-phthalic hemithioacetal functionalized mesoporous 
silica material as a detector for primary amines. In order to improve the selectivity of the 
system, various organic groups such as propyl, phenyl and pentafluorophenyl were 
introduced. In this way selectivity was achieved for dopamine, which has aromatic 
groups, over glycosamine which does not. Through this work a viable strategy was 
demonstrated for improving the selectivity of mesoporous silicas through non covalent 
interactions.68 A method to improve the selectivity of the system was demonstrated by 
installing gate keeper molecules at the pore openings. Polylactic acid was used as the 
gatekeeper (Figure 1.18). The aim of the study was to selectively identify the 
neurotransmitter dopamine in the presence of glutamic acid or tyrosine. The study was 
carried out under physiological conditions (pH 7.4). Under these conditions, the material 
has a negative surface charge due to the polylactic acid groups (pI < 3.0). Tyrosine and 
glutamic acid have isoelectric points below 7.4 and are therefore negatively charged under 
the experimental conditions. Thus the particles did not take up these compounds. 
However, dopamine which has an isolectric point of 9.7, acquires a positive charge a pH 
7.4 and is taken up by the particles and is selectively detected (Scheme 1.9).69 Yu et al. 
recently improved the specificity of this system by using o-pthalic hemithioacetal 
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modified cyclodextrin instead of polylactic acid. Cyclodextrin has a hydrophobic cavity 
and a hydrophilic rim. This system enabled the group to selectively identify dopamine 
with a detection limit of 50 nM in presence of physiological fluids.68 
 
 
Figure 18: TEM image of poly-lactic acid coated mesoporous silica nanoparticle based 
sensor. The outer layer (11 nm) indicates the poly lactic acid layer.68 
 
 
Scheme 1.9a: Synthesis of dopamine sensor based on poly-lactic acid functionalized 
mesoporous silica nanoparticles (RNH2 is dopamine).(Adapted from ref 68). 
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Scheme 1.9b: Mode of action of dopamine sensor 
 The principle of attaching functional groups that respond to specific stimuli 
can be extended to applications such as tracking specific cell organelles. Han et al. 
developed a dye based detection system that is sensitive to pH changes. Mesoporous silica 
nanoparticles with the dyes fluorescein and rhodamine 6G-lactam attached to their 
surface were synthesised. The dyes exhibited an increase in fluorescence intensity as a 
function of pH. Rhodamine 6G-lactam exhibited this under acidic conditions and 
fluorescein under basic conditions. By controlling the ratio of these dyes, the authors 
prepared a material that showed increased fluorescence intensity in the pH range of 3.5 
to 6.0, which is the pH range of the lysosomes. Cell studies revealed that the particles 
were readily internalized and accumulated in the lysosomes. When the lysosome pH was 
increased using bafilomycin A1, an ATP–H1 inhibitor, the fluorescence of the 
Rhodamine 6G-lactam was reduced.71 
 
1.3.3 Catalysis: 
 Organosilica nanoparticles can function as excellent catalysts in part because 
of their high surface area and porosity. In addition to these properties however, the 
particles can be functionalized by a variety of organic groups to improve the selectivity 
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and range of catalytic applications. Lin et al. provided one of the first examples of silica 
nanoparticles as catalysts with the catalyst 3-[2-(2-aminoethylamino)ethylamino]propyl 
(AEP) functionalized nanoparticles for nitradiol condensation (Scheme 1.10).60 The 
selectivity of the reaction was improved by attaching hydrophobic groups such as 
ureidopropyl (UDP), allyl (AL) or mercaptopropyl (MP) groups. 72 
 
 
Scheme 1.10: Nitradiol condensation by AEP functionalized silica 
nanoparticles.(Adapted from ref 71) 
 Similarly, alkylpyridinium group functionalized nanoparticles were used as 
highly efficient catalysts in several nucleophilic substitution reactions such as Baylis-
Hillman, acylation, and silylation.73 Mesoporous silica nanoparticles were also used to 
entrap metal nanoparticles such as magnetite and gold nanoparticles. Ge et al. developed 
a mesoporous silica nanoparticle system to immobilize gold and magnetite nanoparticles. 
Gold nanoparticles catalysed the hydrogenation of 4-nitrophenol by sodium borohydride 
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and magnetite nanoparticles helped separate the particles. The role of the porous silica 
matrix is to protect the metal and metal oxide nanoparticles and the pores in the silica 
matrix promote efficient catalysis.74 
 The particles can also be used to immobilize large quantities of enzymes 
such as lipase75, lactase76, and chymotrypsin.77 The studies showed that immobilization 
of the protein on these particles helped improve their stability against pH and temperature 
inactivation.76, 77 
 
1.4 Characterization of CMSNs 
In this section the analytical tools used for the characterisation of the materials, chemistry 
and biology described in this thesis are briefly described. 
1.4.1 Molecular spectroscopy: 
Molecular spectroscopy is based on the adsorption of energy by molecules and 
examining the response of the molecules to that adsorption of energy. Depending on the 
nature of the absorption energy this can result in specific changes in the molecule from 
the ground state E1 to an excited state E2. The difference in energy between these states 
E2 - E1 = ΔE. In infrared spectroscopy these energies correspond to two different 
vibrational states; in UV-Vis spectroscopy they correspond to two different electronic 
states and in NMR (nuclear magnetic resonance) spectroscopy they correspond to two 
different nuclear spin states.78 
Spectrometers are used to measure the absorption of electromagnetic radiation by 
the molecules. The simplest setup of a spectrometer consists of a radiation source, a 
sample chamber, an amplifier and a detector (Scheme 1.11). The frequency of the 
radiation is continuously varied and the changes in the intensity of the radiation as it 
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passes through the sample is measured. The relation between frequency and absorption is 
plotted and this is known as the spectrum. The interpretation of the spectrum provides 
structural information.78 
 
Scheme 1.11: Basic spectrophotometer design. 
1.4.1.1 Infrared spectroscopy: 
Infrared radiation has wavelengths between 10-4 to 10-6 m. The part of the 
spectrum that lies between 2.5×10-6 to 16×10-6 m is most used for structural 
determination. The most commonly used unit in IR is wave number (cm-1). The region 
between 2.5×10-6 to 16×10-6 m corresponds to wave numbers 4000 to 600 cm-1. When a 
molecule absorbs a photon from the infrared region, it excites the molecule from its 
ground vibrational state to a higher vibrational state. The vibrations include stretching 
and bending modes.78 IR vibrational regions for organic groups are given in Scheme 1.12. 
In addition to this, silica nanoparticles exhibit a characteristic peak between 900 – 1200 
cm-1 corresponding to silicon-oxygen stretching.79 Infrared spectroscopy can therefore be 
used for the identification of various organic groups on silica nanoparticles.80 In this work 
IR was used for compound characterisation. For example it was used to confirm the 
removal of the CTAB, which was determined by the disappearance of the characteristic 
ammonium peak at 2900 cm-1.33 In addition to this IR was also used to confirm the 
presence of protein adsorption on silica nanoparticles. This was determined by the 
presence of amide I and amide II peaks at 1400 and 1600 cm-1 respectively. 
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Scheme 1.12: IR frequencies of various organic groups. (Adapted from ref 81) 
 
1.4.1.2 UV-Vis spectroscopy: 
When white light is passed through a sample it absorbs a characteristic portion of 
the light and the transmitted light assumes the colour complementary to the wavelengths 
absorbed. In UV-Vis spectroscopy, light between the wavelengths of 200 to 800 nm is 
used. The energy of the radiation in the visible region (800 to 400 nm) ranges from 150 
to 300 kJ/mol, while the energy of the UV radiation (400 to 200 nm) ranges from 300 to 
600 kJ/mol. When molecules are irradiated with this radiation they undergo a change in 
their electronic structure. This occurs because absorption of energy by a ground state 
molecular orbital electron promotes it to a higher energy molecular orbital. Molecules 
absorb radiation that has the energy to match a possible electronic transfer within the 
molecule. A UV-Vis spectrophotometer records the wavelengths at which the absorption 
occurs. The absorbance by the sample is proportional to the number of molecules present. 
Therefore, UV-Vis spectroscopy can be used to calculate the concentration of various 
organic molecules that absorb within this region.82 In this work it was primarily used to 
measure the protein uptake by silica nanoparticles.  
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1.4.1.3 Solid State NMR 
Subatomic particles such as protons, neutrons and electrons can be imagined as 
spinning on an axis. The spin of these particles exists in two states 1/2 or - 
1/2  In the nuclei 
the spins of the nucleons are paired with each other. Therefore when even numbers of 
protons and neutrons are present the overall nuclear spin I is zero. When and the number 
of neutrons plus the number of protons is odd then the nuclei have an overall half integer 
spin (1/2, 
3/2, 
5/2) etc. and when odd number protons and odd number neutrons are present, 
it results in integer spin (1, 2, 3 etc.). A spinning charged particle produces a magnetic 
field. Nuclei possessing an overall spin have 2l+1 orientations. In the absence of a 
magnetic field the magnetic nuclei have random orientation. However, in the presence of 
a magnetic field, the nuclei orient either parallel or anti-parallel to the magnetic field. The 
nuclei that are oriented parallel to the magnetic field have a slightly lower energy than 
the nuclei that have an anti-parallel orientation. Therefore, the nuclei with parallel 
orientation have a slightly greater number. When the oriented nuclei are irradiated with 
electromagnetic radiation of specific frequency, energy absorption occurs and the “spin-
flips”. The magnetic nuclei are then said to be in resonance with the applied radiation. 
The energies of the radiation applied to the magnetized samples is quite small (about 
2.4×10-5 kJ/mol), and corresponds to the radio frequency.83, 84 
The magnetic field experienced by the nucleus depends on the location of the 
nucleus within the molecule. This is because, every nucleus is surrounded by electrons 
and the electrons shield the nuclei from the magnetic field, thus the spatial proximity of 
two nuclei changes their interactions with the external magnetic field, the interactions are 
also dependent on the orientation of the molecules. Thus, NMR provides a “map” of the 
nuclei of interest.83 When NMR is carried out on a liquid where the molecules undergo 
Brownian motion, this averages out anisotropic interactions.85 However, NMR carried 
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out on solids display very broad peaks due to these anisotropic interactions. The 
anisotropic interactions can be suppressed by spinning the solid sample oriented at 54.74°, 
also known as “magic angle”. Thus, it is possible to obtain NMR spectra of solid 
samples.86  
In this work we used solid state 29Si and 31P NMR to determine the organic group 
loading and surface coverage of organic molecules. 29Si is the only naturally occurring 
magnetic isotope of silicon.86 It has a natural abundance of 4.7%, a spin of 1/2 and a 
magnetic moment of -0.5548 (Nm/T). Inorganic silica species show peaks 
(Quadrafunctional Si(OR)4, Q sites ) between -110 and -90 ppm, while organosilica 
species show peaks (Trifunctional RSi(OR)3, T ) between -68 and – 58 ppm.88 The 
resonances of the silicon atoms bonded to organic groups may be split due to coupling 
with protons but this is prevented by performing decoupling.87,89 For quantitative analysis 
DPMAS (Direct Polarization Magic Angle Spin) spectra were acquired.88 Phosphorus 
NMR was also obtained to demonstrate the presence of phosphorus in the particles. 31P 
has a low gyromagnetic ratio (108.291), compared to 1H (267.513), which results in a 
smaller signal. In order to enhance the signal CPMAS (Cross Polarized Magic Angle 
Spin) was performed. In this process the signal is enhanced by magnetization transfer 
from protons. Use of CPMAS, however can result in different signals no longer having 
quantitative intensity relationships.90 
 
1.4.1.4 Circular Dichroism 
Samples containing chiral chromophore molecules absorb either right polarized 
light (RCP) or left polarized light (LCP). Circular dichroism (CD) is the difference in the 
absorbance of the (LCP) light and absorbance of (RCP). Far-UV circular dichroism 
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corresponds to the peptide bond absorption and it provides useful information about the 
secondary structure of proteins. The secondary structure of proteins consists of three 
conformations; α-helix, β-sheet and open chain. When a protein is denatured, its α-helices 
are converted into β-sheet and open chain structures. CD provides an estimate of these 
conformations.91  
The CD spectrometer consists of a light source which produces unpolarised light. 
The unpolarised light is converted into linear polarized light by a monochromator. The 
linear polarized light is converted into circular polarized light by a photoelastic modulator 
(PEM). CD spectra of the sample is obtained because there is some switching of the 
polarization of the light incident on the sample. Circular dichroism is measured by 
calculating the difference in absorption of LCP or RCP (Scheme 7).92 In this work circular 
dichroism was used to determine whether denaturing of BSA had occurred following 
adsorption to phosphonate silica nanoparticles. 
 
Scheme 1.13: Schematic representation of circular dichroism 
 
1.4.2 Thermogravimetric Analysis 
Thermogravimetric analysis (TGA) is a technique that measures the sample 
weight loss or gain as a function of the temperature. It provides information about the 
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various organic groups present in a sample. Weight loss or gain can occur due to 
decomposition, oxidation, reduction, dehydration or vaporization of the sample. TGA 
consists of a sample pan loaded onto a precision balance. This setup is placed in a furnace 
and the temperature of the sample is raised at a controlled rate. The balance records the 
changes in the sample mass as a function of temperature. The sample environment can be 
changed by changing the sample purge gas.93 In this work TGA was used to assess 
stability of phosphonate functionalized nanoparticles. 
 
1.4.3 Electron Microscopy 
The general principle of microscopy involves magnification of small objects by using 
lenses. In an electron microscope, electrons are used instead of light waves and the 
electrons are focussed onto the surface of an object by using magnetic lenses. There are 
two main methods of electron microscopy 
1. Scanning Electron Microscope (SEM) 
2. Transmission Electron Microscope (TEM) 
1.4.3.1 Scanning Electron Microscope (SEM) 
The SEM is an excellent tool for imaging nanoparticle surfaces. The SEM consists 
of an electron source, which is usually a tungsten filament. The electrons produced from 
the source are focussed on the sample through the condenser, which controls the size of 
the beam and the objective lens, which focuses the beam. When the electrons strike the 
surface of the sample, they collide with the atoms on the surface and produce secondary 
electrons. These are low energy electrons and they are passed through a detector, the 
detector has a positive potential and it therefore attracts the secondary electrons. The data 
from these electrons is then passed to a scan generator, which produces the final image 
(Scheme 1.14). SEM produces images that have light and dark regions and it is therefore 
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useful in studying the topology of the sample. SEM needs conductive samples, non-
conductive samples like silica nanoparticles are usually coated with gold before imaging 
them.94 In this work SEM was used to measure the particle size, to study the elemental 
composition using EDX (energy dispersive X-ray spectroscopy) and to study the particle 
morphology. 
 
Scheme 1.14: Scanning Electron Microscope (Adapted from ref 94) 
1.4.3.2 Transmission electron Microscope (TEM) 
In a TEM the electrons pass through the sample. It is therefore useful for imaging 
the internal features of the particles such as pore channels. The sample to be used for 
imaging is deposited on a thin electron grid, which is either made of copper or electron 
transparent plastic. The sample thickness must be less than 500 nm to image the sample. 
The electron beams pass through the sample. The electrons that strike the specimen are 
scattered, while the unscattered electrons pass through the sample and hit a phosphor 
screen, which results in image production (Scheme 1.15).95 In this study TEM was used 
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to study the particle morphology and also to study the uptake of nanoparticles by HeLa 
cells. 
 
Scheme 1.15: Transmission Electron Microscope (Adapted from ref 95) 
1.4.4 Dynamic Light Scattering (DLS) 
Dynamic light scattering is used for measuring the particle size of nanoparticles 
dispersed in a solvent. DLS determines the hydrodynamic radius of the particles. The 
value of the hydrodynamic radius depends on the solvent used. For example, the ionic 
strength of the media affects the hydrodynamic radii of the particles. DLS can also be 
used to monitor the stability of the particles in the dispersion media.56 The general 
principle of DLS is as follows. Dispersed nanoparticles scatter light. This results in the 
formation of a speckle pattern. A speckle pattern consists of bright and dark spots. The 
bright spots are the regions where the light undergoes constructive interference and the 
dark spots are regions where light undergoes destructive interference. A DLS instrument 
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contains a device known as photon correlator, which measures the changes in this pattern.  
The parameter Γ, is measured during the experiment according to the following formula.  
Γ = Dq2 
D = translational diffusion coefficient 
𝑞 = (4𝜋𝑛)𝜆𝑜 sin (
𝜃
2
)-----Equation 2 
Where n = refractive index of the medium 
λo = Wavelength of the laser 
θ = scattering angle 
Different measurements of Γ are performed at different scattering angles and the 
final particle size (hydrodynamic radius) RH is calculated (Equation 3)
96 In this study DLS 
was used to determine the hydrodynamic radius of the particles and to determine the 
stability of particle dispersions. 
𝑅𝐻 = 𝑘𝑇
2𝑞2/3𝜋𝜂𝐷-----Equation 3 
Where η = viscosity of the medium and T = temperature. 
 
1.4.5 Porosimetry  
Nitrogen adsorption porosimetry is used to measure the surface area and pore size 
of nanoparticles. The sample is degassed under vacuum to remove any surface 
contamination and exposed to nitrogen at cryogenic temperatures. In practice the sample 
is inserted into liquid nitrogen and known aliquots of nitrogen are introduced. The 
quantity adsorbed and equilibrium pressure is measured. Desorption of the adsorbed 
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nitrogen gas is then measured in similar sequential steps. The result gives nitrogen 
adsorption-desorption isotherms for the material. The data from the isotherm can be used 
to measure the surface area according to BET theory and pore size using BJH theory.97 
1.4.5.1 Surface area: 
BET theory was proposed by Braunner, Emmett and Teller to determine the 
surface areas of solids. The surface area measurements are performed between relative 
pressures of 0.05 and 0.3. First, the volume of the monolayer of the gas adsorbed on the 
particle surface is determined using the equation 4.98 
1
𝑣(𝑝𝑜−𝑝)
=
1
𝑣𝑚𝑐
+
(𝑐−1)𝑝
𝑣𝑚𝑐𝑝𝑜
-----Equation 4 
Where v = volume adsorbed 
vm = volume of monolayer 
p = equilibrium pressure above the sample after adsorption  
po = saturation pressure 
c = constant related to enthalpy of adsorption 
The specific surface area of the sample is determined using Equation 5 
𝑆𝐵𝐸𝑇 =  𝑣𝑚𝑛𝑎𝑎𝑚/𝑚𝑣𝑙---Equation 5 
na = Avogadro’s constant 
am = cross sectional area occupied by nitrogen molecule (0.162 nm
2) 
vl = molar volume of nitrogen (22414 cm
3) 
m = mass of the sample.98 
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1.4.5.2 BJH pore size 
Depending on the pore size, pores are classified into 
1. Micropore : Pore size less than 2 nm 
2. Mesopores : Pore size between 2 to 50 nm. 
3. Macropores : Pore size greater than 50 nm.99 
The pore radius is determined from the Kelvin equation (Equation 6). The BJH model 
assumes that the pores have a cylindrical shape. 
ln (
𝑝
𝑝𝑜
) = (−
2𝛾𝑉𝐿
𝑟𝑅𝑇
) 𝑐𝑜𝑠𝜃 
p = equilibrium vapour pressure 
po = saturation pressure 
γ = surface tension of the liquid 
R = gas constant 
r = pore radius 
θ = contact angle 
VL = molar volume of the liquid.
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1.5 Aims of work in this Thesis 
Reports in the literature discussed above on OCMSNs pointed to the advantages 
in terms of dispersability and drug vehicle efficiency that organofunctionalisation could 
confer of these systems.  However there remained great scope for improvement of these 
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properties as well as a need for better particle size uniformity and access to larger pore 
particles. As mentioned earlier, nanoparticles for drug delivery applications should 
possess five characteristics. a) small size (below 200 nm), stable, biocompatible 
composition and excellent dispersion properties that would allow the particles to remain 
dispersed in the blood stream; b) ability to host a variety of guest molecules like drugs, 
proteins; DNA etc.; c) zero premature release; d) the ability to accommodate different 
functionalities that would allow it to target specific receptors and finally, e) controlled 
release at the target site. The Sullivan group had developed considerable expertise with 
bulk phosphonate silica systems101, 102 and a few reports on phosphonate silica 
nanoparticles had appeared in the literature.103 The phosphonate group is a biocompatible 
entity and we set out to explore the possibility of developing large pore phosphonatesilica 
nanoparticles drug delivery systems for large biomolecule immobilisation and delivery, 
which would potentially meet the above requirements. 
Considering previous reported work it was decided that a base catalysed low 
surfactant route would be used to synthesize nanoparticles of suitable dimensions (sub 
200 nm diameter) and large pore size. The study would entail determining the influence 
of various reaction conditions such as the effects of base, surfactant, co-solvent 
concentration on the particle morphology. These results would be used elucidate the 
mechanism of the particle formation.  
A particular objective was to develop nanoparticles with capacity to act as 
vehicles for large biomolecules like proteins since earlier reported variants were restricted 
to smaller drug molecules owing to smaller pore sizes. To suitably challenge the ability 
of the particles to adsorb protein molecules, bovine serum albumin (BSA, mol wt. 66kD) 
would be used as the model protein. The properties of the protein-particle composites, 
such as protein load, dispersion stability, hydrodynamic radius, variation of particle 
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morphology and secondary structure of the adsorbed proteins would be studied. Also, the 
stability of the protein-particle composites would be studied to determine its usefulness 
as a drug delivery platform. 
With drug delivery vehicle applications in mind the study would also include cell 
work to establish potential cell internalisation and effects on cell viability. Studies would 
involve determining the cytotoxicity of the particles, understanding the rate of particle 
uptake and the mechanism of the particle uptake. 
The scope of the protein-particle composites to act as enzyme immobilizing 
agents would be studied. For this application, an industrially relevant enzyme, lipase 
would be used. The study would involve determining the enzyme kinetics and studying 
the ability of the particles to protect the immobilized enzyme from denaturation. Finally, 
the bulk phosphonatsilica system is also well known in the area of heterogeneous catalysis 
and it was of interest to explore potential of the nanoparticle format in this context as well 
with a selection of test reactions. 
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Chapter 2: Phosphonate functionalized silica 
nanoparticles 
 
Some of the results from this chapter have been published in:  Sai Prakash Maddala , 
Diana Velluto, Zofia Luklinska and Alice C. Sullivan, “Large Pore Raspberry Textured 
Phosphonate@Silica Nanoparticles for Protein Immobilization” J. Mater. Chem. B, 2014, 
2, 903–914. 
 
2.1 Summary 
In this chapter work leading to the synthesis of new large pore (11 to 18 nm) raspberry 
textured organosilica nanoparticles is discussed. The particles were functionalized using 
the organosilane (MeO)3SiCH2CH2PO(OMe)2, 
(dimethylphosphonatoethyltrimethoxysilane, DMPTMS). The particle synthesis was 
performed under base catalysed–low surfactant conditions. Raspberry textured silica 
nanoparticle formation took place under specific reaction conditions including 
temperature, pH, co-solvent (ethanol) concentration and DMPTMS concentration. The 
effect of these components on the particle morphology was studied. The particles were 
characterized by scanning and transmission electron microscopy (SEM and TEM), 
dynamic light scattering (DLS), zeta potential, 29Si and 31P solid state MAS NMR, 
thermogravimetric analysis (TGA) and infrared spectroscopy (IR). The results and 
discussion are presented in separate sections.  
2.2 Background 
Large pore silica nanoparticles (pore size > 5 nm) were demonstrated to have great 
potential for immobilization of large biomolecules such as proteins1 and DNA.2, 3 
However, almost all the major studies involving the synthesis of large pore silica 
nanoparticles to date have involved unfunctionalized silica nanoparticles. Furthermore, 
the applications of these particles are restricted due to the absence of organosilane 
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functionalization. Some of the previously published papers reported on grafting of 
organosilane groups after the particle synthesis.2,3 This method however, resulted in 
uneven distribution of the organic groups on the silica surface (for reasons outlined in 
Chapter 1). In order to improve the organic group distribution on the particle surface and 
thereby improve its interactions with biomolecules, particle synthesis by co-condensation 
was shown to be a better approach.4  
In this chapter a study leading to large pore organosilica nanoparticles through co-
condensation of the silane precursors TEOS and DMPTMS under a base catalysed – low 
surfactant process is described. The organosilane acted both as a surface modifier and 
structure directing agent.5 The final particle morphology was found to have resulted from 
a specific combination of reaction conditions. The organophosphonate functional group 
was chosen in part due to its excellent biocompatibility.6a It had been used by others as a 
precursor (diethylphosphonatoethyl triethoxysilane, DEPTES) for silica materials for 
various applications such as proton conducting6b, metal immobilization6c applications. 
Phosphonates have also been used to surface modify silica nanoparticles to improve their 
dispersion stability.6c,6d The group is an excellent hydrogen bond acceptor and this would 
in principle allow it to interact with a wide range of biomolecules.7 
2.3 Experimental 
2.3.1 Materials  
Cetyltrimethylammonium bromide (CTAB, 95%), dimethylphosphite (DMP, 98%), 
diethylphosphite (DEP, 98%) vinyltrimethoxysilane (VTMS, 98%), vinyltriethoxysilane 
(VTES, 98%) and di-t-butyl peroxide (DTB, 98%) were purchased from Sigma Aldrich 
and used as received. TEOS was purchased from Sigma Aldrich, distilled and dried over 
3Å molecular sieves. DEPTES was prepared as previously described.8 NaOH pellets, 
ethanol and HCl (35% w/w) was purchased from VWR and used without further 
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purification. The particle synthesis was carried out in deionized water dispensed from an 
18 mΩ Millipore system supplied by Elba UK. 
Code-names given to phosphonate silica nanoparticles synthesized in this work and 
explanations of these names are listed below. 
CP_PME(1.6) Colloidal (silica) particles functionalized with phosphonate 
monoester, 
~CH2CH2P(OMe)OH loading at 1.6 mmolg
-1. 
RNP_PME(2.5) Raspberry textured nanoparticles functionalized with phosphonate 
monoester ~CH2CH2P(OMe)OH loading at 2.5 mmolg
-1. 
NP_PME(1.0) Phosphonate monoester ~CH2CH2P(OMe)OH functionalized 
nanoparticles loading at 1.0 mmolg-1. 
NP_PME(0.2) Phosphonate monoester ~CH2CH2P(OMe)OH functionalized 
nanoparticles loading at 0.2 mmolg-1. 
NP_PEE(2.1) Phosphonate monoethylester ~CH2CH2P(OEt)OH functionalized 
nanoparticles loading at 2.1 mmolg-1 
 
2.3.2 Synthesis of DMPTMS 
A 500 mL round bottom flask was charged with a 25 mm stirrer bar and kept 
under nitrogen atmosphere. To this flask DMP (53.9 g, 0.49 mol) and DTB (7.30 g, 0.05 
mol) were added under N2 atmosphere. The flask was heated to 130 °C while stirring 
constantly at 600 rpm. Once the temperature stabilized the addition funnel was charged 
with VTMS (59.2 g, 0.40 mol), which was added dropwise into the reaction vessel for the 
next three hours. After further 2 hours, 1 mL of DTB was added dropwise and the reaction 
was monitored for the next 12 hours using 1H NMR by periodically taking samples. The 
reaction was stopped after the complete disappearance of vinyl peaks. At the end of the 
reaction the crude was distilled to remove unreacted DMP and DTB. The colourless liquid 
obtained after distillation was further distilled under vacuum to give pure DMPTMS 
(60%, b. p. 130-140 °C/10 mm Hg).  
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1H NMR (400 MHz, CDCl3, δ) 0.77–0.86 (2H, bm, CH2Si), 1.69-1.75 (2H, bm, CH2P), 
3.50 (9H, s, SiOCH3), 3.66 (6H, d, POCH3, 
3JP, H= 8 Hz).  
31P NMR (161.9 MHz, CDCl3, δ) 35.6 
 
2.3.3 Synthesis of CP_PME(1.6)  
The molar ratio of reagents used in this formulation (Formulation 1) with respect 
to TEOS was: CTAB(0.19): TEOS(1.00): (DMPTMS(0.61): NaOH(0.52): EtOH(7.74): 
Water(1961). A 250 mL round bottom flask was charged with a 12 mm stirrer bar and 
100 mL of deionized water. To this CTAB (0.2 g, 0.55 mmol) and 2M NaOH (0.73 mL, 
1.46 mmol) were added and the flask was stirred at 1100 rpm. When CTAB completely 
dissolved, the resultant clear solution was heated to 80 °C while maintaining the stirring 
rate. Meanwhile TEOS (0.59 g, 2.83 mmol) and DMPTMS (0.45 g, 1.74 mmol) were 
weighed in a vial and dissolved in ethanol (1.01 g, 21.9 mmol). This solution was added 
dropwise to the round bottom flask containing the micellar solution (once the temperature 
stabilized) using a syringe while stirring continuously. Following the addition of the 
silane precursors the reaction mixture first turned cloudy and after around 10 to 15 
minutes a white precipitate started to settle at the bottom of the flask. The reaction was 
carried out overnight. The white solid was then filtered, washed with ethanol and dried. 
A 100 mL round bottom flask was charged with a stirrer bar, the dried powder (0.35 g) 
from the first step and 2 g of ammonium nitrate. To this mixture 50 mL of ethanol was 
added and the mixture was heated under reflux to 90 °C under constant stirring overnight. 
The reaction mixture was then cooled and the particles were filtered by Buchner filtration 
and washed with water and ethanol and dried (0.25 g, 38.9%). IR spectroscopy was 
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performed on the dried powder to determine the complete removal of the surfactant. 
Details of the characterization are provided in section 2.3.6.  
 
2.3.4 Variations of reaction parameters on the particle morphology: 
In order to study the effects of the temperature and reagents on the particle 
morphology, the reaction temperature and the mole ratio of the reagents used in 
Formulation 1 as described in the above procedure was varied as tabulated for each 
parameter changed below. Results are given and discussed in sections 2.4 and 2.5. 
Sample Name Temperature CTAB:TEOS 
mole ratio 
Ethanol:TEOS 
mole ratio 
NaOH:TEOS 
mole ratio 
CP_PME(1.6)a 80°C 0.19 7.74 0.52 
CP_PME(1.6)_60 60°C    
CP_PME(1.6)_40 40°C    
CP_PME(1.6)_20 20°C    
CP_PME(1.6)_0.00CTAB  0.00   
CP_PME(1.6)_0.05CTAB  0.05   
CP_PME(1.6)_0.10CTAB  0.10   
CP_PME(1.6)_0.00EtOH   0.00  
CP_PME(1.6)_2.12EtOH   2.12  
CP_PME(1.6)_11.0EtOH   11.0  
CP_PME(1.6)_0.00NaOH    0.00 
CP_PME(1.6)_0.17NaOH    0.17 
RNP_PME(2.5)    0.34 
a These conditions apply except where indicated. 
 
Raspberry textured nanoparticles (RNP_PME(2.5)) were obtained when the NaOH mole 
ratio was reduced to 0.34. The formulation used to prepare RNP_PME(2.5) was denoted 
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as Formulation 2: CTAB(0.19): TEOS(1.0): (DMPTMS(0.61): NaOH(0.34): 
EtOH(7.74): Water(1961). 
2.3.5 Variation of Formulation 2 
Formulation 2 was further varied in terms of temperature and mole ratio of 
reagents other than base as tabulated below. Results are given and discussed in sections 
2.4 and 2.5. 
Sample Name Temperature CTAB:TEOS 
mole ratio 
Ethanol:TEOS 
mole ratio 
DMPTMS:TEOS 
mole ratio 
RNP_PME(2.5)a 80°C 0.19 7.74 0.34 
RNP_PME(2.5)_60 60°C    
RNP_PME(2.5)_40 40°C    
RNP_PME(2.5)_20 20°C    
RNP_PME(2.5)_0.00CTAB  0.00   
RNP_PME(2.5)_0.05CTAB  0.05   
RNP_PME(2.5)_0.10CTAB  0.10   
RNP_PME(2.5)_0.00EtOH   0.00  
RNP_PME(2.5)_2.12EtOH   2.12  
RNP_PME(2.5)_11.0EtOH   11.0  
NP_PME(0.0)    0.00 
NP_PME(0.2)    0.10 
NP_PME(1.0)    0.20 
a These conditions apply except where indicated. 
DMPTMS in Formulation 2 was replaced with DEPTES and the reaction was 
carried out under the conditions described in the preparation of RNP_PME(2.5) to 
produce NP_PEE(2.1). 
2.3.6 Characterization: 
Solid state spectra were obtained using a Bruker AMX 600MHz instrument: 29Si 
HPDec MAS, frequency 119.2 MHz, spinning speed 12 kHz; 1 minute recycle delay, with 
2 s ~ 45 pulse; 31P CPMAS; frequency 242.9 MHz, spinning speed 12 kHz, 1 ms contact 
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time, 1.5 s delay, 90 pulse for 2.0 s. IR spectra were recorded on a Bruker-FTIR 
spectrophotometer with an ATR accessory containing ZnSe crystal. 16 scans between 600 
-4000 cm-1 were performed for each sample. The hydrodynamic radius, RH of the particles 
was measured on a Malvern Zetasizer Nano ZS instrument equipped with a 633 nm laser. 
For analysis 1 mg/mL particle dispersion in a glass cuvette was prepared by sonication 
for (15 min) in PBS (10 mM) with pH adjusted to 4.73 or 7.4 using 1 M HCl and 2 M 
NaOH a 5 mm ultrasonic probe was used for sonication of the sample. Stock dispersions 
of the particles were prepared by dispersing 20 mg of particles in 10 mL of PBS and the 
height of liquid was kept constant at 80 mm, the inner radius of the tube was 15 mm. 
Sonication was carried out at 65% amplitude. TEM (Transmission Electron Microscope) 
images were obtained using a JEM JEOL 2010 TEM operating at 200 kV. Samples were 
prepared by dipping carbon coated TEM grids (Agar Scientific) into the particle 
dispersions. SEM (Scanning Electron Microscope) images were obtained from gold 
coated samples, using an FEI 100 instrument (Oxford Instruments) operating at 20 kV; 
spot size of 10 nm was used for the analysis. The surface area of the particles was 
measured at 77 K using a Quantachrome NOVA 1200e nitrogen adsorption porosimeter. 
The surface area was obtained using the Brunauer-Emmett-Teller (BET) method and the 
pore size distribution and pore volume were obtained using the Barrett-Joyner-Halenda 
(BJH) method. TGA (thermogravimetric analysis) was performed on TA Instruments 
Q500 thermogravimetric analyser; the measurement was performed under a flow of air 
(60 mL/min) between room temperature and 750 °C at scan rate 10 °C/min. 
2.4. Results  
2.4.1 DMPTMS synthesis 
DMPTMS was synthesized by a free radical addition reaction in the manner 
previously described for DEPTES.8 Di-tertbutylperoxide (DTB) was used as the initiator. 
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DTB undergoes homolysis above 120 °C.9 The resulting free radicals help initiate the 
reaction. The reaction was followed by observing the consumption of VTMS using proton 
NMR. The product was isolated by distillation under reduced pressure. The reaction 
scheme is as follows (Scheme 2.1): 
Scheme 2.1: DMPTMS synthesis 
2.4.2 Nanoparticle Synthesis 
The aim of the study was to synthesize large pore phosphonatesilica nanoparticles 
for drug delivery applications. The particle synthesis was carried out at low surfactant 
concentrations, using a method that was previously reported to synthesize pure silica 
nanoparticles.10 TEOS and DMPTMS were used as silica and organic modifier sources, 
CTAB was used as the surfactant template, NaOH (2M) as the base and ethanol as the co-
solvent. The initial ratio of the reagents with respect to TEOS was CTAB(0.19): 
TEOS(1.00): (DMPTMS(0.61): NaOH(0.52): EtOH(7.74): Water(1961). This 
formulation was denoted as Formulation 1.  
Particle synthesis took place through the base catalysed hydrolysis and co-
condensation of the silane monomers (TEOS and DMPTMS) while CTAB acted as a 
template to guide the particle formation. Under the basic conditions of the reaction the 
phosphonate diester component ~PO(OMe)2 was partially hydrolysed to the monoester 
form ~PO(OMe)(ONa) and converted to the monoacid form ~PO(OMe)(OH) after 
surfactant removal (Scheme 2.2). 
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Scheme 2.2: Phosphonate monoester (PME) functionalized silica particle synthesis 
The surfactant was removed by refluxing the particles in ethanolic ammonium 
nitrate solution.11 The removal of the surfactant was confirmed by the disappearance of 
the characteristic ammonium ion peak.12 The composition of the particles and the 
presence of phosphorus was verified by 1H and 31P NMR after dissolving a small amount 
(10 mg) of the surfactant-free particles in NaOD/D2O solution (See appendix 1 for 
spectra). The total loading of phosphonate was determined by 29Si solid state NMR using 
fractional signal intensity (see below) and the particles were denoted as CP_PME(1.6) 
(with 1.6 mmol/g phosphonate loading) (Figure 2.1). 
2.4.3 29Si and 31P solid state NMR for CP_PME(1.6) 
The phosphonate loading and the surface coverage was determined by 29Si MAS 
NMR. The spectrum revealed T2, T3, Q2 and Q3 peaks (Figure 3) with terms T and Q as 
defined in Chapter 1.5 The surface coverage of the particle was determined using the 
formula ((T2+ T3)/(Q2 +Q3+ T2+ T3)).5 The surface coverage was used to calculate the 
number of phosphonate groups per nm2 of the particle surface. The 31P CPMAS NMR of 
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the particles revealed that the particles had the monoester group (Figure 2.1).13 A 
summary of the NMR data for CP_PME(1.6) is given in Table 2.1. 
 
Figure 2.1: CP_PME(1.6) A) 29Si MAS NMR B) 31P CP-MAS NMR. 
 
Table 2.1: Solid state 29Si and 31P NMR results of CP_PME(1.6) with deconvolution. 
Property CP_PME(1.6) 
P : Si ratio1 0.12 
29Si T2, T3, Q3, Q4 
((%) T2, T3, Q3, Q4) 
-58.4,-63.8,-97.8,-107.0 
(4, 8, 39, 49) 
% Condensation in T, Q sites 88,89 
(%)T of surface coverage* 23 
31P 34.5 
Number of Phosphonate groups/nm2 0.29 
* (T2+ T3/ Q2 +Q3+ T2+ T3)5  
2.4.4 CP_PME(1.6) Morphology 
SEM and TEM analysis of the particles revealed that CP_PME(1.6) had nearly 
spherical shape and demonstrated a polydisperse particle size distribution (between 170 
and 330 nm). The TEM image of the particles (Figure 2.2) also showed that some of the 
particles were fused together. The particles had a rough surface and were otherwise 
featureless. The surface analysis of the particles was performed using nitrogen adsorption 
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porosimetry (Figure 2.3). The particles had a high surface area of 765 m2/g but were 
essentially non-porous. A summary of the particle morphology is given in Table 2.2. 
 
Figure 2.2: A) SEM (Scale 1000 nm) and B) TEM (Scale 100 nm) images of 
CP_PME(1.6).  
 
Figure 2.3: Nitrogen adsorption-desorption isotherm of CP_PME(1.6) 
 
Table 2.2: Morphological properties of CP_PME(1.6) 
Property CP_PME(1.6) 
Particle shape Spherical 
Particle size distribution 170 – 330 nm 
Surface area 765 m2/g 
Pore volume 0.05l mL/g 
Pore size microporous (< 2 nm) 
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In order to fine-tune the particle morphology, specifically to identify conditions to 
increase porosity and decrease particle size distribution, the effect of each component in 
the formulation was studied. The reaction parameters were varied as follows: 
1. Effect of temperature 
2. Effect of surfactant 
3. Effect of ethanol 
4. Effect of NaOH 
 
2.4.5 Effect of temperature  
Reduction in temperature had a significant effect on the particle morphology 
wherein the average particle size increased while the particle surface became smoother 
(Figure 2.4). When the particle synthesis was attempted at 20 °C only fused particles were 
obtained. A summary of the particle morphology observed is given in Table 2.3 
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Figure 2.4: SEM after changing temperature with Formulation 1 to A) 20 B) 40 C) 60 
°C (Scale 1000 nm) 
 
Table 2.3: Summary of morphological properties after changing temperature in 
Formulation 1 
Sample Morphology 
CP_PME(1.6)* Spherical particles 
CP_PME(1.6)_60 Spherical particles 
CP_PME(1.6)_40 Large spherical 
particles 
CP_PME(1.6)_20 Fused particles 
*Temperature of synthesis 80 °C 
2.4.6 Effect of CTAB 
The presence of the surfactant was found to be essential for particle synthesis. 
When the particle synthesis was carried out in the absence of surfactant, particle 
formation was not observed. When the mole ratio CTAB: TEOS was increased to 
0.05:1.00, amorphous silica and a few particles in sub-micron size range were observed 
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(Figure 2.5). Further increase in the surfactant concentration (mole ratio CTAB: TEOS 
0.10: 1.00) resulted in a greater proportion of particles relative to amorphous silica and 
also a reduction in particle size. A summary of the particle properties is given in Table 
2.4. 
 
Figure 2.5: SEM after changing surfactant mole ratio in Formulation 1 to A) 0.05; B) 
0.1 (Scale 1000 nm) 
 
Table 2.4: Summary of morphological properties after changing surfactant mole ratio in 
Formulation 1 
Sample Morphology 
CP_PME(1.6)* Spherical particles 
CP_PME(1.6)_0.00CTAB No particles observed 
CP_PME(1.6)_0.05CTAB Mostly amorphous silica and a few large particles 
CP_PME(1.6)_0.1CTAB Mostly large particles and some amorphous silica 
 
* CTAB mole ratio 0.19 
2.4.7 Effect of ethanol 
Ethanol was used as a co-solvent in this reaction. Variation in ethanol 
concentration resulted in changes in the particle size. When the particle synthesis was 
carried out in the absence of ethanol, the resultant particles showed monodisperse particle 
size distribution (Figure 2.6). Ethanol, however had no effect on porosity as the above 
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system was non-porous. Increase in ethanol concentration resulted in an increase in the 
polydispersity of the particles. Particles produced at ethanol: TEOS mole ratio of 11 had 
a size distribution of 50 to 200 nm (Figure 2.6). A summary of the particle properties is 
given in Table 2.5. 
 
Figure 2.6: SEM after changing ethanol mole ratio in Formulation 1 to A) 0; B) 2.12; C) 
11 (Scale 1000 nm) 
 
Table 2.5: Summary of morphological properties after changing ethanol mole ratio in 
Formulation 1 
Sample Morphology 
CP_PME(1.6)* Spherical particles 
CP_PME(1.6)_0.00EtOH Monodisperse spherical particles 
CP_PME(1.6)_2.12EtOH Spherical particles 
CP_PME(1.6)_11.0EtOH Polydisperse spherical particles 
*EtOH mole ratio 7.74 
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2.4.8 Effect of base 
The hydrolysis and condensation of the silane precursors is catalysed by base. In 
the absence of the base, particle formation wasn’t observed. When NaOH: TEOS mole 
ratio was increased to 0.17 (Figure 2.7), aggregates of 10 nm particles were observed. 
Further increase to 0.34 lead to the formation of raspberry textured particles. These 
particles (denoted RNP_PME(2.5)) showed an extremely monodisperse particle size 
distribution (70 to 90 nm). SEM analysis revealed that the particles were composed of 
aggregated smaller 5 to 10 nm particles. A summary of the particle properties is given in 
Table 2.6. 
 
Figure 2.7: SEM after changing base mole ratio in Formulation 1 to A) 0.17 (Scale 500 
nm); B) 0.34 (Scale 1000 nm) 
 
Table 2.6: Summary of morphological properties after changing ethanol mole ratio in 
Formulation 1 
Sample Morphology 
CP_PME(1.6)* Spherical particles 
CP_PME(1.6)_0.00NaOH No particle formation 
CP_PME(1.6)_0.17NaOH Fused 10 nm particles 
RNP_PME(2.5)** Raspberry textured monodisperse 
particles 
mole ratio of base *0.52 **0.34  
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2.4.9 RNP_PME(2.5) 
The formulation used to produce RNP_PME(2.5) nanoparticles was CTAB(0.19): 
TEOS(1.00): DMPTMS(0.61): NaOH(0.34): EtOH(7.74)Water(1961) and it was denoted 
Formulation 2. 29Si NMR RNP_PME(2.5) (Figure 2.8) showed degree of phosphonate 
loading (2.5 mmol/g) compared to CP_PME(1.6). Deconvolution of the spectrum 
revealed that while the overall degree of condensation was similar to CP_PME(1.6) 
(Table 2.7), the surface coverage of RNP_PME(2.5) was greater. Further confirmation of 
the presence of the organic groups was obtained by thermogravimetric analysis (TGA). 
The particles showed > 2% weight loss below 150 °C, which corresponded to surface 
adsorbed water molecules, a 16% weight loss was observed between 175 and 375 °C that 
corresponded to the loss of organic groups. The weight loss above 375 °C corresponded 
to the loss of phosphonate groups from the particles (Figure 2.9).14 
 
 
Figure 2.8: RNP_PME(2.5) A) 29Si MAS NMR B) 31P CP-MAS NMR. 
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Table 2.7: Solid state 29Si and 31P NMR results of RNP_PME(2.5) with deconvolution 
Property RNP_PME(2.5) 
P : Si ratio 0.22 
29Si T2, T3, Q3, Q4 
((%) T2, T3, Q3, Q4) 
-55.3,-63.9,-98.6,-106.9 
(8, 14, 24, 54) 
% Condensation in T, Q sites 88,92 
(%)T of surface coverage* 48 
31P 35.6 
Number of phosphnate groups per nm2 0.94 
 
 
Figure 2.9: TGA of RNP_PME(2.5) 
The nitrogen adsorption isotherm of the particles (Figure 2.10) revealed that the 
surface area of the particles (772 m2/g) (Table 2.8) was about the same as for 
CP_PME(1.6) (765 m2/g). However, the mesopore surface area of the RNP_PME(2.5) 
(472 m2/g) was a lot higher than that of CP_PME(1.6) (126 m2/g). The RNP_PME(2.5) 
particles also displayed porosity and had an average pore size of 11.1 nm and a pore 
volume of 0.576 mL/g (Table 2.8 and Figure 2.10 inset). However the textural properties 
of the particles was found to vary between samples. The surface area varied between 584 
to 772 m2/g, with an average surface area of 672.5 ± 81.1 m2/g (no. of batches = 6). The 
pore size varied between 11.1 to 17.6 nm with an average pore size of 13.9 ± 3 nm (no. 
of batches = 6) and the pore volume varied between 0.54 and 0.82 mL/g with an average 
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pore volume of 0.71 ± 0.17 mL/g (n = 6). All the samples, however displayed similar 
shaped adsorption isotherms.  
 
Figure 2.10: RNP_PME(2.5) N2 sorption isotherm (inset pore radius distribution) 
 
Table 2.8: Morphological properties of RNP_PME(2.5) 
Property RNP_PME(2.5) 
Particle shape Spherical 
Particle size distribution 70- 90 nm 
Surface area 772 m2/g 
Pore volume 0.576 mL/g 
Pore size 11.1 nm 
Hydrodynamic radius 165 (±1.0) 
 
The particles showed excellent dispersion properties being easily dispersed in 
water and also in PBS (Phosphate buffered saline). The hydrodynamic radius RH, was 
164.86 (± 1.19) and 161.18 (± 5.11) nm at pH 4.73 and 7.40, respectively in PBS (Figure 
2.11). The measurement was performed on 1 mg/mL particle dispersion. This particle 
size was as expected larger than the size observed using SEM and TEM (Figure 2.12) 
(Table 2.8). The particles showed good dispersion stability with dispersions remaining 
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stable for up to 3 months when dispersed in water. A Zeta potential of – 28 mV was 
measured for the particles RNP_PME(2.5) dispersed in water (2 mg/mL). 
 
Figure 2.11: Hydrodynamic radius of particles at pH 4.73 and pH 7.40 
 
 
Figure 2.12: RNP_PME(2.5) particles A) SEM (Scale 500 nm); B) TEM (Scale 50 nm) 
 
2.4.10 Variations in Formulation 2 
The variations in parameters such as temperature, CTAB concentration and 
ethanol concentration in Formulation 2 showed in the main the same trends as the 
variations studied in Formulation 1. The trends are illustrated below using SEM images 
for samples from each set of reaction conditions. 
2.4.11 Effect of temperature 
Variation of temperature resulted in significant changes in the particle 
morphology. When the particle synthesis was carried out at 20 °C (Figure 2.13 A), only 
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fused particles were obtained. Increase in temperature resulted in the formation of distinct 
particles. Raspberry texture was observed from 60 °C onwards up to 80 °C (Figure 2.13 
C). 
 
Figure 2.13: Effect of temperature on Formulation 2 A) 20 °C; B) 40 °C; C) 60 °C. 
(Scale 1000 nm) 
2.4.12 Effect of CTAB 
Reduction in CTAB concentration resulted in polydisperse, fused particles in 
micron size range (Figure 2.14 A). When synthesis was carried out in the absence of 
CTAB, particle formation was not observed. Gradual increase in CTAB concentration 
resulted in the formation of more discrete particles (Figure 2.14 B). 
 
Figure 2.14: Effect of variation of CTAB mole ratio on Formulation 2 A) 0.05 (scale 
1000 nm) B) 0.10. (Scale 2000 nm) 
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2.4.13 Effect of ethanol 
Variation in ethanol concentration resulted in changes in the particle size, however 
the raspberry particle texture was not affected. When the synthesis was carried out in the 
absence of ethanol polydisperse particles were observed (Figure 2.15 A). Addition of a 
small quantity of ethanol (mole ratio silane to ethanol 1: 2.12) resulted in larger but more 
monodisperse particles (Figure 2.15 B). Further increase resulted in RNP_PME(2.5) 
particles (mole ratio 1: 7.78). Further increase resulted in polydisperse particles (mole 
ratio 1: 11) 
 
Figure 2.15: Effect of ethanol on Formulation 2 A) mole ratio 0; B) mole ratio 2.12 C) 
mole ratio 11.0 (Scale 1000 nm) 
 
2.4.14 Effect of DMPTMS on particle morphology in Formulation 2 
In order to fully understand the role of DMPTMS as a structure directing agent, 
the ratio of DMPTMS: TEOS in Formulation 2 was varied, while keeping the overall 
silane concentration constant. When DMPTMS was not used, discrete particle formation 
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was not observed. Instead the particles had fused morphology (Figure 2.16). When the 
mole ratio of was increased to 0.1 leading to material (NP_PME(0.2)) monodisperse 
spherical particles (65 to 70 nm diameter) (Figure 2.17) were obtained. Further increase 
in the ratio to 0.2 lead to a slight increase in the particle size (75 to 80 nm) (Figure 2.18). 
 
 
Figure 2.16: DMPTMS: TEOS mole ratio of 0 A); (SEM Scale 1000 nm) B) (TEM 
Scale 100 nm) 
 
 
Figure 2.17: DMPTMS: TEOS mole ratio of 0.1(NP_PME(0.2)) A);SEM (Scale 1000 
nm) B) TEM (Scale 100 nm) 
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Figure 2.18: DMPTMS: TEOS mole ratio of 0.2 (NP_PME(1.0)) A)SEM (Scale 1000 
nm) B)TEM (Scale 100 nm) 
 
29Si NMR revealed that both NP_PME(0.2) and NP_PME(1.0) particles showed 
only T2 environments( Figures 2.19 and 2.20). The surface coverage of the particles was 
4% and 21% respectively (Table 2.9). The hydrodynamic radii of these particles were 
larger than those of RNP_PME(2.5) (Table 2.10) suggesting that the particles aggregated. 
The stability of the particle dispersion decreased with the decrease in the phosphonate 
loading. Nitrogen adsorption isotherms of NP_PME(0.2) and NP_PME(1.0) revealed that 
both particles had similar surface areas and pore sizes, while the pore volume decreased 
slightly with the increase in phosphonate loading (Table 2.10). 
 
 
Figure 2.19: NP_PME(0.2) A) 29Si MAS NMR B) 31P CP-MAS NMR. 
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Figure 2.20: NP_PME(1.0) A) 29Si MAS NMR B) 31P CP-MAS NMR. 
 
Table 2.9: Solid state 29Si and 31P NMR results of NP_PME(0.2) and NP_PME(1.0) 
with deconvolution 
Property NP_PME(0.2) NP_PME(1.0) 
P : Si ratio 0.01 0.07 
29Si T2, T3, Q3, Q4 
((%) T2, Q3, Q4) 
-59.9(T2),-98.8,-107.2 
(1, 28, 71) 
-58.7(T2),-97.3,-106.7 
(7, 25, 68) 
% Condensation in T, Q sites 66, 93 66, 93 
(%)T of surface coverage* 4 22 
31P 34.1 32.9 
Number of phosphonate groups  
per nm2 
0.006 0.18 
 
Table 2.10: Morphological properties of NP_PME(0.2) and NP_PME(1.0) 
Property NP_PME(0.2) NP_PME(1.0) 
Particle shape Spherical Spherical 
Particle size distribution 65 - 70 nm 75 -80 nm 
Surface area 766 m2/g 742 m2/g 
Pore volume 0.411 mL/g 0.356 mL/g 
Pore size 2.9  nm 2.9 nm 
Hydrodynamic radius, RH 278 192±33.0 
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2.4.15 Effect of DEPTES on particle morphology in Formulation 2 
In order to further understand the effects of DMPTMS on the particle formation, 
it was replaced with the ethoxysilane DEPTES in Formulation 2 for particle synthesis. 
Fused particle clusters were produced by this method and the particles were denoted 
NP_PEE(2.1). 29Si NMR (Figure 2.21a) showed that the organic group loading (2.1 
mmol/g) was similar to that of RNP_PME(2.5) particles (Table 2.11). The particles had 
a uniform particle size of ~ 60 nm. However, the particles were fused together and could 
not therefore be dispersed (Figure 2.22). Nitrogen adsorption isotherms revealed that the 
surface area of the particles decreased to 599 m2/g and the mesopore surface area of the 
particles was only 173 m2/g (Figure 2.22) (Table 2.12).  
 
Figure 2.21: NP_PEE(2.1) a) 29Si MAS NMR b) 31P CP-MAS NMR 
Table 2.11: Solid state 29Si and 31P NMR results of NP_PEE(2.1) with deconvolution 
Property NP_PEE(2.1) 
P : Si ratio 0.18 
29Si T2, T3, Q3, Q4 
((%) T2, T3, Q3, Q4) 
-57.3,-63.6,-98.2,-106.6 
(8, 10, 31, 51) 
% Condensation in T, Q sites 84, 91 
(%)T of surface coverage* 37 
31P 34.1 
Number of phosphonate groups per 
nm2 
0.78 
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Table 2.12: Morphological properties of NP_PEE(2.1) 
Property NP_PEE(2.1) 
Particle shape Fused spherical particles 
Particle size  ~ 60 nm  
Surface area 599 m2/g 
Pore volume 0.400 mL/g 
Pore size Microporous (< 2 nm) 
Hydrodynamic radius Not dispersible 
 
 
Figure 2.22 NP_PEE(2.1) A) SEM (Scale 1000 nm); B) TEM (Scale 50 nm) 
 
2.5 Discussion  
2.5.1 Variation of Reaction parameters 
CP_PME(1.6) particles were produced by adapting a previously published 
report.22 The particles displayed high surface area (765 m2/g) and good organic group 
loading of 1.6 mmol/g. However, they lacked the porosity that is essential for protein 
immobilization applications.1 In order to optimise the particle properties, the role of each 
component in the reaction was analysed. The components analysed were: 1) Temperature; 
2) Ethanol mole ratio; 3) Surfactant (CTAB) mole ratio; 4) Base mole ratio 
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The particle size was strongly influenced by temperature. Previous studies on the 
role of temperature in Stöber silica nanoparticle synthesis showed that the particle size 
decreased with an increase in temperature.15 This is due to an increase in the hydrolysis 
and condensation of the silane monomers which leads to increased seed nuclei formation 
and smaller particle size. This was precisely what was observed when the temperature 
was varied from 20 to 80 °C. Higher temperature lead to a reduction in the particle size 
and relatively improved the particle monodispersity (Figure 2.4 and Table 2.3). 
Ethanol was used as the co-solvent in the particle synthesis to assist the even 
distribution of the silane monomers. Previous studies have shown that its use resulted in 
the production of spherical particles.16 In the current study it was observed that low 
concentration of ethanol had a favourable influence on the particle size distribution, 
resulting in monodisperse particles (mole ratio ethanol:TEOS of 2) (Figure 2.6 and Table 
2.5). Possible reasons for this are that ethanol reduces the rates of hydrolysis and 
condensation of the silane monomers17 and also causes the surfactant micelles to assemble 
slowly. Consequently monodisperse particles are produced. However, higher 
concentration of ethanol (mole ratio ethanol: TEOS of 11) resulted in the formation of 
highly polydisperse spheres (Figure 2.6 and Table 2.5). This result could be attributed to 
a strong reduction in the co-hydrolysis and co-condensation of the silane precursors and 
also a disruption of the micellar structure. 
Surfactants play a crucial role in the formation of silica nanoparticles. Particle 
formation did not take place when the particle synthesis was carried out in the absence of 
CTAB. The crucial step in surfactant assisted formation of silica nanoparticles is the 
formation of silica-surfactant seed template through the association of silica oligomer and 
surfactant molecules. The seed particles thus formed aggregate and grow via monomer 
addition.18,19 Therefore in the absence of surfactant, particle formation was not observed. 
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Gradual increase in the surfactant concentration (CTAB: TEOS mole ratio of 0.05) 
resulted in the formation of bulk silica and a few sub-micron spheres. Further increase 
(mole ratio of 0.10) resulted in an increase in the number of particles. (Figure 2.5 and 
Table 2.4). 
The presence of base had the strongest effect on the particle morphology. The 
primary role of base was that of a catalyst for the silane hydrolysis and condensation 
reactions. Not surprisingly, particle formation did not take place in the absence of base. 
A small increase in the concentration of base (NaOH:TEOS mole ratio of 0.17 (Figure 
2.7) resulted in the formation of 10 nm fused particle aggregates. These particles could 
not be dispersed. Further increase (mole ratio of 0.34 (Figure 2.7)) resulted in the 
formation of highly monodisperse nanoparticles (70 – 90 nm). The rates of hydrolysis 
and condensation are strongly dependent on the pH. Under basic conditions the rate of 
hydrolysis increased with increase in pH, while the rate of condensation decreased.20 This 
was reflected by the fact that CP_PME(1.6) particles (mole ratio of 0.52) had a large 
particle size and a relatively smooth surface compared to RNP_PME(2.5) particles.  
2.5.2 Role of DMPTMS 
Lin et al. demonstrated that the organosilanes act as structure directing agents by 
modifying the surfactant-silica interactions.5 DMPTMS was found to be crucial to particle 
formation in Formulation 2. Fused, irregularly shaped particles were obtained in the 
absence of DMPTMS (Figure 2.16). Increase in DMPTMS concentration 
(DMPTMS:TEOS mole ratios 0.1 and 0.2) resulted in spherical particles (Figures 2.17 
and 2.18). In addition to acting as a structure directing agent, DMPTMS apparently had 
a second role (as illustrated in Scheme 2.2). DMPTMS reacted with NaOH forming the 
monoester P(O)OMe(O–), and thus reduced the concentration of the base in solution. The 
effect of this was seen as the concentration of DMPTMS in the reaction mixture was 
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increased from NP_PME(0.2) , NP_PME(1.0) to RNP_PME(2.5) while the NaOH : 
DMPTMS mole ratio decreased from 2.5, 1.3 to 0.56 respectively. This reduction in the 
concentration of available base resulted in a reduction in the reaction pH as the reaction 
progressed, which influenced the hydrolysis and condensation rates of the silane 
monomers and consequently the particle morphology of the formed products. The 
RNP_PME(2.5) particles showed the best particle properties such as average pore size 
(11.1 nm) and pore volume (0.576 mL/g). Nitrogen adsorption porosimetry of the 
particles illustrated this wherein the isotherm showed hysteresis at higher relative 
pressure ( > 0.8), suggesting the presence of large amounts of textural porosity. In the 
case of the raspberry textured particles this porosity was most likely due to the pores 
located between the interstices of the fused 5 to 10 nm seed particles. Batch to batch 
variations in the textural properties of the RNP_PME material was observed with average 
surface area of 672.5 ± 81.1 m2/g (n = 6) and average pore size of 13.9 ± 3 nm (n = 6) 
over six separate batch syntheses.  These differences may reflect sensitivity to some 
variation in stirring rates and the rates of precursor addition. 
As stated above, the nanoparticle porosity is due to the consequence of the unique 
nanoparticle texture. Two recent publications23,24 reported similarly large pore sizes 
arising from unfunctionalized silica nanoparticles or microparticles with raspberry 
texture. Neither reports involved the use of strong bases such as NaOH but instead small 
quantites of organic amines triethanolamine23 and triethylamine24 were used and the pH 
of the reaction was close to neutral. The reaction conditions would have promoted silane 
condensation at a rate which could have resulted in the formation of the raspberry texture.  
In contrast the present work illustrated how the organosilane played the role of the 
structure directing agent and pH quencher (due to monophosphosphoate formation during 
the reaction).  
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Phosphonate functionalization also improved the dispersion properties of the 
nanoparticles. Organosilica nanoparticles with very low or no silane content, 
NP_PME(0.2) and MSN respectively showed poor or no dispersion stability. Increasing 
organosilane loading (RNP_PME(2.5)) resulted in excellent particle dispersion stability. 
The phosphonate group is extremely hydrophilic and a strong hydrogen bond acceptor.7 
The strong negative zeta potential -28 mV, of the RNP_PME(2.5) particles dispersed at 
pH 7 was the result of the dissociation of the phosphonate monosodium salt. These two 
factors could have resulted in an increase in the dispersion stability.  
In order to further investigate the role of organosilane in influencing the particle 
morphology, DMPTMS was replaced with DEPTES. In this case only fused particles 
were obtained (Figure 2.22). This could be accounted for by the fact that the ethoxysilanes 
are known to have lower rates of hydrolysis and condensation compared to 
methoxysilanes.21 
 
2.6 Conclusion 
Phosphonate monoester functionalized silica nanoparticle synthesis was 
performed using the organosilane (dimethylphosphonatoethyltrimethoxysilane, 
DMPTMS (MeO)3SiCH2CH2PO(OMe)2,) and TEOS as alkoxysilane precursors. The 
particle synthesis was carried out using CTAB as surfactant. Ethanol was used as the co-
solvent and sodium hydroxide was used as the base to catalyse the nanoparticle formation.  
Preliminary reaction (Formulation 1) resulted in particles (CP_PME(1.6)) with 
good phosphonate loading of 1.6 mmol/g. However, the particles lacked porosity and 
were polydisperse. Reaction parameters (temperature, base concentration, ethanol 
concentration and surfactant concentration) were varied. From these experiments it was 
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determined that while temperature and ethanol concentration influenced the particle shape 
and size distribution, surfactant and base influenced the particle formation.  
Variation of base concentration resulted in the formation of large pore (13.9 ± 3.0 
nm, n = 6) raspberry textured phosphonate functionalized silica nanoparticles 
(RNP_PME(2.5) (Formulation 2). The particle formed by the aggregation of small (5 to 
10 nm) seed particles. The particles displayed a monodisperse particle size distribution 
(70 – 90 nm) and high surface area (672.5 ± 81.1 m2/g, n = 6) and high pore volume (0.71 
± 0.12 mL/g, n = 6). The porosity of these particles most likely arises due to the presence 
of textural pores in the interstices formed between the aggregated seed particles.  
Previous studies aimed at increasing the pore size used pore enlargement agents 
such as mesitylene1 or through the use of a dual surfactant system containing fluorinated 
surfactant, FC-4 and CTAB.2,3 The use of mesitylene resulted in the formation of irregular 
and polydisperse particles. Fluorinated surfactants are highly expensive and the resultant 
nanoparticles contained a mixture of porous and non-porous silica nanoparticles. 
Hydrothermal treatment was required to remove the non-porous silica particles.2 The 
strategy used in the synthesis of RNP_PME(2.5) involved the use of a low-surfactant 
system and did not involve any additional tough or damaging processing steps. The 
raspberry textured nanoparticles (RNP_PME(2.5)) represented a significant improvement 
in organosilica nanoparticle synthesis. 
The influence of the organosilane on the particle morphology was studied by 
varying the concentration of DMPTMS in the reaction (while keeping the total silane 
concentration constant). In the absence of DMPTMS, irregular silica aggregates were 
formed. Addition of DMPTMS lead to the formation of small pore (2.96 nm) and 
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monodisperse particles (NP_PME(0.2) and NP_PME(1.0). When DMPTMS was 
replaced by  DEPTES, fused silica nanoparticles (NP_PEE(2.1)) were formed. 
The organosilane loading on the particles also represented another major 
improvement. Increasing the concentration of organosilane often resulted in a reduction 
in the pore size and pore volume.5,14 In some cases the particle size also increased.14 In 
this study, high phosphonate loading resulted not only an increase in the pore size, but it 
also increased the pore volume. The particle size showed only a slight increase. Finally, 
RNP_PME(2.5) nanoparticles showed excellent dispersion stability. Therefore, these 
particles are well suited for various biomedical applications. 
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Chapter 3: Phosphonate functionalized organosilica 
nanoparticles for immobilization of the model protein, 
BSA (Bovine Serum Albumin)  
 
Some of the results from this chapter have been published in:  Sai Prakash Maddala , 
Diana Velluto, Zofia Luklinska and Alice C. Sullivan, “Large Pore Raspberry Textured 
Phosphonate@Silica Nanoparticles for Protein Immobilization” J. Mater. Chem. B, 2014, 
2, 903–914. 
 
3.1 Summary 
In this chapter, the application of large pore (11.1 nm) raspberry textured phosphonate 
monoester nanoparticles (RNP_PME(2.5)) as a host for proteins is reported. Protein 
immobilization studies were performed using Bovine Serum Albumin (BSA) on small 
pore (3 nm) particles (MSN, NP_PME(0.2) and NP_PME(1.0)) and on large pore (11.1 
nm) particles (RNP_PME(2.5)). The protein uptake by the particles was measured using 
UV-Vis spectroscopy. The protein-particle composites were characterized using IR, SDS-
PAGE, electron microscopy (SEM and TEM), DLS and circular dichroism (CD). The 
RNP_PME(2.5) gave the highest protein loading 266 mg/g and also showed stable 
dispersion properties. CD studies showed no distortion in the structure of the BSA 
immobilized on RNP_PME(2.5) at physiological pH (7.40). The results and discussion 
are presented in separate sections. 
3.2 Background 
Intracellular delivery of protein molecules has attracted a considerable amount of 
research interest due to potential therapeutic and research applications.1 For example, 
various enzymes such as lysine oxidase2 and arginine deiminase3 inhibit the growth of 
tumours by degrading the amino acids. Therapeutic enzymes are also used to treat 
inflammatory diseases, antibacterial and antiviral diseases.4 Peptides such as endostatin 
(mol. wt 20 kD) are currently in clinical trials for cancer treatment.5 Intracellular delivery 
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of antibodies such as monoclonal antibodies to shutdown various cellular processes has 
great potential in the area of cancer treatment and can potentially be used in the 
development of personalized medicine.6,7 Protein molecules such as antibodies are vitally 
important to study various cellular pathways.8 Improved understanding of various cellular 
pathways can help in finding new drug targets.9  
Protein molecules, however, cannot be delivered intracellularly. Medicinally 
relevant peptides and proteins display low stability under physiological conditions.4 In 
vitro administration of protein molecules is achieved using techniques such as 
microinjection or electroporation. However, these techniques are highly invasive and 
damage the cell membrane.4,10,11 In vitro and in vivo delivery of proteins was also 
achieved using liposomes.12 Liposomes are non-toxic and can carry large quantities of 
the protein molecules.13 However, the drug molecules loaded into liposomes displayed 
delayed adsorption, restricted biodistribution, decreased volume of drug clearance and 
retarded drug metabolism.14 Other commonly used techniques involved the use of cell 
penetrating peptides. TAT-peptide and Herpes Simplex Virus VP22 protein demonstrated 
high efficiency in intracellular delivery of protein molecules.4 TAT peptide is an 86-mer 
trans-acting transcriptional activator from HIV-1, when conjugated with proteins through 
genetic engineering.15 These methods were used to deliver protein molecules of various 
sizes (15 to 115 kD) to a wide range of cells.4,15-17 Despite these advantages, synthesis of 
TAT and VP22 conjugated proteins are highly expensive4 and action non-specific.18 
Other methods of delivery included using carbon-nanotube composites, however these 
protein-nanotube composites did not show any endosomal escape19, which can result in 
the degradation of the proteins.20  
Several groups devised a variety to strategies for protein entrapment. The most 
commonly used method involved growing a silica shell around the protein molecules 
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using reverse emulsion synthesis.21 The particles thus obtained had good protein loading 
and were used for biosensing applications. 21,22 However, the method lends itself only to 
small scale synthesis as it required large quantities of surfactants and organic solvents.21,22 
In addition to this, leaching of encapsulated protein was observed in a few cases.21 
Mesoporous silica nanomaterials have attracted a great deal of interest due to their 
biocompatiblilty23 and properties such as high surface area and tunable pore size.24 Bulk 
silica materials such as SBA-15 have been used to immobilize the proteins.25 
Immobilization of enzymes in the silica pores was found to preserve the enzyme 
activity.26 Difficulty in controlling the particle morphology of these materials renders 
them unsuitable for intracellular delivery.27 Mesoporous silica nanoparticles can be used 
to overcome these problems, however most reports of MSNs involved the synthesis of 
small pore (3 to 4 nm) nanoparticles. While this pore size is suitable for the 
immobilization and delivery of small molecules, it is not suitable for large biomolecules 
such as proteins.28 This is due to the pore size exclusion effect, which limits the adsorption 
and retention of biomolecules that are larger than the pore size.29 Some recent studies 
involved the synthesis of large pore silica nanoparticles using pore enlargement agent 
resulting in a modest increase in the pore size from 3 nm to 6 nm, which is suitable for 
smaller proteins such as cytochrome c.30,31a However, the pore size reported has been 
shown to be unsuitable for larger proteins like BSA.31b In addition, the particle 
morphology was greatly altered and the particle size increased to 300 to 600 nm range30 
by the synthesis, further limiting the application of these particles for drug delivery. 
Recently, large pore (20 nm pore size) nanoparticles were synthesized using fluorocarbon 
surfactants.32 As stated in the previous chapter, the fluorocarbon surfactants are expensive 
and the synthesis involved hydrothermal treatment to remove amorphous silica.  
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In this chapter, the details of studies that determined the capacity of the 
phosphonate functionalized nanoparticles (described in Chapter 2) for protein (BSA) 
immobilisation are presented and discussed. The protein uptake was measured using UV-
Vis spectroscopy. Both concentration and time dependent uptake of the protein was 
studied. RNP_PME(2.5) particles were shown to have excellent protein immobilization 
properties. The final protein uptake was found to depend on the particle morphology and 
also phosphonate loading. Dispersion properties of the protein-particle composites were 
measured using DLS (Dynamic Light Scattering). The effect of the particles on the 
protein structure was studied using circular dichroism (CD). 
 
3.3 Experimental 
3.3.1 Materials 
RNP_PME(2.5), NP_PME(0.2) and NP_PME(1.0) were synthesized using the 
methods described in the previous chapter. MSN was synthesized using a previously 
published method33 (See appendix 2 for characterization details). BSA and PBS 
(Phosphate Buffered Saline) tablets were purchased from Sigma Aldrich and used without 
any further purification. PBS (10 mM) solution was prepared by dissolving one PBS 
tablet in 200 mL of deionized water. NaOH pellets, ethanol and HCl (35% w/w) was 
purchased from VWR and used without further purification. The particle synthesis was 
carried out in deionized water dispensed from an 18 mΩ Millipore system supplied by 
Elba UK. 
 
3.3.2 Characterization 
IR spectra were recorded on a Bruker-FTIR spectrophotometer with an ATR 
accessory containing a ZnSe crystal. 16 scans between 600- 4000 cm-1 were performed 
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for each sample. UV measurements were performed on a Perkin Elmer UV 
spectrophotometer, containing a Deuterium lamp source for the UV region and Tungsten 
lamp source for the visible region. Gel electrophoresis was carried out on a Novex 4-20% 
Tris-Glycine gradient gel from Life Technologies. The hydrodynamic radius, R of the 
particles was measured on a Malvern Zetasizer Nano ZS instrument equipped with a 633 
nm laser. For analysis, a 1 mg/mL particle dispersion in a glass cuvette was prepared by 
sonication for (15 min) in PBS (10 mM) with pH adjusted to 4.73 or 7.4 using 1 M HCl 
and 2 M NaOH a 5 mm ultrasonic probe was used for sonication of the sample. Stock 
dispersions of the particles were prepared by dispersing 20 mg of particles in 10 mL of 
PBS and the height of liquid was kept constant at 80 mm, the inner radius of the tube was 
15 mm. Sonication was carried out at 65% amplitude. TEM (Transmission Electron 
Microscope) images were obtained using a JEM JEOL 2010 TEM operating at 200 kV. 
Samples were prepared by dipping carbon coated TEM grids (Agar Scientific) into the 
particle dispersions. SEM (Scanning Electron Microscope) images were obtained from 
gold coated samples, using an FEI 100 instrument (Oxford Instruments) operating at 20 
kV; spot size of 10 nm was used for the analysis. CD (Circular Dichroism) measurements 
were performed on 300 µL samples in 1mm path length cuvettes using an Applied 
Photophysics Chirascan CD Spectrometer, equipped with a 150 W air cooled Xe arc lamp.  
 
3.3.3 Adsorption of BSA 
The pH of PBS solution (10 mM) was adjusted to 4.73 using 1 M HCl solution. 2 
mg/mL dispersions of the nanoparticles (RNP_PME(2.5), NP_PME(0.2), NP_PME(1.0), 
MSN and CP_PME(1.6)) were prepared by sonicating the particles (20 mg) in PBS (pH 
4.73, 10 mL) using an ultrasonic probe for 45 minutes. The sonicator amplitude was set 
to 65% and pulse time of 45 seconds was used for sonication. After sonication the 
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dispersion was allowed to cool down to room temperature. Particle dispersions (1 mL) 
were then added to different concentrations (from 0.06 to 2 mg/mL) of BSA solutions (1 
mL), gently mixed and allowed to stand for 45 minutes (at 20 °C). After 45 minutes, the 
dispersions were centrifuged at 14,000 rpm for 10 minutes and the supernatant was 
collected. BSA concentration in the supernatant was determined by measuring its 
absorbance at 280 nm in a UV-Vis spectrophotometer. 
 
3.3.4 Time dependent BSA adsorption 
Nanoparticle dispersions were prepared as described above. The dispersions (1 
mL) were then added to 2 mg/mL BSA solutions (1 mL), gently mixed and allowed to 
stand (at 20 °C). At different time intervals, the samples were centrifuged at 14000 rpm 
for 10 minutes. The BSA concentration in the supernatant was determined by measuring 
the absorbance of the supernatant at 280 nm in a UV-Vis spectrophotometer. 
 
3.3.5 BSA@RNP_PME(2.5) composite stability study 
RNP_PME(2.5) dispersions in PBS(pH 4.73) were prepared as described above. 
To 1 mL samples of this dispersion equivolumes of BSA solutions (0.4 mg/mL and 0.6 
mg/mL) were added and incubated at 20 °C for 30 minutes. After 30 minutes the pH of 
the solutions was raised to 7.4 by adding 0.1 M NaOH solution. The dispersions were 
then transferred to an incubator at 37 °C and shaken at 300 rpm. Over the next 24 hour 
period 200 µL aliquots of the dispersion was collected and centrifuged at 13000 rpm for 
10 minutes. The protein concentration in the supernatant was determined by Bradford 
assay.34 The protein concentration determined at 0 hour (first sample) was used as the 
reference and this value was used to determine any increase in the concentration of BSA 
in the supernatant (indication of BSA release). 
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3.3.6 SDS-PAGE 
SDS-PAGE (Sodium Dodecyl Sulphate-Poly Acrylamide Gel Electrophoresis) 
was performed on BSA and BSA loaded particle dispersions. BSA was loaded onto the 
particles in PBS buffer as described in the previous sections. Equivolumes of particle 
dispersion (1 mg/mL) and BSA solution (0.27 mg/mL for RNP_PME(2.5), 0.17 mg/mL 
for NP_PME(1.0) and 0.15 mg/mL for NP_PME(0.2)) were mixed at 20 °C and allowed 
to stand for 45 minutes. The concentration of BSA solutions used to load different types 
of particles reflect the loading capacities determined from the corresponding adsorption 
study. 20 µL aliquots of these dispersions were mixed with similar volume of SDS 
loading buffer in a 1 mL centrifuge tube. This mixture was then heated to 95 °C for 10 
minutes to denature the proteins. After 10 minutes the tube was cooled to room 
temperature and centrifuged to remove any suspended solids. 15 µL aliquot of the 
supernatant was then transferred to the polyacrylamide gradient gel and the 
electrophoresis was performed at 180 V during 60 min. 
 
3.3.7 Circular Dichroism 
Circular dichroism (CD) was performed on BSA and BSA loaded particle 
dispersions (BSA@RNP_PME(2.5), BSA@NP_PME(0.2) and BSA@NP_PME(1.0)). 
BSA was loaded onto the particles in PBS buffer as described in the previous sections. 
Equivolumes of particle dispersion (1 mg/mL) and BSA solution (0.27 mg/mL for 
RNP_PME(2.5), 0.17 mg/mL for NP_PME(1.0) and 0.15 mg/mL for NP_PME(0.2)) 
were mixed at 20 °C and allowed to stand for 45 minutes. The concentration of BSA 
solutions used to load different types of particles reflect the loading capacities determined 
from the corresponding adsorption study. CD scans were performed between the 
wavelengths 200 to 260 nm. A total of 5 scans were performed at scan rate 10 nm/min 
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and data interval 0.5 nm. The sample volume was 300 µL. Measurements at pH 7.4 were 
performed by adjusting the pH of the dispersion using 0.1 M NaOH. The spectra thus 
obtained were then processed by averaging and subtracting the background. Savitsky-
Golay algorithm, window size of 3 was used to smooth the spectra. The spectra were 
zeroed at 255 nm. 
 
3.4 Results  
3.4.1 BSA Adsorption study 
Adsorption studies were performed to determine the capacity of the particles to 
immobilise BSA. Nanoparticle dispersions (2 mg/mL) were treated with various BSA 
concentrations ranging from 0.06 to 2 mg/mL. The study was carried out at pH 4.73, the 
isoelectric point of BSA, to promote high BSA uptake.35 The amount of BSA taken up by 
the particles was determined by measuring the absorbance of the supernatant at 280 nm. 
Typical concentration dependent UV spectra from which the data were extracted are 
shown in Appendix 2. All the particles showed the same protein uptake profile up to 
concentration of 0.2 mg/mL (Figure 3.1). RNP_PME(2.5) particles took up 266 ± 0.84 
mg/g. All other particles used in the study adsorbed significantly smaller quantities of 
BSA (Table 3.1 and Figure 3.1). Hard sphere particles CP_PME(1.6) adsorbed a 
negligible amount of protein (~ 1 mg/g).  
Table 3.1: BSA load of BSA@phosphonatesilica materials at pH 4.73 
Sample Name Pore size (nm) BSA load (mg/g) Kd(mL/mg) 
BSA@RNP_PME(2.5) 11.1 266(±0.842) 0.35 
BSA@NP_PME(1.0) 2.96 180(±2.19) 0.22 
BSA@NP_PME(0.2) 2.96 152(±9.50) 0.19 
BSA@MSN 3 142(±9.28) 0.16 
BSA@CP_PME(1.6) Microporous ~1  
BSA load n = 3 ±std 
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Figure 3.1: Concentration dependent BSA uptake (n = 3) 
3.4.2 Time dependent BSA adsorption and dispersion stability 
Time dependent BSA adsorption studies were performed on the same batch 
nanoparticles. The results showed that irrespective of the particle morphology, all the 
particles reached their maximum loading within 20 minutes of exposure to protein 
solutions. This suggests that the unlike the total protein uptake, organic functionalization 
and particle morphology had little impact on the rate of protein uptake (Figure 3.2).  
 
Figure 3.2: Time dependent BSA adsorption profiles (n = 3) 
The stability of the BSA@RNP_PME(2.5) composite was measured under 
physiological conditions (pH 7.4 and 37 °C) for 24 hours. The protein release from the 
particles was measured by Bradford assay.34 The study was performed at two different 
protein loadings (17 and 22 wt%). Protein release from the BSA@RNP_PME(2.5) was 
not observed even after 24 hours. Thus, BSA@RNP_PME(2.5) represented a stable 
composite.  
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3.4.3 SDS-PAGE and IR spectroscopy 
Evidence for the presence of BSA on the nanoparticles was obtained using SDS-
PAGE (Figure 3.3) and IR spectroscopy (Figure 3.4). SDS-PAGE is an excellent 
technique for separating macromolecules by weight. Separation of the macromolecules 
takes place under the influence of an electric field and is hence termed electrophoresis. 
The principle behind this method is as follows; sodium dodecylsulphate (SDS) is an 
anionic surfactant (Figure 3.3b) and is a well-known protein denaturant. SDS also has a 
negative charge at a wide pH range. Polypeptide chains bind to SDS in proportion to mass 
and this results in a negatively charged protein-surfactant complex. When the protein-
surfactant complex is placed under an electric field it moves towards the anode. The 
charge/mass ratio is nearly the same for all polypeptides, therefore the separation of the 
polypeptides takes place based on the mass of the polypeptide. The polyacrylamide gel 
traps the proteins within its matrix and retards the motion of the proteins. Higher the 
concentration of polyacrylamide, the denser the gel and greater the retardation.36 For this 
experiment 4 to 20% polyacrylamide gradient gel was used. At higher concentration 
(between 12 to 20%) the gel is densely packed and retards the motion of large proteins. 
The sample preparation involved treating the protein samples with SDS-PAGE 
loading buffer. The buffer consisted of 1% SDS, mercaptoethanol, 10% glycerol, 10 mM 
Tris-Cl, pH 6.8, 1 mM ethylenediamine tetraacetic acid (EDTA), 2-mercaptoethanol and 
bromophenol blue, which served as tracking agent. 2-mercaptoethanol was the reducing 
agent and it was responsible for breaking the disulphide bridges and denaturing the 
protein molecules.37 The gel was stained with coomassie blue. Bands were observed at 
66 kDa and no other bands were observed. This suggested that the particles did not cleave 
the protein (Figure 3.3). 
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Figure 3.3: Gel Electrophoresis of BSA from LHS Marker (M), 1 BSA, 2 
BSA@NP_PME(0.2); 3 BSA@NP_PME(1.0); 4 BSA@RNP_PME(2.5) 
Further evidence demonstrating BSA immobilization on the nanoparticles was 
obtained from IR spectroscopy. IR spectroscopy was performed on lyophilized 
BSA@RNP_PME(2.5) particles. The spectrum showed two prominent peaks at 1649 and 
1543 cm-1 corresponding to C=O and C-N stretching and NH bending in Amide I and 
Amide II groups (Figure 3.4).38  
 
Figure 3.4: of BSA (red) RNP_PME(2.5) (blue) and BSA@RNP_PME(2.5) (black) 
 
3.4.4 Particle dispersion properties and morphology 
The protein-particle dispersion properties were studied using dynamic light 
scattering (DLS). This was done to assess the dispersion stability of the particles. As 
prepared nanoparticle-protein composites were used for this measurement. The 
measurements were performed at pH 4.73 and pH 7.40. BSA@RNP_PME(2.5) was the 
most stable composite. DLS measurements showed that the hydrodynamic radius of the 
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particles (RH) did not change greatly from the parent to the BSA loaded material (Figure 
3.5) thus suggesting that the composite represented discrete protein-particle composite. 
The particle size measurement was performed over a 2 hour period and during this time 
the particle size remained the same, indicating the stability of the composite. Other 
particle systems including BSA@NP_PME(1.0) and BSA@NP_PME(0.2) exhibited 
much poorer levels of stability and showed aggregation, as indicated by increased 
hydrodynamic radii (Table 1.2). The BSA@MSN composite could not be dispersed and 
was not used in further analysis. 
 
Table 3.2: Hydrodynamic radius of BSA loaded particle composites 
Sample Name RH pH 4.73 RH pH 7.40 
BSA@RNP_PME(2.5) 172.76(±2.01) 167.97(±0.90) 
BSA@NP_PME(1.0) 484(±113) 217 (±3.0) 
BSA@NP_PME(0.2) 5470 2750 
n = 6 ±std for BSA@RNP_PME(2.5) measured over a 2 hour period; n = 3 ±std for 
BSA@NP_PME(1.0) measured during 30 minute period and n = 1 for 
BSA@NP_PME(0.2) at 25 minutes. 
 
 
Figure 3.5: Hydrodynamic radius distribution of RNP_PME(2.5) and 
BSA@RNP_PME(2.5) particles at pH 7.4 and pH 4.73. 
 
To further explore the effects of protein uptake on the particle morphology, 
electron microscopy analysis of the protein-particle composites was performed. SEM and 
TEM analysis of the BSA@RNP_PME(2.5) particles showed that the particles did not 
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undergo any size change upon protein adsorption (Figure 3.6 compared to Figure 2.12). 
This observation was in line with the results obtained from DLS experiments (Figure 3.5). 
SEM analysis of the BSA@NP_PME(0.2) and BSA@NP_PME(1.0) particles showed 
thatwhile the particle size or shape did not change, the protein loaded particles (Figures 
3.6 and 3.7) showed a reduction the surface roughness compared to the parent particles 
(Chapter 2 Figures, 2.12 (RNP_PME(2.5); 2.16 (NP_PME(0.2), 2.17 (NP_PME(1.0))). 
 
 
Figure 3.6: BSA@RNP_PME(2.5) particles A) SEM image(scale 1000 nm) B) TEM 
image (Scale 50 nm) 
 
Figure 3.7: SEM of A) BSA@NP_PME(0.2) and B) BSA@NP_PME(1.0) (Scale bar 
1000 nm) 
 
3.4.5 Circular Dichroism 
CD spectra of the protein loaded particles were measured to determine the effect 
of the particles on the protein structure. The spectra were collected between 200 to 260 
nm. The spectra obtained at pH 4.73 revealed that BSA adsorbed on all three types of 
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particles showed a strong distortion in the protein structure. When the pH of the 
dispersions was raised to 7.40 by adding 0.1 M NaOH, the protein structure in 
BSA@RNP_PME(2.5) was fully restored, while in the other two particle systems 
complete restoration was not observed. (Figure 3.8) 
 
Figure 3.8: Circular dichroism spectra of protein loaded particles A) pH 4.73 and B) pH 
7.40 
 
3.5 Discussion 
In Chapter 1 the characteristics of an ideal drug delivery system were discussed. 
They were 1) biocompatible material; 2) large quantity of drug uptake; 3) zero-premature 
release; 4) targeted delivery; 5) controlled release at the target site.39 In Chapter 2, the 
synthesis of silica nanoparticles with phosphonate functionality was discussed. 
Phosphonate functionality was chosen to functionalize the particles due to its excellent 
biocompatibility.40 The focus of this chapter is on the properties 2) and 3) mentioned 
above. As stated in the introduction, there is an urgent need to develop novel protein 
delivery systems that can adsorb and deliver large quantities of proteins across the cell 
membrane. The RNP_PME(2.5) nanoparticles have a pore size of 11.1 nm, which is 
suitable for the immobilization of a large number of protein molecules. In order to suitably 
challenge this system, bovine serum albumin (BSA) was chosen as the model protein. 
BSA has a molecular weight of 66 kD and has the molecular dimensions of 5 x 7 x 7 nm3 
(from the Protein Data Bank).41 
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Non-covalent immobilization of proteins predominantly involves three 
interactions; electrostatic, hydrogen bond and hydrophobic interactions.42 Electrostatic 
forces strongly interfere with protein adsorption on surfaces. To minimize these effects 
and to optimise the protein uptake, the adsorption was carried out at the isolectric point 
(pH 4.73 for BSA).35,43 All particles showed Langmuir type adsorption profiles (Figure 
3.1 and Appendix 2 for Langmuir plots). The results from the adsorption study showed 
that the raspberry textured nanoparticles had very high protein uptake (266 ± 0.84 mg/g) 
which is higher than the reports on large pore bulk silica materials such as SBA-15 and 
hollow silica.35,43-46 
 
3.5.1 BSA adsorption 
As stated earlier, all nanoparticles reached their maximum protein load within a 
short time (20 minutes) (Figure 3.2) after exposure to protein solution. This result was a 
significant improvement over the bulk silica materials, which have been reported to take 
a few hours to reach their maximum loading.35,43-46 The rapid uptake in all nanoparticles 
suggested that the morphological differences such as pore size (11.1 nm for 
RNP_PME(2.5) and ~3 nm for all other nanoparticles), surface area (772 m2/g for 
RNP_PME(2.5) and 890 m2/g for MSNs) or chemical differences such as phosphonate 
load (0.0 mmol/g for MSNs to 2.5 mmol/g for RNP_PME(2.5)) had little influence on the 
rate of protein uptake among these porous nanoparticles. These factors did however 
influence the final protein load on the particles.  
While the particle morphology or composition had little influence on the rate of 
the protein uptake, these had considerable impact on the total protein uptake by the 
particles. Nanoparticles with low or no phosphonate loading (NP_PME(0.2) and MSNs 
respectively) did not show any statistically significant differences in the protein uptake 
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(p=0.05) (final protein load 152 (± 9.50) and 142 (± 9.28) mg/g respectively) (Figure 
3.1). In comparison, a 5-fold increase in the phosphonate functionalization 
(NP_PME(1.0)) resulted in an 18 % increase in the BSA uptake despite no significant 
morphological differences (compared to NP_PME(0.2)). A further 2.5 fold increase in 
the phosphonate functionalization (RNP_PME(2.5)) resulted in a 74% increase in the 
protein loading (Table 3.1). The increase in the phosphonate load on the particles also 
resulted in an increase in the pore size from 3 nm to 11.1 nm. However, it must be noted 
that the microporous CP_PME(1.6) despite relatively high phosphonate loading adsorbed 
only 1 mg/g, indicating that accessible porosity is vital for protein uptake. It was therefore 
identified that a combination of high degree of porosity and phosphonate functionality 
was needed for high protein uptake. The BSA@RNP_PME(2.5) composites exhibited 
excellent stability. Protein release was not observed at pH 4.73 or at pH 7.40 at 37 °C 
suggesting that the protein was strongly bound to the particle surface. The phosphonate 
group is a strong hydrogen bond acceptor41 and it is likely that the proteins were held on 
the particle surface through strong hydrogen bond interactions between the phosphonate 
group and the silane. The role of phosphonate was in protein binding was further 
established by measuring the distribution co-efficients (Kd) of the mesoporous 
nanoparticles. High Kd value corresponds to high binding affinity
47, the Kd values showed 
the following trend RNP_PME(2.5)> NP_PME(1.0)>NP_PME(0.2)>MSN, indicating a 
strong link between phosphonate load and protein binding (Table 3.1). 
 
3.5.2 Dispersion properties 
The presence of phosphonate on the particle surface also contributed to the 
stability of the particle dispersions. Based on DLS measurements the order of the stability 
of particle dispersion is BSA@RNP_PME(2.5)>> BSA@NP_PME(1.0)> 
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BSA@NP_PME(0.2)>>> BSA@MSN (Table 3.2 and Figure 3.5). It must also be noted 
that the protein-particle composites underwent irreversible aggregation when separated 
from the dispersion by centrifugation and could not be redispersed.  
 
3.5.3 Protein structure 
The presence of the protein on the particles was confirmed by IR and gel 
electrophoresis. Gel electrophoresis confirmed that the protein molecules did not undergo 
any degradation after immobilization on the particle surface (Figures 3.3 and 3.4). 
However, structural information could not be obtained from these results. Protein 
molecules are prone to denaturation and ideal protein delivery candidates should preserve 
the protein structure. In order to determine changes to protein structure post-
immobilization, circular dichroism (CD) spectra of the protein particle composites were 
obtained. It should be noted that previous studies involving bulk mesoporous silica 
materials as BSA hosts did not present any protein structural information. The CD 
spectrum of BSA consists of α-helix signals including π-π* at 208 nm and n-π* at 222 
nm.48 Protein denaturation results in an attenuation of these CD signals.42 CD therefore 
represented an excellent method to study protein structure changes. CD spectra obtained 
at pH 4.73 showed significant differences between the free and immobilized protein (on 
all three particles), whereby the strong attenuation of the CD signal suggested that the 
protein underwent significant denaturation on adsorption at this pH (Figure 3.8).49 When 
the pH was raised to physiological 7.40, the protein structure of BSA@RNP_PME(2.5) 
was fully restored, while only partial restoration was observed in the case of 
NP_PME(1.0) and NP_PME(0.2) (Figure 3.8). The porosity of the particles could have 
played a significant role in driving the restoration of the protein structure. At pH 7.40, 
BSA molecules would have obtained a significant negative charge and this charge build-
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up within the constrained environment in the pores of the raspberry textured particles 
would have resulted in a greater degree of restoration of the protein structure than for the 
smaller pore particles, which would have predominantly surface adsorbed protein.50 
 
3.6 Conclusion 
As described in the previous section an ideal drug delivery agent should be able 
to take up large quantities of protein molecules and prevent their premature release (zero 
premature release). The results presented above conclusively demonstrate that 
RNP_PME(2.5) nanoparticles are excellent candidates for protein uptake and delivery 
applications. BSA was chosen as the model protein for the study. The pore size of 
RNP_PME(2.5) nanoparticles was 11.1 nm, which was large enough to accommodate 
BSA molecules. In order to establish the factors affecting protein uptake by the 
nanoparticles a variety of studies were performed. The protein uptake by the particles was 
determined by UV-Vis spectroscopy. The presence of the protein on the particles was 
studied using IR and SDS-PAGE. The effect of the protein on the dispersion properties 
was studied using DLS. Electron microscopy (SEM and TEM) was used to study the 
morphological changes in the particle-protein composites. Finally, CD was used to 
monitor the changes in the protein structure, following particle uptake. 
The rate of protein uptake by the particles was studied by treating the particles 
with protein solutons at pH 4.73. All the particles, irrespective of their pore size and 
composition, reached the maximum loading in less than 20 minutes. The results suggested 
that the particle morphology and pore size had no effect on the rate of protein uptake. 
Previous experiments involving BSA uptake by mesoporous bulk silica materials required 
at least a few hours of exposure to reach maximum loading. The particles presented here 
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therefore represent a major improvement in the development of substrates for protein 
immobilization. 
RNP_PME(2.5) particles were found to be an excellent system for protein 
immobilization. Adsorption studies showed that the particles adsorbed 266 ± 0.84 mg/g 
protein, which was significantly higher than all the other types of particles. Based on the 
adsorption study the order of protein uptake was, BSA@RNP_PME(2.5) >> 
BSA@NP_PME(1.0) > BSA@NP_PME(0.2) ≈ BSA@MSN. This result suggested that 
the protein uptake was influenced by a combination of the phosphonate loading and pore 
size of the particles. The final protein load of the BSA@RNP_PME(2.5) particles was 
comparable to that obtained using large pore mesoporous silica materials. The 
BSA@RNP_PME(2.5) composite also displayed excellent stability, protein desorption 
was not observed under in vitro conditions. The material thus demonstrated the “no 
premature release” and the high protein load properties needed by a drug delivery system. 
BSA@RNP_PME(2.5) particles displayed good dispersion stability compared to 
the other protein-particle systems. The order of dispersion stability was 
BSA@RNP_PME(2.5)>> BSA@NP_PME(1.0)> BSA@NP_PME(0.2)>>> 
BSA@MSN. However, none of the protein-particle systems could be redispersed after 
precipitation by centrifugation.  
Finally the effect on the protein structure was determined by SDS-PAGE and 
circular dichroism. SDS-PAGE results showed that the protein molecules did not undergo 
cleavage after immobilization. The effect of the particles on the protein structure was 
studied using circular dichroism. CD studies revealed that the adsorbed proteins 
underwent significant denaturation when adsorbed at pH 4.73. However, when the pH of 
the media was increased to 7.40 the protein underwent either partial (NP_PME(0.2) and 
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NP_PME(1.0)) or complete (RNP_PME(2.5)) restoration of the native protein structure. 
The constrained environment within the pores of RNP_PME(2.5) particles is proposed to 
be responsible for the restoration of the protein structure. The results presented in this 
chapter demonstrate that the RNP_PME(2.5) nanoparticles possess properties that make 
them excellent protein immobilization agents. The next chapter discusses the results 
involving the study of the intracellular delivery of BSA. 
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Chapter 4: RNP_PME(2.5) nanoparticles for intracellular 
protein delivery 
 
The effect of nanoparticles on cell viability results (Figure 4.5) from this chapter have 
been published in:  Sai Prakash Maddala, Diana Velluto, Zofia Luklinska and Alice C. 
Sullivan, “Large Pore Raspberry Textured Phosphonate@Silica Nanoparticles for Protein 
Immobilization” J. Mater. Chem. B, 2014, 2, 903–914. 
 
4.1 Summary 
Protein (FITC_BSA, Fluorecein isothiocyante (FITC) labelled BSA) (hereafter BSA#) 
uptake and intracellular delivery using BSA#@RNP_PME(2.5) nanoparticles was 
achieved. HeLa cells were used as the model system. Both protein loaded and unloaded 
nanoparticles were rapidly taken up by HeLa cells. Nanoparticle uptake and localization 
within the cells was studied using confocal microscopy and transmission electron 
microscopy. Protein free Rhodamine B isothiocyante (RITC) labelled RNP_PME(2.5), 
RITC@RNP_PME(2.5) (hereafter RNP*_PME(2.5)) particles were taken up by caveolar 
receptor mediated uptake, while BSA#@RNP*_PME(2.5) particles were taken up by folic 
acid receptor mediated uptake. Folic acid receptors are over expressed on many types of 
cancers and BSA#@RNP*_PME(2.5) nanoparticles have great potential for cancer cell 
targeting applications. 
4.2 Background 
Proteins and nucleic acids are integral components of the cells. Proteins drive 
essential cell functions such as gene regulation, DNA replication and enzyme catalysis.1 
Many diseases such as cardiovascular disease, cancer, arthritis arise due to the presence 
of defective proteins, which in turn arise from defective genes.2 Molecular evaluation of 
various diseases routinely involves the detection of defective genes and proteins.3 For 
example, p53 is a protein involved in the regulation of cell cycle and plays an important 
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role in inducing apoptosis or cell death upon detecting defective genes and is therefore 
vital in preventing the occurrence of cancer. However, as much as 60% of the cancers 
have a defective TP53 gene (gene associated with p53 protein).4 Thus large biomolecules 
are not only important for disease detection and diagnosis, they are also important clinical 
targets and can also be used as therapeutic agents.2 The focus of this chapter is on the 
latter, specifically involving the immobilization and delivery of proteins. 
Protein delivery presents an attractive option for treating various disorders such 
as cancer, neurological diseases such as Alzheimer’s, heart disease and vaccine 
development.5 During the last two decades, extensive research has been focussed on the 
development of monoclonal antibodies that can target and shut down specific cell 
pathways. Drugs based on these antibodies are currently on the market. However, there 
are many challenges involved in efficient delivery of these proteins. The most formidable 
challenge arises from the exclusion of large molecules (> 1000 Da) by the cell 
membrane.5 Some of the negatively charged proteins are prevented from entering the cells 
due to charge repulsion.2 For therapeutic purposes, it is important to develop pathways 
that can help the proteins retain their structure and function. 
The primary means of delivering proteins involves the use of small cell 
penetrating peptides (CPP). There are three different types of CPPs. The most commonly 
used CPPs are polycationic and contain large numbers of arginine and lysine residues.6 
The widely used TAT peptide (trans-activating transcriptional activator) is an example of 
this kind of CPPs. Other types of CPPs contain alternating polar charged and non-polar 
residues or a sequence of hydrophobic residues. CPPs have been shown to be highly 
versatile and have been used to deliver proteins with sizes between 15 to 115 kDa. TAT 
conjugated antibodies have been evaluated at preclinical stage and have shown good 
results. However, there are two major challenges involved in the use of CPPs. First the 
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TAT peptide must be conjugated to the protein. In order to achieve this, the protein must 
be modified chemically to conjugate it to the CPPs.  Second, many of the TAT conjugated 
proteins have been shown to remain entrapped in the endosomes.7 Other methods of 
protein delivery include electroporation,8 where small pores are introduced in the cell 
membrane through the application of electric current in order to facilitate protein uptake 
and cell membrane permeabilization through the use of detergents or pore forming 
bacterial toxins.9 Neither of these methods lend themselves to clinical protein delivery 
applications and have been shown to irreparably damage the cell membrane.8 Various 
pathways that a protein carrier might take are illustrated in Scheme 1. 
 
Scheme 1: Various pathways a protein carrier might follow upon cell entry a) protein 
carrier uptake, b) encapsulation in early endosome, c) endosomal escape and carrier 
release, d) controlled release of encapsulated protein, e) protein action inside the cell, f) 
transfer to endosomes and digestion, g) exocytosis of the carrier. 
Nanoparticle based delivery agents offer an attractive option for protein delivery. 
They have been used to address the three main challenges involved in protein delivery, 
1) cell uptake; 2) endosomal escape; 3) controlled delivery. Additionally, the particles 
have been functionalized with specific ligands to achieve targeted delivery. Protein 
loading in nanoparticle carriers was achieved either by direct conjugation, physical 
adsorption or encapsulation as discussed below.  
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Direct conjugation has been performed between proteins and PEG (polyethylene 
glycol) derived polymers. Several FDA (Food and Drug Administration) approved PEG-
protein conjugates have been approved for clinical use.10 The main advantage of 
PEGylation was to increase the circulation times of these proteins. Polyethyleneimine 
(PEI) protein conjugates have attracted much attention due to their superior cell uptake 
properties. PEI is a cationic polymer. It can be conjugated to the acid groups on the protein 
surface through DCC coupling. Several proteins such as ribonuclease (RNase), enhanced 
green fluorescent protein or IgG antibody for example, have been conjugated to PEI 
without any loss in function and were successfully internalized into the cells.11 An 
important therapeutic application of the system involved the delivery of the denatured 
tumour suppressor protein p53 into sarcoma derived Saos-2 cells. The denatured protein 
underwent reassembly under the reducing conditions of the cytosol and induced apoptosis 
in the cancer cells.12 Lackey et al. developed a delivery system for anti-CD3 antibody 
using poly(propylacrylic acid) (PPAAc) as the conjugating polymer.  PPAAc is a pH 
sensitive polymer, which has been shown to destabilize the endosomes. PPAAc 
conjugated anti-CD3 antibody was observed through confocal microscopy to have 
escaped the endosomes and was successfully delivered into the cytosol.13 In all the above 
studies conjugation of the protein molecules to polymers helped in cell uptake and 
endosomal escape of the protein. This was due to the properties of the individual polymers 
that were used for conjugation. However, the method has a few drawbacks. Polymer 
conjugation to the protein surface was achieved through DCC coupling. The method 
requires the availability of free amine or carboxylic acid groups on the surface. These 
surface groups play an important role in stabilizing the protein structure. Excessive 
conjugation would therefore disrupt the delicate tertiary structures of the proteins, which 
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could result in loss of function.2 The method is therefore not entirely suitable for drug 
delivery applications. 
Polymeric micelles and liposomes have been widely used to entrap and deliver 
protein molecules. The method can be used to entrap large quantities of protein molecules 
and release at the target site in a controlled way. Encapsulation of the protein prevents the 
need for chemical conjugation, thus preventing unnecessary structural changes.2 The 
method, therefore has an advantage over direct conjugation. Polymeric micelles consist 
of AB or ABA type block co-polymers (where A is a hydrophilic polymer such as PEG 
and B is a hydrophobic polymer such as polypropylene glycol). Lee et al. used cationic 
block co-polymer PEG-pAsp(DET) micelles to encapsulate membrane impermeable 
protein, cytochrome c. The micelles underwent dissociation at pH 5.5 (pH of the 
endosomes). The micelles were used to escape the endosomes and efficiently deliver 
protein molecules into the cytosol.14 Other groups used poly(L-lysine)-poly(ethylene 
glycol)-folate (PLL-PEG-FOL) co-polymers to encapsulate and deliver FITC-BSA into 
folate receptor expressing, KB cells.15 Poly(γ-glutamic acid) modified with amino acid 
derivatives, L-phenylalanine ethylester and L-tryptophan methylester groups was used to 
encapsulate ovalbumin and recombinant HIV-1 gp120 and was injected into mice. The 
protein encapsulated micellar system elicited immune responses in mice, demonstrating 
the possibility of using this system for vaccine development.16 Many phospholipids and 
lipids self-assemble to form bilayered vesicles, known as liposomes. Liposomes have 
been used to encapsulate a variety of molecules for drug delivery applications. Liposomes 
are highly versatile and were used to encapsulate and deliver a variety of protein 
molecules into the cells. Liposomes also display endosomal escape making them more 
suitable for intracellular protein delivery.17 Liposomes derived from N-[1-(2,3-
dioleyloxy)propyl]-N, N, N-trimethylammonium chloride (DOTMA) were used to 
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encapsulate T7X556, a mammalian transcriptional regulator and a glucocorticoid receptor 
derivative. The encapsulated protein was successfully delivered to nucleus.18 Other 
groups reported the encapsulation of β-galactosidase, caspase-3, caspase-8 and gramzyme 
B in liposomes synthesized from trifluoroacetylated lipopolyamine and dioleoyl 
phosphatidylethanolamine (DOPE).19 The protein expression was observed following 
uptake in a variety of cell types. The latter three proteins induced apoptosis. Other 
proteins such as anti-α-tubulin IgG and therapeutic membrane proteins, pro-apoptotic 
BAK and voltage-dependent anionic channel proteins were also encapsulated and 
delivered into cells.20 The above examples illustrate the versatility of the encapsulation 
approach. However, the delivery vehicles used have numerous drawbacks. Polymeric 
micelles, for example, are difficult to synthesize. Additionally, the micelles have been 
demonstrated to have chronic cytotoxity to the liver.21 Liposomes on the other hand are 
highly expensive, displayed premature drug release and have been shown to have very 
low shelf life. Thus, the applications of these vehicles are limited.22 
Finally, protein molecules can be attached to various polymers through 
electrostatic or van der Waals interactions.2 Physical interactions between the protein 
molecules and the polymers can be fine-tuned to change the delivery profile of the 
adsorbed polymer. Cationic polymers such as polyethyleneimine, polylysine and 
polyarginine have been used to deliver a variety of proteins across the cell membrane. 
These polymers were chosen due to their ability to penetrate the cell membrane and 
display endosomal escape.22 However, polymers have low surface area and therefore only 
have a limited capability to carry protein molecules across the cell membrane. 
Inorganic nanoparticles such as mesoporous silica nanoparticles (MSNs) have 
been be used to overcome the limitations described above. Mesoporous silica 
nanoparticles have unique features such as high surface area, high pore volume and 
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tunable pore size.23 The particle surface chemistry can be altered by attaching various 
organosilanes. The particle properties can thus be fine-tuned to enable endosomal 
escape.24 This highlights the suitability of these nanoparticles for protein delivery. 
However, only a few reports exist that describe protein uptake and delivery by MSNs.29 
The main challenge here involves the production of MSNs with large pores. Pore sizes 
greater than 10 nm are required for protein delivery, as they promote efficient protein 
encapsulation. MSNs typically have pore sizes in the range of 2 to 4 nm, many protein 
molecules have dimensions larger than those pore sizes, and as a result little or no protein 
adsorption was observed due to pore size exclusion effect.25 A few studies describing the 
use of small pore MSNs as potential vaccine delivery agents have been reported.26 An 
alternative encapsulation method has been published, which involved reverse micellar 
encapsulation of the protein molecules. While the method resulted in high weight percent 
of protein adsorption, the protein molecules were not accessible, hence these protein 
encapsulate particles could not be used for drug delivery applications.27,28 Lin et al. 
developed large pore MSN synthesis using pore enlargement agents. Pore size of 5.4 nm 
was observed using this method. However, severe distortion in the particle shape was also 
observed, which could potentially limit the biomedical applications of these particles.29 
Large pore silicas such as SBA-15 have been used to encapsulate large quantities of 
proteins mainly for catalytic applications. The studies using these systems revealed that 
the immobilized proteins had superior stability to temperature and denaturing agents 
compared to native proteins.30,31 This example highlights the potential of large pore silica 
nanoparticles for protein delivery applications. The following chapter discusses this 
application using RNP_PME(2.5) nanoparticles to deliver bovine serum albumin (BSA) 
across the cell membrane of HeLa cells. 
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4.3 Experimental 
4.3.1 Materials 
RNP_PME(2.5) was synthesized using the methods described in the previous 
chapter. BSA and PBS (Phosphate Buffered Saline) tablets were purchased from Sigma 
Aldrich and used without any further purification. PBS (10 mM) solution was prepared 
by dissolving one PBS tablet in 200 mL of deionized water. NaOH pellets, ethanol and 
HCl (35% w/w) was purchased from VWR and used without further purification. The 
particle synthesis was carried out in deionized water dispensed from an 18 mΩ Millipore 
system supplied by Elba UK. 
 
4.3.2 Characterization 
IR spectra were recorded on a Bruker-FTIR spectrophotometer with an ATR 
accessory containing a ZnSe crystal. 16 scans between 600 and 4000 cm-1 were performed 
for each sample. UV measurements were performed on a Perkin Elmer UV 
spectrophotometer, containing a Deuterium lamp source for the UV region and Tungsten 
lamp source for the visible region. The hydrodynamic radius, RH of the particles was 
measured on a Malvern Zetasizer Nano ZS instrument equipped with a 633 nm laser. For 
analysis a 1 mg/mL particle dispersion in a glass cuvette was prepared by sonication for 
(15 min) in PBS (10 mM) with pH adjusted to 4.73 or 7.4 using 1 M HCl and 2 M NaOH 
a 5 mm ultrasonic probe was used for sonication of the sample. Stock dispersions of the 
particles were prepared by dispersing 20 mg of particles in 10 mL of PBS and the height 
of liquid was kept constant at 80 mm, the inner radius of the tube was 15 mm. Sonication 
was carried out at 65% amplitude. TEM (Transmission Electron Microscope) images 
were obtained using a JEM JEOL 2010 TEM operating at 200 kV. Samples were prepared 
by dipping carbon coated TEM grids (Agar Scientific) into the particle dispersions. SEM 
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(Scanning Electron Microscope) images were obtained from gold coated samples, using 
an FEI 100 instrument (Oxford Instruments) operating at 20 kV; spot size of 10 nm was 
used for the analysis. CD (Circular Dichroism) measurements were performed on 300 µL 
samples in 1mm path length cuvettes using an Applied Photophysics Chirascan CD 
Spectrometer, equipped with a 150 W air cooled Xe arc lamp. FLUOstar OPTIMA optical 
plate reader was used to analyze HeLa cell cultures following MTT assay. Cells were 
imaged by Leica TCS SP5 confocal microscope. 
4.3.3 Synthesis of FITC labelled BSA or BSA# 
FITC labelled BSA was synthesized as follows. BSA (20 mg) was dissolved in 
carbonate buffer, pH 9.2 (10 mL). FITC (1 mg) was dissolved in 1 mL of carbonate buffer. 
The BSA solution was placed in a temperature controlled shaker at 25 °C and was shaken 
gently at 150 rpm and was allowed to equilibrate for 30 minutes. After equilibration, the 
FITC solution was added in aliquots of 50 µL, while gently shaking the reaction flask. 
The flask then shaken in the dark for 4 hours. After 4 hours, the reaction mixture was 
transferred to a dialysis tube and dialyzed against water for 48 hours (3 washes), in the 
dark to prevent quenching of fluorescein. After 48 hours, the contents of the dialysis bag 
were lyophilized. The yellow-orange solid obtained was used for further experiments. 
 
4.3.4 Synthesis of Rhodamine B labelled RNP_PME(2.5) or RNP*_PME(2.5)  
To Rhodamine B isothiocyante solution (0.2 mg/mL, 10 mL) in absolute ethanol, 
aminopropyltriethoxysilane, APTES, (3.3x10-6 mol) was added and stirred for 5 hours. 
The resultant solution was then stored at -25 °C. Prior to use, the dye mixture was allowed 
to stand in the dark, until it reached room temperature. Rhodamine B labelled 
RNP_PME(2.5) was syntesized by treating RNP_PME(2.5) (73.9 mg) with the above dye 
solution. Following the reaction, the particles were separated by centrifugation and the 
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supernatant was discarded. The particles were then passed through repeated 
centrifugation and suspension cycles until the supernatant was clear of any dye. The pink 
coloured particles were then dried under high vacuum at 60 °C for 10 hours. The particles 
thus obtained were designated RNP*_PME(2.5) 
4.3.5 Adsorption of BSA 
The pH of PBS solution (10 mM) was adjusted to 4.73 using 1 M HCl solution. 2 
mg/mL dispersions of the nanoparticles (RNP*_PME(2.5), were prepared by sonicating 
the particles (20 mg) in PBS (pH 4.73, 10 mL) using an ultrasonic probe for 45 minutes. 
The sonicator amplitude was set to 65% and pulse time of 45 seconds was used for 
sonication. After sonication the dispersion was allowed to cool down to room 
temperature. Particle dispersions (1 mL) were then added to different concentrations 
(from 0.06 to 2 mg/mL) of BSA solutions (1 mL), gently mixed and allowed to stand for 
45 minutes (at 20 °C). After 45 minutes, the dispersions were centrifuged at 14,000 rpm 
for 10 minutes and the supernatant was collected. BSA concentration in the supernatant 
was determined by Bradford assay (Calibration curve provided in Appendix 4) .32 
 
4.3.6 Synthesis of BSA#@RNP*_PME(2.5) 
The general protocol for BSA#@RNP*_PME(2.5) synthesis was as follows. 
RNP*_PME(2.5) (2 mg/mL) dispersions in PBS (pH 4.73) were prepared by 
ultrasonicating the particles in the buffer. Protein solutions were prepared at the same pH 
(as described above). Different concentrations ranging from 0.247 to 0.574 mg/mL were 
prepared and mixed with equivolumes of particle dispersions. Adsorption studies 
revealed that complete protein uptake took place at these concentrations. 
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4.3.7 Cellular uptake: General protocol 
HeLa cells, a cervical cancer cell line, were chosen as the model system to study 
the nanoparticle uptake. The cells were seeded on coverslips in 12 well plates with a 
density of 105 cells/mL in 2 mL of Dulbecco’s modified eagle medium. The cells were 
incubated for 24 hours at 37 °C under 5% CO2 and after the 24 hours confluent cell growth 
was observed. The cell culture media was then removed and 0.9 mL of fresh media and 
0.1 mL of particle dispersions (e.g.1 mg/mL RNP*_PME(2.5)) in PBS at pH 7.4 were 
added and incubated for different time periods between 1 to 6 hours. The cell media was 
then removed and thoroughly washed with PBS to remove any loosely adsorbed particles. 
The cells were fixed using paraformaldehyde (4 wt%) and stained with mounting media 
containing DAPI. The particle uptake was studied using a Leica TCS SP5 confocal 
microscope.  
4.3.8 Cellular uptake: Time dependent uptake 
The cells were cultured according to the procedure described above. Following 
the addition of nanoparticles, RNP*_PME(2.5) (1 mg/mL) or BSA#@RNP*_PME(2.5) 
(1 mg/mL with BSA# load 223 mg/g), the cells were incubated for different time periods 
between 1 to 6 hours. The particles were fixed and stained as described above. The 
experiment was performed in duplicate. 
 
4.3.9 Cellular uptake: Protein load dependent uptake 
The procedure described above was followed to prepare the cell culture. 
Following this, different protein loaded particles, 111.1, 166 and 223 mg/g BSA# load 
were incubated with the cells for 6 hours. Following this, the cells were fixed and stained 
as described above. The experiment was performed in duplicate. 
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4.3.10 Cellular uptake: Prolonged incubation 
Protein loaded BSA#@RNP*_PME(2.5) (1 mg/mL and BSA# load 223 mg/g) and 
protein free RNP*_PME(2.5) (1 mg/mL) particles were used for this experiment. HeLa 
cells were incubated with the particles as described above for 6 hours. After 6 hours the 
media was removed and cells were washed twice with PBS and fresh media was added. 
The cells were the incubated again for different time periods, 1.5 hours, 2.5 hours and 3 
hours. The cells were fixed and stained as above. The experiment was performed in 
duplicate. 
 
4.3.11 Cellular uptake: Mechanism of uptake 
In order to determine the mechanism of uptake, the cells were pre-treated with 
various receptor blocking reagents as described in the literature.24,33 The general 
procedure is as follows; the confluent cells were treated with the receptor blocking agents 
(450 mM sucrose for clathrin, 5 µg/mL Nystatin for caveolar and 10 mM folic acid for 
folate receptor blocking). All blocking reagents were dispersed in DMEM media for 30 
minutes. After treatment for 30 minutes the cells were washed thrice with PBS to remove 
traces of the reagents and fresh media (0.9 mL) with nanoparticles (0.1 mL, 1 mg/mL) 
were added and incubated for 6 hours. Following this, the cells were stained and fixed as 
described above.  
 
4.3.12 HeLa cell sample preparation for TEM analysis 
Cell culture and incubation with nanoparticles (both protein loaded (223 mg/g) 
and protein free nanoparticles) were performed as described above. Samples were 
prepared for TEM analysis based on a previously published method.34 After incubating 
the particles for the required time period, the cells were treated with 4 wt% gluteraldehyde 
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in 0.125 M PBS for 2 hours. After 2 hours, the cells were suspended in 0.125 M PBS and 
washed twice. The cells were then transferred to fresh PBS (0.125 M) and stored at 4 °C, 
overnight. The cells were then treated with 1% osmium tetroxide and incubated at room 
temperature for 1 hour. The cells were then washed twice with distilled water. Following 
the washes, the cells were suspended in 30% industrial methylated spirt (IMS) for 15 
minutes. The cells were then isolated by centrifugation and the suspended in 50% IMS 
for 15 minutes and centrifuged again. The cells were then suspended in 70% IMS for 15 
minutes and centrifuged. The cells were then suspended in 90% IMS for 15 minutes and 
centrifuged. The cells were then suspended in 100% IMS for 20 minutes and centrifuged. 
The last step was repeated twice. The cells were next dispersed in propylene oxide for 5 
minutes and centrifuged. The step was repeated twice. Finally, the particles obtained after 
this final step were transferred to 50 wt% araldite and the resin was allowed to set and the 
set resin was added to specially designed moulds. Once the resin settled, the araldite stubs 
(thickness 50 nm) were sectioned using a diamond knife. The newly cut sections were 
placed on copper TEM grids for characterization. 
 
4.3.13 Cell viability study 
HeLa cells were seeded in 24 well plates with a density of 105 cells/mL in 1 mL 
of Dulbecco’s modified eagle medium and incubated at 37 °C under 5% CO2. The media 
was then removed and fresh media containing different particle concentrations ranging 
from 0 (control) to 0.2 mg/ mL, was added to the wells and incubated for 24 hours. For 
the protein loaded samples, the nanoparticle concentration was fixed at 1 mg/mL and the 
protein load was varied between 47 to 223 mg/g. BSA# cytotoxicity was also analysed, 
protein weight between 0 (control) to 50 µg was used for analysis. The study was done in 
triplicate. After incubation the cell culture medium was removed and the cells were 
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washed with PBS. The cells were then incubated for 2 hours with 0.5 mL of 5 mg/mL 
MTT solution, prepared by dissolving MTT tetrazolium salt in PBS. After 2 hours the 
MTT solution was discarded and 0.3 mL of isopropanol was added to the wells and 
thoroughly mixed to dissolve the formazan crystals. 0.1 mL of this solution was then 
transferred into 96 well plates and the optical density (OD) at 570 nm was measured using 
a microplate reader.35 Cell viability was calculated by measuring the ratio of the mean 
OD at each particle concentration to that of the control (no particles). The values are given 
in % survival ± % RSD (relative standard deviation). 
 
4.4 Results 
4.4.1 Nanoparticle characterization 
RNP*_PME(2.5) nanoparticles were synthesized as described in Chapter 1 and 
labelled as described in section 4.3.4. The label free particles had an average size of 80 
nm (size distribution between 60 to 90 nm) (Figure 4.1). Following synthesis, the particles 
were modified with Rhodamine B silane reagent prepared by reacting Rhodamine B 
isothiocyanate (RITC) with 3-aminopropyl triethoxysilane (Scheme 2). The particles had 
high surface area of 641.8 m2/g, the pore size of the particles was 11.6 nm and the pore 
volume was 0.821 mL/g.  (Figure 4.2 and Table 4.1). 
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Scheme 2: Rhodamine B silane synthesis 
 
 
Figure 4.1: TEM images of RNP*_PME(2.5) (Scale A) 200 nm ; B) 100 nm) 
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Figure 4.2: Nitrogen sorption porosimetry of RNP_PME(2.5) A) Sorption isotherm; B) 
BJH pore size distribution 
 
Table 4.1: Morphological properties of RNP_PME(2.5) 
No. Property RNP_PME(2.5) 
1 Particle shape Spherical 
2 Particle size distribution 60-90 nm 
3 Surface area 641.8 m2/g 
4 Pore volume 0.821 mL/g 
5 Pore size 11.64 nm 
 
4.4.2 BSA# adsorption on RNP*_PME(2.5) 
BSA# was synthesized by reacting FITC to BSA under basic conditions, and 
characterized by UV-Vis spectroscopy to confirm the presence of fluorescein (Appendix 
4). Adsorption of BSA# to RNP*_PME(2.5) was performed at the isoelectric point of 
BSA (pH 4.73, PBS) and the total maximum load of BSA# adsorbed onto the 
RNP*_PME(2.5) particles was determined (Figure 4.3). The maximum protein load was 
240.13 ± 5.62 mg/g. 
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Figure 4.3: Adsorption of BSA# to RNP*_PME(2.5) particles (n = 2 ± Std. dev.) 
 
4.4.3 Properties of the BSA# adsorbed nanoparticles BSA#@ RNP*_PME(2.5): 
Following the adsorption study, the suitability of the particles for cell studies was 
determined by measuring the dispersion properties and by determining the effect of 
adsorption on the secondary structure of the protein (determined using CD). The 
dispersion properties of the particles were measured in Dulbecco’s Modified Eagle 
Medium (DMEM) media (at physiological pH, 7.4). The RNP*_PME(2.5) particles 
showed an increase in the hydrodynamic radius, compared to the dispersion in PBS. This 
was probably due to aggregation of the nanoparticles due to the high ionic strength of the 
media (Figure 4.4) (compared to PBS Figure 3.5). The protein loaded particles, BSA#@ 
RNP*_PME(2.5) however, did not show any aggregation. It is possible that some of the 
BSA# was present on the particle surface and acted as a stabilizing agent. 
 
Figure 4.4: DLS data of the BSA loaded and unloaded particles in DMEM media. 
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Analysis of the effect of immobilization on the protein structure was performed by 
Circular Dichroism (CD), the analysis was performed in PBS at physiological pH 7.40. 
CD analysis revealed that immobilization and FITC functionalization did not affect the 
protein structure (Figure 4.5). 
 
 
Figure 4.5: Circular Dichroism spectra of BSA, BSA# and BSA#@ RNP*_PME(2.5) 
 
4.4.4 Cell Viability studies 
HeLa cells were chosen as the model system to study nanoparticle uptake. Protein 
free nanoparticles were tested for concentration dependent toxicity (RNP*_PME(2.5) 
concentration ranging from 0.025 to 0.2 mg/mL in cell culture media) (Figure 4.6). BSA# 
loaded nanoparticles BSA#@ RNP*_PME(2.5) were tested for the effect of varying 
protein concentration on the cell cytotoxicity (BSA#@ RNP*_PME(2.5) concentration 
was kept constant at 0.1 mg/mL so maximum BSA dose concentrations were 0.07-0.42 
μM) (Figure 4.7). In both cases no toxicity was observed. BSA# cytotoxicity was also 
tested and no cytotoxicity towards HeLa cells was observed upon exposure to 50 µg/mL 
or 0.75 μM of the protein. 
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Figure 4.5: Effect of RNP*_PME(2.5) particle concentration on HeLa cell survival. (n = 
3 ± Std. dev.) 
 
 
Figure 4.6: Effect of BSA# load in nanoparticles BSA#@ RNP*_PME(2.5) on cell 
survival (n = 3 ± Std. dev.) 
 
4.4.5 Time dependent uptake of RNP*_PME(2.5) 
Nanoparticle uptake by HeLa cells was studied using the Spots package in Imaris 
software. RNP*_PME(2.5) nanoparticles were rapidly taken up by the cells. About 63% 
of the total particle uptake was measured within the first hour. A slight increase in the 
particle uptake was observed during the next hour and the value remained constant for 
the next two hours followed by a further increase after 6 hours, this was however not 
statistically significant at p =0.01 (Figure 4.7 and 4.8). The Spots package was used to 
prepare 3D representations of the particle distribution in the cells (Figure 4.9). It must be 
mentioned that the particles localized over the nucleus were found to be either above or 
below the plane of the nucleus and were absent in the confocal image sections that 
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contained the nucleus. The confocal images from Figure 4.8 and 3D representations from 
Figure 4.9 show that the particles were initially distributed around the cells in aggregates 
(at  the 1 hour time point), further increase in time resulted in an even distribution of the 
particles within the cells. TEM analysis was performed on the cell after 6 hours of 
exposure to the particles. Many of the particles were located in the cytoplasm (Figure 
4.10 B), some of the particles were observed in vesicles (Figure 4.10 C) and particle 
uptake by caveolae (Figure 4.10 D) was also observed. No particles were detected in the 
nucleus (Figure 4.10 E) 
 
 
Figure 4.7: RNP*_PME(2.5) nanoparticle uptake versus time (n = 20 ± SEM (standard 
error of mean)) 
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Figure 4.8: Time dependent uptake of RNP*_PME(2.5) nanoparticles by HeLa cells 
(Scale 20 µm). The red spots indicate the presence of Rhodamine B isothiocyanate 
functionalized nanoparticles RNP*_PME(2.5) 
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Figure 4.9 : Distribution of RNP*_PME(2.5) nanoparticles in HeLa cells at different 
exposure times (Scale bar 10 µm in all images); A ) 1 hour; B) 2 hours; C) 4 hours and 
D) 6 hours 
 
 
Figure 4.10: TEM images of HeLa cells 6 hours after RNP*_PME(2.5) particle uptake. 
A) HeLa cell (Scale 5 µm); B) Particles in cytoplasm (black arrows) (Scale 500 nm); C) 
Particles within vesicles (black arrow) (Scale 500 nm) (Inset 2X magnification of the 
region containing the particles, indicated by black arrows); D) Caveolae on the cell 
surface (black arrow) (Scale 500 nm) (Inset 2X magnification of the region containing 
the particles, indicated by black arrows); E) Nucleus (Scale 500 nm) 
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4.4.6 Uptake of BSA#@ RNP*_PME(2.5) nanoparticles by HeLa cells 
Protein loaded nanoparticles BSA#@ RNP*_PME(2.5) showed a comparatively 
lower amount of uptake, the particle uptake was about half that of protein free 
nanoparticles. Also during the first hour only about 17% of the total uptake was observed 
(Figure 4.11). The particle uptake reached saturation after 4 hours. Confocal images 
clearly demonstrated that the protein molecules were successfully delivered into the cells. 
A control study involving BSA# without nanoparticles was performed and the study 
revealed that BSA# uptake did not take place in the absence of the nanoparticles. Further, 
it was clear from the confocal images that much of the BSA# remained co-localized with 
the particles (Figure 4.12). 3D distribution of BSA# and RNP*_PME(2.5) particles 
showed that as the particle exposure time increased from 1 hour to 6 hours, some protein 
release occurred, as evidenced by the presence of clusters of green spheres, however much 
of the BSA# remained in close proximity to the particles (Figure 4.13). Similar to the 
RNP*_PME(2.5) particles, BSA#@RNP*_PME(2.5) also showed clustering at initial 
time points (1 – 2 hours), however, as the exposure time increased, the particles spread 
more evenly around the cells. 
 
Figure 4.11: BSA#@ RNP*_PME(2.5) uptake versus time  (n = 20 ± SEM) 
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Figure 4.12: Time dependent uptake of BSA#@RNP*_PME(2.5)nanoparticles by HeLa 
cells (Scale 20 µm). The red spots indicate the presence of Rhodamine B isothiocyante 
functionalized nanoparticles RNP*_PME(2.5) and the presence of protein molecules 
was determined by identifying fluorescein isothiocyanate functionalized BSA, green 
spots. 
 
 
Figure 4.13 : Distribution of BSA#@RNP*_PME(2.5)nanoparticles in HeLa cells at 
different exposure times; A ) 1 hour(Scale bar 5 µm); B) 2 hours (Scale bar 7 µm); C) 4 
hours (Scale bar 10 µm) and D) 6 hours (Scale bar 5 µm) 
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Further analysis of the particle distribution was performed by TEM analysis. The 
vast majority of the particles were present in the cytoplasm. A few particles were observed 
to be localized within the mitochondria, demonstrating the ability of the particles to 
penetrate the mitochondrial cell membrane. In all cases, the particles were identified by 
their spherical morphology and from the difference in contrast from the surrounding cell 
organelles. Finally, the particles were observed to be localized within endosomes (Figure 
4.14E), suggesting that the particles were taken up by receptor mediated uptake (Figure 
4.14). 
 
 
Figure 4.14: TEM images A) HeLa cell (Scale 5000 nm); B) Protein loaded 
nanoparticle  BSA#@ RNP*_PME(2.5)localisation (black arrows) within the cytoplasm 
(Scale 1000 nm) (Inset 2X magnification of the region containing the particles, 
indicated by black arrows); C) Localization of nanoparticles within mitochondria (Scale 
500 nm); D) Nucleus , note that particles were not observed (Scale 1000 nm) (Inset 2X 
magnification of the region containing the particles, indicated by black arrows); E) 
Particles within endosomes (indicated by black arrows) (Scale 1000 nm) (Inset 2X 
magnification of the region containing the particles, indicated by black arrows). 
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4.4.7 Effect of BSA# load on the particle uptake 
BSA# load on the particles was varied from 111.1 to 166.7 to 223 mg/g and the 
effect of the loading on the particle uptake was studied. Lowest BSA# loading resulted in 
the smallest uptake levels. Particle uptake was nearly identical in the other two samples. 
(Figure 4.15) The samples were fixed after 6 hours. In all the cases, much of the BSA# 
was localized near the particles (Figure 4.16). 3D localization of the protein (green 
spheres) and particles (red spheres) showed that in samples with lower protein load 111.1 
mg/g and 166.7 mg/g, protein molecules were in close proximity to the particles. At 223.0 
mg/g the particles showed higher protein release (Figure 4.17). 
 
 
Figure 4.15: BSA#@ RNP*_PME(2.5) Particle uptake versus protein load. (n = 20 ± 
SEM.) 
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Figure 4.16: Effect of protein load in BSA#@ RNP*_PME(2.5) particles on particle 
uptake (Scale bar 20 µm). The red spots indicate the presence of Rhodamine B 
isothiocyanate functionalized nanoparticles RNP*_PME(2.5) and the presence of 
protein molecules was determined by identifying fluorescein isothiocyanate 
functionalized BSA, green spots. 
 
 
Figure 4.17: Distribution of BSA#@RNP*_PME(2.5)nanoparticles in HeLa cells at 
different protein load; A ) 111.1 mg/g (Scale bar 5 µm); B) 166.7 mg/g  (Scale bar 5 
µm); C) 223.0 mg/g (Scale bar 10 µm) 
 
4.4.8 Effect of prolonged incubation on the nanoparticle retention 
In order to determine the fate of the particles following uptake, the 
RNP*_PME(2.5) and BSA#@ RNP*_PME(2.5) particle loaded cells were incubated in 
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particle free media for up to 3 hours. It was observed that protein loaded and unloaded 
particles demonstrated different properties.  
Protein free RNP*_PME(2.5) particle numbers dropped significantly during the 
first hour of incubation in cell free media. Further incubation led to a small decrease in 
the particle numbers, which remained stable between 2.5 to 3 hours of incubation in 
particle free media (Figures 4.18 and 4.19). The observations were further validated by 
the 3D particle localization image. (Figure 4.20). TEM images of the HeLa cells from 
particle loaded cells following 3 hours of incubation in particle free media, showed very 
few particles and that all the particles were located in cytoplasm. Some of the particles 
were seen at the cell membrane, indicating that some of these particles were in the process 
of being exocytosed (Figure 4.21). 
 
 
Figure 4.18: Effect of RNP*_PME(2.5) particle numbers on incubation in particle free 
media  (n = 20 ± SEM) 
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Figure 4.19: Effect of incubation in particle free media on RNP*_PME(2.5) particle 
loaded cells (Scale 20 µm). The red spots indicate the presence of Rhodamine B 
isothiocyanate functionalized nanoparticles RNP*_PME(2.5).  
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Figure 4.20: Distribution of RNP*_PME(2.5)nanoparticles in HeLa cells at different 
incubation times in particle free media; A ) 0 hours (Scale bar 10 µm); B) 1.5 hours 
(Scale bar 10 µm); C) 2.5 hours (Scale bar 10 µm) and D) 3 hours (Scale bar 10 µm) 
 
 
Figure 4.21: TEM images of RNP*_PME(2.5) particle loaded cells after 3 hours of 
incubation in cell free media. A) Complete HeLa cell (Scale 5000 nm); B) Localization 
of the particles in cytoplasm (Scale 500 nm) (Inset 2X magnification of the region 
containing the particles, indicated by black arrows); C) Particle exocytosis (indicated by 
black arrows) (Scale 200 nm) 
BSA# loaded nanoparticles BSA#@ RNP*_PME(2.5) exhibited significantly 
different properties. The particle numbers did not change upon incubation in particle free 
media (Figures 4.22 and 4.23). The 3D particle localization images (Figure 4.24) showed 
that while the particles and protein quantity remained the same there was a small increase 
in the number of BSA# spheres (green spheres) that were not associated with the 
RNP*_PME(2.5) particles. TEM analysis of the cells loaded with BSA#@ 
RNP*_PME(2.5) particles were evenly distributed across the cell membrane, validating 
the observations from the confocal microscopy study. Furthermore the particles were not 
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found to be associated with any endosomes or lysosomes, suggesting that all the particles 
exhibited endosomal escape (Figure 4.25). 
 
 
Figure 4.22: Effect of BSA#@RNP*_PME(2.5) particle numbers on incubation in cell 
free media (n = 20 ± SEM) 
 
Figure 4.23: Effect of incubation in cell free media on BSA#@RNP*_PME(2.5) particle 
loaded cells (Scale 20 µm). The red spots indicate the presence of Rhodamine B 
isothiocyanate functionalized nanoparticles RNP*_PME(2.5) and the presence of 
protein molecules was determined by identifying fluorescein isothiocyanate 
functionalized BSA, green spots. 
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Figure 4.24: Distribution of BSA#@RNP*_PME(2.5) nanoparticles in HeLa cells at 
different incubation times in particle free media; A ) 0 hours (Scale bar 5 µm); B) 1.5 
hours (Scale bar 10 µm); C) 2.5 hours (Scale bar 10 µm) and D) 3 hours (Scale bar 10 
µm) 
 
. 
 
Figure 4.25: TEM images of BSA#@RNP*_PME(2.5) particle loaded cells after 3 hours 
of incubation in cell free media. A) Complete HeLa cell (Scale 5000 nm); B) 
Localization of the particles in cytoplasm (Scale 1000 nm) (Inset 2X magnification of 
the region containing the particles, indicated by black arrows); C) Nucleus, note the 
absence of particles (Scale 1000 nm) 
4.4.9 Mechanism of particle uptake 
The mechanism of particle uptake was studied by blocking specific nanoparticle 
uptake mechanisms. Clathrin receptors were blocked by treating cells with 450 mM 
sucrose, caveolar receptors were blocked using 5 µg/mL nystatin and folic acid receptors 
were blocked using 10 mM folic acid.  
RNP*_PME(2.5) nanoparticles were taken up predominantly by caveolar 
receptors, as upon blocking the caveolar receptors, a reduction of over 70% in particle 
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uptake was observed , while blocking clathrin and folic acid receptors resulted in apparent 
18% decrease and 32% increase in the particle uptake respectively (Figures 4.26 and 
4.27). The statistical significance of the result was determined at p-value of 0.01 using 
Wilcoxon ranked sum test by comparing results obtained after 6 hours of incubation 
against particle uptake following receptor blocking. The study showed that blocking 
caveolar receptors using nystatin resulted in statistically significant change at p-value of 
0.01 while blocking other receptors (clathrin and folic acid) did produce any statistically 
significant change. The observations were confirmed by the 3D particle localization 
images (Figure 4.28) 
 
 
 
Figure 4.26: Receptor mediated uptake of RNP*_PME(2.5) particles (n = 20 ± SEM.). 
Statistical significance was measured at p-value of 0.01 using Wilcoxon ranked sum 
test. Statistical significance was determined by comparing against the uptake when 
surface receptors were not blocked as in Sample: None. Statistical significance is 
denoted by ** and non-significant results by *.  
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Figure 4.27: Confocal microscope images depicting the effects of blocking surface 
receptors on RNP*_PME(2.5) particle uptake. (Scale 20 µm). The red spots indicate the 
presence of Rhodamine B isothiocyanate functionalized nanoparticles RNP*_PME(2.5).  
 
 
Figure 4.28: Distribution of RNP*_PME(2.5)nanoparticles in HeLa cells in presence of 
various cell surface receptor inhibitors; A ) No inhibitor (Scale bar 10 µm); B) Clathrin 
(Sucrose) (Scale bar 10 µm); C) Folate receptor (Folic acid) (Scale bar 10 µm) and D) 
Caveolae (Nystatin) (Scale bar 10 µm) 
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BSA#@ RNP*_PME(2.5) particles were taken up predominantly by the folic acid 
receptor mediated pathway. Over 80% of the particle uptake was blocked, when the folic 
acid receptors were blocked while 24% of the particle uptake was blocked when caveolar 
receptors were blocked. Statistical significance of the result was determined at p-value of 
0.01 using Wilcoxon ranked sum test by comparing results obtained after 6 hours of 
incubation against particle uptake following receptor blocking. The study showed that 
blocking folic acid receptors using folic acid resulted in statistically significant change at 
p-value of 0.01 while blocking other receptors (clathrin and caveolar) did produce any 
statistically significant change. (Figures 4.29 and 4.30). 3D localization images further 
confirm these observations (Figure 4.31). 
 
 
Figure 4.29: Receptor mediated uptake of BSA#@ RNP*_PME(2.5) particles  (n = 20 
±Rel. std. dev.) Statistical significance was measured at p-value of 0.01 using Wilcoxon 
ranked sum test. Statistically significance was  determined by comparing against the 
uptake when surface receptors were not blocked  as in Sample: None. Statistical 
significance is denoted by ** and non-significant results by *. 
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Figure 4.30: Confocal microscope images depicting the effects of blocking surface 
receptors on RNP*_PME(2.5) particle uptake. (Scale 20 µm). The red spots indicate the 
presence of Rhodamine B isothiocyanate functionalized nanoparticles RNP*_PME(2.5) 
and the presence of protein molecules was determined by identifying fluorescein 
isothiocyanate functionalized BSA, green spots. 
 
 
Figure 4.31: Distribution of BSA#@RNP*_PME(2.5) nanoparticles in HeLa cells at in 
presence of various cell surface receptor inhibitors; A ) No inhibitor (Scale bar 10 µm); 
B) Clathrin (Sucrose) (Scale bar 10 µm); C) Folate receptor (Folic acid) (Scale bar 10 
µm) and D) Caveolae (Nystatin) (Scale bar 10 µm) 
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4.5 Discussion 
The applications of RNP_PME(2.5) nanoparticles for immobilization and 
intracellular delivery of FITC labelled BSA was studied. The aim of these experiments 
was to demonstrate the ability of the particles to deliver large protein molecules across 
the cell membrane. The pore size of the RNP*_PME(2.5) was 11.6 nm and was therefore 
considered suitable to entrap BSA (molecular dimensions 5 x 7 x 7 nm3). Also BSA 
(molecular weight 66 kDa) is twice the size of cytochrome c, which was used in two 
previous studies, and was therefore considered a suitable candidate to test the ability of 
the particles as potential protein delivery agents.  
An adsorption study was performed to determine the total loading of BSA# on 
RNP*_PME(2.5) particles and the maximum loading obtained was 240.13 ± 5.62 mg/g. 
A lower BSA# load of 223 mg/g was chosen for the drug delivery applications to exclude 
the possibility of free BSA# in the solution. DLS was used to measure the hydrodynamic 
radii of the particles before and after loading. The measurements were performed in 
DMEM media. The studies revealed that the RNP*_PME(2.5) particles displayed 
aggregation in the media, evidenced by the observation that the hydrodynamic radius 
increased and the particle size distribution broadened. The particle aggregation could 
have resulted from the increased ionic strength of the media. The protein loaded particles 
BSA#@ RNP*_PME(2.5), however, did not show an increase in the hydrodynamic radius 
or a broadening of the particle size distribution. SEM analysis of protein immobilized 
particles revealed a smoothened particle surface (Figure 3.7) indicating the presence of 
protein molecules on the surface of the particles. These surface immobilized protein 
molecules could have played the role of steric stabilizing agents, which could have 
provided protection against aggregation in the cell culture media. Neither dispersion, 
however displayed any visible precipitate formation even after a few hours of exposure. 
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The integrity of the BSA# structure before and after immobilization was studied using 
CD. The study revealed that neither FITC attachment nor particle uptake resulted in 
changes to the protein structure at pH 7.40 (Figure 4.5).  
Cell uptake and viability studies were performed on HeLa cell line. HeLa cell 
lines are cervical cancer cell lines and have been demonstrated as excellent systems to 
study nanoparticle-cell interactions. The cell viability study following particle uptake was 
performed using the MTT assay.33 The study revealed that the neither particles nor BSA# 
showed any cytotoxicity. The RNP*_PME(2.5) particles were tested for concentration 
dependent cytotoxicity and were non-toxic up to the concentration of 0.2 mg/mL. This 
value was twice that of the previously published reports on MSNs.37 The result indicates 
high levels of biocompatibility, which most likely benefits from the presence of a 
phosphonate functional group on the particle surface. BSA#@RNP*_PME(2.5) particles 
were tested for the cytotoxic effects by varying the protein load on the particles, while 
keeping the particle concentration fixed at 0.1 mg/mL. BSA# load ranging from 47 mg/g 
to 223 mg/g was used. Statistically significant differences in cell viability were not 
observed in any of these cases. These results conclusively demonstrate the high level of 
biocompatibility of these nano materials. 
Nanoparticle uptake by the cells was analysed by confocal microscopy and the 
spots package on Imaris software. The package allows the visualization of spherical 
objects throughout the image stack based on the intensity of the point it represents.38 This 
method was used previously to quantitatively estimate the fluorescent nanoparticle 
uptake.39 A fixed nanoparticle concentration of 0.1 mg/mL was used for the study. The 
study revealed that the protein free RNP*_PME(2.5) nanoparticles showed a progressive 
and time dependent uptake and reached saturation after 6h of nanoparticle exposure. 
Previous studies involving silica nanoparticles required between 16 to 24 h of exposure 
185 
 
to facilitate uptake so the studies here showed a dramatic improvement in the time 
required for uptake.29 The vast majority (~ 50% of the uptake occurred within the first 
hour (Figure 4.7). The protein loaded nanoparticles BSA#@RNP*_PME(2.5) showed a 
similar progressive trend in particle uptake, however the rate of particle uptake was lower 
(Figure 4.11). The final particle uptake was nearly half that of the RNP*_PME(2.5) 
particles suggesting that protein immobilization lowered the extent of particle uptake.  
The mechanism of the particle uptake was analysed by blocking clathrin, caveolar 
and folic acid receptors. Previous studies involving the MSNs revealed that these are the 
dominant pathways involved in nanoparticle uptake.24 Other pathways such as 
phagocytosis and macro-pinocytosis were not considered as they are predominantly 
involved in the uptake of medium sized (> 500 nm) particles and small molecule uptake 
respectively.40 It was observed that RNP*_PME(2.5) particles showed caveolar receptor 
mediated uptake from confocal microscope analysis of the cells obtained from particle 
uptake experiments (Figure 4.26). Caveolar pathway is a non-destructive nanoparticle 
endocytosis pathway. Caveolar uptake involves caveolae, which are 50 to 100 nm 
invaginations in the cell membrane. They consist of lipid rafts, which are made of lipids 
such as cholesterol and the protein caveolin. Caveolin is a small (21 kDa) protein, which 
associates with lipids to form lipid rafts. Unlike the clathrin mediated nanoparticle uptake, 
caveolar endocytosis does not involve the lysosomes and therefore does not result in 
biomolecule degradation (the final particle destination is golgi apparatus) (Scheme 
3).Further direct evidence was obtained from TEM analysis of cell sections (Figure 4.10 
D), where the image showed the particle uptake by coated 80 nm pits, which are most 
likely caveolar receptors.41 Additionally, vesicles containing particles (Figure 4.10 C) 
were observed, further strengthening the case for receptor mediated uptake. 
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Scheme 3: Caveolar uptake, Various pathways a protein carrier might follow upon cell 
entry; a) protein carrier uptake through caveolar receptors, b) encapsulation in early 
endosome coated with caveolin, c) endosomal escape and carrier release, d) controlled 
release of encapsulated protein, e) protein action inside the cell, f) conversion of early 
endosomes to late endosomes, g) transfer to golgi apparatus. 
 
 Electron microscope analysis of the HeLa cells incubated with the nanoparticles 
RNP*_PME(2.5) showed that the particles were located in the cytoplasm (Figures 4.10 
B and 4.21 ). This strongly indicates that the particles displayed endosomal escape. 
Previous reports noted that negatively charged nanoparticles display more rapid 
endosomal escape.22, 41  
Protein loaded nanoparticles (BSA#@RNP*_PME(2.5) displayed folic acid 
receptor mediated uptake (Scheme 4), determined from confocal microscope analysis of 
the cells obtained from particle uptake experiments (Figure 4.29). Folic acid receptors are 
over expressed on many cancer cells and are one of the most important targets for various 
drugs.42 HeLa cells display folic acid receptor α on their surface.43 Folic acid receptors 
have been found to be located on the caveolae,43 so it can therefore be surmised that the 
change in the particle uptake pathway does not represent a significantly different receptor 
mediated uptake All the previous studies that involved targeting these receptors required 
functionalization of the particle surfaces with folic acid groups.44 In the current study folic 
acid receptor mediated uptake was observed despite the absence of folic acid 
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functionalization on the particles. TEM analysis of the HeLa cells following 
BSA#@RNP*_PME(2.5) particle uptake showed that some of the particles were present 
in the endosomes (Figure 4.14). The remaining particles were observed in the cytoplasm. 
This indicates that the particles displayed endosomal escape.  
Wosikowski et al. demonstrated the uptake of Methotrexate (MTX) by KB cells.45 
KB cell lines are cancer cells and they express folate receptor alpha (FR-α) similar to 
HeLa cells.41 MTX is an anti-folate drug, however FR-α have low affinity for this drug 
and is therefore not taken up by KB cells.46 Wosikowski et al. demonstrated that 
conjugation of MTX to human serum albumin (HSA) increased the drug uptake by these 
cells, additionally, MTX-HSA conjugates were taken up by folate receptor mediated 
uptake.45 In the above study, BSA (which has high degree of similarity to HSA47) loaded 
nanoparticles were taken up by folate receptor mediated pathway. It is therefore suggested 
that this protein-nanoparticle conjugate stimulates the folate receptor and leads to particle 
uptake.  
 
Scheme 4: Folic acid receptor mediated uptake a) folic acid receptor coating, b) 
encapsulation within endosomes, c) endosomal escape, d) controlled release of 
encapsulated protein, e) protein action inside the cell 
Following the above experiments, which demonstrated particle uptake by the cells 
further experiments looked at the behaviour of the endocytosed particles over time. Thus 
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the media containing the particles was removed from the cultures and particle-free media 
was added to the cells and incubated for different time periods. RNP*_PME(2.5) 
nanoparticles numbers showed a steady drop during this time period. Three hours of 
incubation in the particle free media resulted in a near complete depletion of the number 
of nanoparticles observed. The result suggests that the particles were exocytosed from the 
cells. This observation was confirmed by TEM analysis. The BSA#@RNP*_PME(2.5) 
nanoparticles on the other hand, did not show any depletion in numbers. The particle were 
however, evenly distributed across the cell membrane, suggesting complete endosomal 
escape.29 TEM analysis of the cells showed that the particles were not associated with any 
cell membrane and were evenly distributed across the cell membrane, confirming the 
observation by confocal microscopy. The vast majority of the BSA molecules, continued 
to remain associated with the particles, suggesting that the protein loaded particles 
showed slow release of the adsorbed protein molecules (Figure 4.12). 
 
4.6 Conclusion 
Nanoparticle mediated intracellular protein (BSA#) delivery was achieved by 
RNPPME(2.5) nanoparticles. The protein loaded particles were successfully used to 
deliver protein molecules across the cell membranes and the labelled protein entry into 
the cells was confirmed by confocal microscopy. . The particles demonstrated the ability 
to carry significantly large quantities of proteins, compared to the previously published 
reports.48 Broadly, the study investigated four specific parameters. 1) cytotoxicity of the 
particles; 2) time dependent uptake; 3) fate of the particles loaded in cells incubated in 
fresh particle free media; 4) mechanism of particle uptake.  
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Cytotoxic assessment of the particles (BSA# loaded and unloaded) was made 
using MTT assay. Concentration dependent cytotoxicity and protein load dependent 
cytotoxicity were assessed for protein free RNP*_PME(2.5) and loaded 
BSA#@RNP*_PME(2.5) particles respectively. The particles were found to be non-toxic 
during 24 hours of exposure to the cells. Following this, the time dependent uptake was 
studied. Confocal microscope images of HeLa cells with BSA# loaded particles showed 
that there was strong co-localization between RNP*_PME(2.5) and BSA#. The result 
indicated that during the time of the experiment, the protein molecules remained localized 
on the particles. Protein load dependent particle uptake was also studied. Particles with 
166.7 and 223 mg/g BSA# were taken up in similar numbers, while the particles with 
111.1 mg/g BSA# were taken up in smaller numbers.  
Particle exocytosis was studied by incubating the cells in particle free media. 
Strong reduction in the numbers of unloaded particles was observed just after incubation 
for one hour. The particle numbers remained relatively stable for the next two hours. TEM 
images of the HeLa cells containing RNP*_PME(2.5) particles showed exocytosis of the 
particles. The BSA# loaded particles on the other hand were evenly distributed in the cell 
membrane and the numbers of these particles did not show any reduction due to 
incubation in particle free media. TEM analysis of both the samples described above also 
showed that all the particles were present in the cytosol, indicating that the particles 
showed endosomal escape. 
Finally, the mechanism of particle uptake was studied. Three receptor mediated 
uptake pathways were studied. 1) clathrin; 2) caveolar; 3) folic acid. The protein free 
RNP*_PME(2.5) particles were taken up predominantly by caveolar pathway, as 
demonstrated by the significant reduction in particle numbers due to blocking of the 
corresponding receptors. Blocking folic acid receptors was found to strongly reduce the 
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uptake of BSA# loaded nanoparticles BSA#@ RNP*_PME(2.5). The results presented 
above demonstrate novel properties of folic acid receptors; the roles of these receptors in 
nanoparticle entry regulation and in the uptake of protein loaded particles were previously 
unknown. The results presented here have potential applications in the areas of targeted 
drug delivery, since folic acid receptors are over expressed on cancer cells. 
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Chapter 5: Chemical and Biological catalytic activity of 
RNP_PME(2.5) :C.rugosa lipase@RNP_PME formation and 
use; RNP_PME catalytic conversion of glucose and fructose 
to platform chemical precursor HMF. 
 
5.1 Summary 
Applications of RNP_PME(2.5) nanoparticles in the fields of catalysis and enzyme 
immobilization (specifically C. rugosa Lipase enzyme subsequently referred to as 
enzyme) were explored. RNP_PME(2.5) nanoparticles acted as excellent Brönsted acid 
catalysts to convert fructose to 5-(Hydroxymethyl)furfural (HMF). Yields of 87% were 
obtained using 10 wt% fructose. The catalyst demonstrated excellent recyclability. Large 
pore nanoparticles were also used to immobilize lipase on the particles. Following 
immobilization, an increase in the maximum velocity and Michaelis constant of the 
enzyme was observed. The particles also afforded protection against denaturation. 
 
5.2 Introduction 
5.2.1 Heterogeneous catalysts for the synthesis of HMF from sugars 
Currently petrochemicals are the source for the vast majority of chemicals and 
energy. However, diminishing petrochemical reserves and pollution caused during the 
production and use of petrochemicals resulted in the search for cleaner and renewable 
sources for platform chemicals and energy.1 Biomass, especially in the form of 
carbohydrates is the most widely available carbon source on the planet and is considered 
an attractive source of new platform chemicals.1 Carbohydrates contain carbon, hydrogen 
and oxygen atoms. In order to be used as platform chemicals or energy source it is 
important to reduce the number of oxygen atoms. Three strategies have evolved to 
achieve this aim. The elimination of small molecules such as carbon dioxide, 
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formaldehyde or formic acid reduces the number of oxygen atoms, however it also 
eliminates vital carbon atoms. Hydrogenation, preserves the total number of carbon 
atoms, however this method has limited application since only polyols can be produced 
by this method. Finally, dehydration reactions have been used to eliminate water 
molecules from the carbohydrate molecules. This method has been used to synthesize a 
variety of platform chemicals such as HMF (Scheme 1), furfural, levulenic acid etc.2  
 
Scheme 5.1: HMF 
HMF is an important platform chemical. It is naturally produced in carbohydrate 
rich foods such as honey and is considered as an indicator of food deterioration.2 
However, HMF is also a very important platform chemical. It has been used to synthesize 
a wide variety of commercially important compounds. Structures of these HMF 
derivatives are presented in Scheme 2. HMF was first synthesized by Düll and Keirmeyer 
in 1895, by heating sugars in presence of oxalic acid under pressure.3 
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Scheme 5.2: HMF derivatives 
Two general mechanisms were proposed to explain the formation of HMF under 
aqueous conditions. The acyclic pathway (Scheme 3), where the first step involved the 
formation of linear 1,2-enediol, by the Lobry deBruyn-Alberda van Ekenstein (LBAE) 
transformation. 1,2-enediol undergoes two further β-dehydrations and a ring closure to 
form HMF.4 The cyclic pathway (Scheme 4) starts from cyclic ketofuranose, which is 
expected to undergo dehydration of the hemiacetal at C2 to form carbenium cation, which 
then undergoes two consecutive β-dehydrations to form HMF.5 Conclusive experimental 
evidence to support either mechanism has not been established. Studies have also shown 
that the choice of carbohydrates strongly affected the yield of HMF. Use of fructose 
resulted in higher yields compared to glucose as the starting material.6 
 
199 
 
 
Scheme 5.3: Acyclic pathway for HMF synthesis  
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Scheme 5.4: Cyclic pathway for the synthesis of HMF 
Synthesis of HMF in high yields remains a technical challenge. Under aqueous 
conditions, HMF produced from carbohydrates is rapidly converted to a variety of by 
products such as formic acid, levulenic acid or alternatively the sugars are converted to 
insoluble polymers called humins.2 The challenge therefore is to improve the selectivity 
and isolated yield of HMF. Dumesic et al. developed a biphasic system designed to take 
advantage of the differences in the solubility characteristics of HMF and the by-products.7 
HMF is soluble in both aqueous and organic solvents (such as methyl isobutyl ketone 
(MIBK)), while the starting material glucose and the by-products such as formic acid are 
water soluble. In order to efficiently separate HMF from the aqueous phase Dumesic et 
al. used MIBK : 2-butanol (7:3 ratio). 2-butanol increased the solubility of HMF in the 
organic phase. However only modest yields between 40 to 60% were obtained using this 
method, when fructose was used as starting material.7 Other groups have used DMSO as 
the solvent. In these reactions DMSO acted both as the solvent and as a catalyst.8 
However, the isolation of HMF from DMSO is an energy intensive process and is 
expected result in a significant loss of the product due to carbonization when carried out 
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on an industrial scale.7 Other strategies for synthesis included using ionic liquids and 
Lewis acid catalysts such as CrCl3
9 and AlCl3 .
10 The use of ionic liquids resulted in 
excellent yields.11 However, due to the high cost of ionic liquids, the process would only 
lend itself to laboratory scale synthesis. The use of CrCl2 and CrCl3 produced good yields 
of HMF, especially when used in combination with ionic liquids9 or solvents such as 
dimethyl acetamide (DMA).12 In addition to the disadvantages mentioned above, the 
toxicity of the chromium salts severely limit the application of this process. Finally, the 
use of AlCl3 resulted in moderate yields (~ 60%), however stoichiometric amounts (50%) 
of catalyst were used in the reaction.10 
In order to overcome these problems, heterogeneous catalysts such as Amberlyst-
13 were used in the synthesis of HMF.7 These catalysts are more efficient, robust, easily 
separated and do not produce toxic by-products.13 However, only moderate HMF yields 
were obtained using heterogeneous catalyst systems. Heterogeneous catalysts, especially 
zeolites, have been widely used in the petrochemical industry. Zeolites have a robust 
chemical structure and have been demonstrated to withstand extreme temperatures.14 
Various zeolites were used to convert sugars (glucose and fructose) to HMF with 
moderate yields.15 The main challenge in the use of zeolites as catalysts resulted from the 
microporosity of these materials (pore size around 0.8 nm).16 Previous studies on zeolites 
demonstrated that the materials exhibited diffusion limitation, which arose due to the 
small pore size of these materials. This caused inefficient removal of the product 
molecules resulting in deactivation of the catalyst.17 Mesoporous bulk silica materials 
have been used to overcome this problem.17 These materials have tunable pore size and 
have a robust structure. Moderate HMF yields were obtained using sulphonic acid 
functionalized mesoporous silcas.18 Despite the moderate yields, organically 
functionalized SBA-15 silicas were used to develop flow based reactor systems for HMF 
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synthesis, highlighting the potential of heterogeneous catalysts.19 Mesoporous silica 
nanoparticles have been demonstrated to have higher mass transfer co-efficient, therefore 
these particles could potentially be used as better catalysts.20 Several studies involving 
MSNs showed little or no improvement over bulk materials.21 Therefore there is a need 
to develop better and more efficient catalysts for HMF synthesis.  
5.2.2 Lipase immobilization 
Lipases are one of the most industrially important enzymes. Lipases can perform 
esterification at the oil-water interface and are classified as triacylester hydrolases EC 
3.1.1.3 ((EC numbers are used to classify enzymes based on the reactions they catalyse. 
Lipases belong to a class of enzymes known as hydrolases, which catalyse hydrolysis of 
a chemical bond. EC 3.1.1 classify the enzymatic reaction as hydrolysis of ester bonds).22 
Unlike other enzymes lipases do not have substrate specificity and can catalyse a variety 
of reactions such as esterification, de-esterification, transesterification, acylation and can 
be used to perform enantiomeric separation of organic compounds.23 Due to their 
excellent properties, lipases are used for a variety of applications ranging from organic 
synthesis to cheese making.24 However, difficulty in recycling and reusing the enzymes 
have prevented applications in the area of large scale chemical synthesis.25 
Immobilization of lipases on various surfaces has been demonstrated to improve 
catalytic efficiency. Immobilization of enzymes on solid surfaces typically limits 
conformational changes and affords protection.26 Three dominant strategies have been 
used so far to immobilize lipase. The first strategy involved physical immobilization on 
mesoporous silica materials, such as SBA-15 or MCM-41.27 Immobilization on 
mesoporous silica surfaces protected the enzymes from degradation. However, enzyme 
leaching was observed when unfunctionalized silica was used.28 The second strategy 
involved chemical conjugation to nanoparticle surfaces and this method has been 
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extensively used with polymer or polymer coated nanoparticles.25 This method helped 
overcome the problem of protein leaching.28 Polymeric materials have low recyclability, 
which limits the applications of these systems.29 However, the recyclability of the 
materials was improved when the robust materials such as carbon nanotubes30 or 
mesoporous silica31 were used. The final strategy involved encapsulation of lipases inside 
silica shells. This method resulted in good enzyme encapsulation,32 especially when 
histidine tagged lipases were used.33 Until recently, mesoporous silica nanoparticles have 
not been used to encapsulate lipases. Mesoporous silica nanoparticles have higher mass 
transfer co-efficient compared to bulk silicas20 and could therefore act as good 
encapsulation substrates. The dimensions of lipase molecules are 5x4.2x3.3 nm3. 
Previous studies involving SBA-15 silicas demonstrated that nanomaterials with pore 
diameter of around 15 nm are best suited for lipase immobilization.34 The lack of studies 
detailing lipase encapsulation in mesoporous silica nanoparticles could be explained by 
the fact that very few reports have been published detailing the synthesis of nanoparticles 
with that pore diameter. 
5.3 Experimental 
Materials: RNP_PME(2.5) was synthesized using the methods described in 
Chapter 2. Lipase from C. rugosa (CRL), type VII, 4-nitrophenyl acetate, 4-nitrophenol 
(≥ 99%), methyl isobutyl ketone (≥ 98.5%), 2-butanol (99%), BSA (bovine serum 
albumin), sodium dihydrogen phosphate were purchased from Sigma Aldrich and were 
used without any further purification; fructose and dibasic sodium phosphate was 
purchased from BDH chemicals; NaOH pellets, ethanol, acetonitrile (99%) and HCl (35% 
w/w) was purchased from VWR and used without further purification. The particle 
synthesis and buffer preparation were carried out in deionized water dispensed from an 
18 mΩ Millipore system supplied by Elba UK. 
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5.3.1 HMF synthesis 
Fructose (100 mg, 0.55 mmol) was dissolved in deionized water (0.9 g) and 
RNP_PME(2.5) (15 mg) was added to this solution. An organic phase (4 g) containing 
MIBK and 2-butanol in 7:3 ratio was added to the reaction vessel to obtain a biphasic 
mixture. The biphasic mixture was sonicated using an ultrasonic probe in pulsed mode. 
The amplitude of the probe was set to 65%. Ultrasonic waves were applied with a 45 
second pulse and 15 second pause sequence. The total sonication time was 5 minutes. It 
was found that the reproducible results were obtained only when the probe was properly 
centred in the reaction vessel. After sonication the mixture was allowed to settle for 15 
minutes, at which point it separated into water-in-oil (upper) and oil-in-water (lower) 
phases. The reaction mixture was heated to 180 ◦C, while stirring at 600 rpm for 3 h. After 
the 3 hours the reaction was allowed to cool and the emulsion was broken by centrifuging 
the reaction vessel at 1000 rpm for 1 minute and the organic layer was separated and the 
solvent removed by using a rotary evaporator. The product was weighed and 
characterized by 1H NMR. 
Catalyst recyclability: After completion of the reaction, the reaction mixture was cooled 
without stirring and the emulsion was broken by adding a small amount of diethyl ether 
and the organic phase (top layer) removed. Following the organic layer removal, another 
batch of fructose (0.1g, 0.55 mmol ) and organic phase (4 g, MIBK and 2-butanol in 7:3 
ratio) was added and the process repeated. In this manner five catalytic cycles were 
assessed. In each case pure HMF (by NMR) was obtained from the organic phase. The 
experiment was performed in duplicate. 
Effect of fructose concentration: The same process was repeated with different 
concentrations of fructose (from 10 to 50 wt%), while keeping the weight of the catalyst 
constant (15 mg). 
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Kinetic study: The kinetics of HMF production was assessed. Reactions were stopped 
after 5, 15, 30 and 60 minutes. For each time point, the upper (organic) phase was 
collected and the weight of HMF obtained was determined by solvent removal.  
5.3.2 Reaction characterization 
Optical microscopy: oil-in-water and water-in-oil emulsion mixtures were 
prepared as described above using 10 wt% of fructose in the aqueous phase. One drop of 
each emulsion was placed on a clean glass slide and observed using an optical microscope 
at 20X and 50X magnification. Images were collected and processed using ImagePro 
Express software. 
Cryo-Scanning Electron Microscopy (Cryo-SEM): Cryo-SEM was used to image the 
emulsions generated during HMF synthesis. The analysis was carried out on Quanta FEG 
450 SEM, equipped with Gatan ALTO 2500 cryotransfer for SEM. Sample preparation 
involved the following steps: 
Instrument setup: Prior to sample preparation, the cryo stage was inserted into 
the SEM and the system was flushed with nitrogen gas and cooled using 
liquid nitrogen.  
Sample preparation: One drop (~ 100 µL) of emulsion (oil in water (O/W) 
and water in oil (W/O) was placed on an aluminium stub and the sample was 
rapidly frozen by dipping in nitrogen slush for 5 minutes. The sample was 
then transferred to a vacuum pod and transferred into the preparation chamber 
of the SEM and chamber pressure was set to 8 bar. Following this, the sample 
temperature was raised to – 90 ± 3 °C and the sample was kept at this 
temperature for 2 minutes to sublimate ice. The sample temperature was then 
decreased to -130 °C. 
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Sample coating and imaging: When the sample temperature reached -130 °C, 
the chamber was flushed with ultra-pure argon gas (99.999 vol%) and the 
sample was coated with platinum. Following this, the sample was inserted 
into the microscope. The samples were imaged at 10 and 5 kV voltage for 
O/W and W/O emulsions respectively and the spot size for both samples was 
5 nm. 
 
Catalyst stability NMR study: The stability of the catalyst was determined by measuring 
the total phosphonate loading on the particles at different stages of the reaction. The 
reactions were set up based on the procedure described above. The reactions were stopped 
after different time periods (between 5 minutes and 1 hour). A blank reaction was 
performed for 3 hours without using any fructose to study the effect of the reaction 
conditions on the particles. Following this, the aqueous phases were freeze dried (for 30 
hours) to obtain dry particles. These particles were then dissolved in 400 µL NaOD/D2O 
and centrifuged to remove any undissolved impurities. 300 µL of the supernatant and 100 
µL of internal standard solution (potassium dihydrogen phosphate35 in D2O) were added 
to an NMR tube.  
 
5.3.3 CRL immobilization 
CRL was supplied as a crude mixture, containing two isoforms of lipase36 and a 
variety of biomolecules of non-enzymatic nature with specifications of 700 U/mg (U = 
µmol/ min). In this work the CRL loading was quantified by Bradford assay extrapolated 
from a BSA calibration curve (Appendix 4) and enzyme activity was measured from the 
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conversion of the substrate (4-nitrophenyl acetate) to product (4-nitrophenol) (Appendix 
4 ). 
Preparation of CRL solution: 3 g of C. rugosa lipase was added to 30 mL of sodium 
phosphate buffer (PB) (25 mM), pH adjusted to 5.00 by adding 1 M HCl, at 4 °C. After 
16 hours of gentle stirring, the suspension was centrifuged at 14000 rpm for 25 minutes 
to separate the insoluble products. The clear brown solution thus obtained was stored at 
4 °C. 
Measurement of CRL concentration: Protein concentration was determined using 
Bradford assay37 and the calibration curve obtained using BSA stock solution (0.1 
mg/mL) (Appendix 4). 
CRL adsorption study: Nanoparticle dispersions (1 mg/mL) of RNP_PME(2.5), in PB 
(25 mM) at pH 4.99 were prepared by sonication for 30 min. Different concentrations 
(0.06 – 2 mg mL-1) of Lipase in PB (pH 4.99) were prepared. Mixtures containing 1 mL 
enzyme solution and 1 mL of nanoparticle dispersion were gently agitated and allowed 
to stand for 45 minutes at 20 °C. Next these enzyme-protein dispersions were centrifuged 
at 14000 rpm (10 min) and the particles and supernatant collected and the latter analysed 
by Bradford assay. Measurements were performed in triplicate 
CRL load vs Time study: Nanoparticle dispersions RNP_PME(2.5) (2 mg mL-1) were 
prepared by sonicating the particles in PB (25 mM, pH 4.99). Samples of this dispersion 
(1 mL) were added to lipase solutions (1 mL of 2 mg/mL), gently mixed and allowed to 
stand for different time periods. Then the enzyme-protein dispersion was centrifuged at 
14000 rpm (15 min) and the particles and supernatant collected and analyzed by Bradford 
assay. Measurements were performed in duplicate 
208 
 
Enzyme catalysis: A 100 mM stock solution of the enzyme substrate 4-nitrophenyl 
acetate (4-NPA) in acetonitrile was prepared. Lipase stock solution of 0.03 mg mL-1 
(determined by Bradford assay) was prepared in 25 mM PBS (pH 7.0). 0.3 mL of the 
substrate solution was mixed with 2.7 mL of the enzyme solution and the reaction was 
followed by UV-Vis spectroscopy, by monitoring the peak absorbance at 400 nm 
(corresponding to 4-nitrophenol). The reaction was carried out in a shaker at 250 rpm and 
the temperature was set at 25 °C. In order to perform enzyme kinetics study, the substrate 
concentration was varied from 1-100 mM. Each measurement was repeated 8 times. The 
reaction velocity (q) was calculated by determining the absorbance of nitophenol/minute 
and this was plotted against substrate concentration [S] in mM units. 
Denaturation study: Urea is a protein denaturant and the effect of this on the reaction 
was studied by treating the reaction mixture described in the enzyme catalysis section 
with varying amounts of urea (from 1 to 4 M). The formation of 4-nitrophenol was 
followed spectroscopically by measuring the absorbance of the solution at 400 nm. 
Measurements were performed in triplicate. 
 
5.4 Results 
5.4.1 Nanoparticle characterization 
SEM analysis revealed that the particles, RNP_PME(2.5) employed in this study, 
had, as previously, a spherical shape and raspberry texture. The particles were 
monodisperse with particle size ranging from 70 to 90 nm (Figure 5.1). Surface area and 
the pore size of the particles were determined using nitrogen adsorption porosimetry 
(Figure 5.2). The surface area of the particles was 724 m2/g the particles displayed large 
pore diameter of 17.8 nm. A summary of the morphology of the particles is given in Table 
5.1 
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Figure 5.1: SEM images of RNP_PME(2.5) nanoparticles. Scale bar A) 1000 nm; B) 
500 nm 
 
 
Figure 5.2 Nitrogen adsorption isotherm of RNP_PME(2.5) nanoparticles 
Table 5.1 Morphological properties of RNP_PME(2.5) nanoparticles 
Property RNP_PME(2.5) 
Particle shape Spherical 
Particle size distribution 70 -90 nm 
Surface area 724 m2/g 
Pore volume 0.732 mL/g 
Pore size 17.86 nm 
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5.4.2 HMF synthesis 
Pickering emulsion formation  
RNP_PME(2.5) nanoparticles were added to the biphasic mixture of aqueous 
fructose solution and the organic phase (MIBK:2-butanol in 7:3 volume ratio) and 
sonicated using an ultrasonic probe. Sonication resulted in the formation of a homogenous 
white emulsion, which slowly separated into two phases, the bottom phase was milky 
white oil in water (O/W) emulsion. This phase was visually identified, by shaking the 
reaction tube, to be more viscous than the original fructose solution. The second phase 
was the water in oil (W/O) phase. This layer had a cloudy appearance.  
Optical microscopy was used to characterize the emulsions. One drop from each 
emulsion was placed on a clean microscope slide. The oil-in-water showed a large number 
of droplets. The size of the droplets varied between 2 to 20 µm. The droplets had a 
distorted spherical shape. Interestingly, aggregation between the droplets in the form of 
Ostwald ripening was not observed, suggesting that the emulsion was stable under the 
observation conditions (Figure 5.3). The water-in oil emulsion had smaller, more uniform 
sized droplets. The average droplet size was around 2 µm (Figure 5.4) and there were 
fewer droplets in this phase compared to the oil-in-water layer. 
 
Figure 5.3: Optical microscope images of oil-in-water emulsion A) At 20X 
magnification (Scale bar 50 µm) and B) At 50X magnification (Scale bar 20 µm) 
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Figure 5.4: Optical microscope images of water-in-oil emulsion A) At 20X 
magnification (Scale bar 50 µm) and B) At 50X magnification (Scale bar 20 µm) 
 
Cryo-SEM imaging 
The Pickering emulsions were further imaged by cryo-SEM imaging. The 
technique allowed direct imaging of the emulsion droplets. The images, revealed that the 
droplets were covered by nanoparticles. The droplets from the aqueous phase (Figure 5.5) 
had a sea urchin like surface texture. The cryo-SEM images further revealed the presence 
of smaller particles (~ 1 µm in diameter, Figure 5.5), which were not observed using 
optical microscopy, due to lower resolution of the optical microscope. The particles were 
found to be localized on the surface of the droplets in irregularly shaped aggregates. 
However, images revealed that the particles displayed high interconnectivity, suggesting 
network formation. The images conclusively established the presence of Pickering 
emulsion (Figure 5.6). 
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Figure 5.5: Cryo-SEM image of O/W emulsion (Scale bar figures A and B - 5000 nm) 
 
Figure 5.6: High magnification Cryo-SEM image of O/W emulsion (Scale bar figures A 
and B - 2000 nm) 
The droplets observed in the organic phase had irregular morphology, as observed 
in the optical images and fewer nanoparticle stabilized water droplets were observed in 
the organic phase. (Figure 5.7). The irregular morphology was probably due to the 
collapse of the emulsion, following the sublimation step during sample preparation. 
Particles were observed on the irregularly shaped structures. The particles, however 
showed lower level of interconnectivity. 
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Figure 5.7: Cryo-SEM image of W/O emulsion (Scale bars, A – 10 µm and B – 
5 µm) 
 
5.4.3 HMF synthesis and catalyst recyclability: 
HMF was synthesized using RNP_PME(2.5) nanoparticles as acid catalysts and 
fructose was used as the starting material (Scheme 5.4). The reaction was carried out in a 
thick glass sealed tube at 180 °C for 3 hours. As the reaction progressed both O/W and 
W/O layers underwent colour change. The W/O layer changed from cloudy to dark 
brown. The aqueous phase changed to dark orange from the initial milky white. In order 
to break the emulsion, the vial was centrifuged at 1000 rpm for 1 minute after it cooled 
to room temperature. The organic layer was then separated and the solvent was removed 
under vacuum. The final product yield of 87.36 ± 0.83 % was obtained. 
In order to demonstrate the reusability of the catalyst a catalyst recycle study was 
carried out. Cycle 0 represented the first reaction, the catalyst was then subsequently 
recycled 4 times. After each reaction, the reaction was stopped and the organic layer was 
separated as described above. Following this, fructose and fresh organic layer were added 
to the reaction tube and sonicated and the reaction was carried out as described above. 
The results (Figure 5.8) showed that the isolated yield was constant, suggesting that the 
catalyst was highly efficient and recyclable with TON (turnover number) of 61.7 
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moles/mol of acid per gram of catalyst (on the basis of 2.5 mmol phosphonate /gram on 
the nanoparticles) after 5 cycles. 
 
Figure 5.8: Catalyst recycle study (n= 2 ± std. dev.) 
 
5.4.4 Effect of fructose concentration 
The effects of fructose concentration on overall yield was studied. Different 
concentrations of fructose ranging from 10 wt% to 50 wt% were used. The reaction 
conditions were those described above and the isolated yields of HMF were calculated 
using the methods described above. The isolated yield of HMF decreased slightly from 
87.36 % at 10 wt% to 79.97% at 50 wt% fructose concentration (Figure 5.9). 
 
Figure 5.9: Effect of Fructose concentration on HMF yield (n= 2 ± std. dev.) 
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5.4.5 Kinetics profile of HMF formation 
The kinetics of HMF formation were studied by stopping the reaction employing 
10 wt% fructose at various time points during the first hour of the reaction. Isolated yield 
for each sample was calculated by collecting HMF from the organic phase. Figure 5.10 
shows the variation of HMF isolated yield with time. A turnover frequency of 6.40 mol 
h-1g-1 was determined. 
 
 
Figure 5.10: HMF yield versus time 
 
5.4.6 Catalyst stability study 
As the reaction progressed, the catalyst underwent chemical change. The catalyst 
at the start of the reaction was composed of phosphonate monoester, as the reaction 
progressed the phosphonate ester group was gradually converted to the acid group 
(Scheme 5). The conversion was tracked using 31P NMR. Figure 5.11 shows the 
percentage of phosphonate monoester that was converted to phosphonate diacid. 31P 
NMR spectra showing the conversion of phosphonate monoester to phosphonate diacid 
are shown in Figure 5.12 and 5.13.  
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Scheme 5.5: Conversion of phosphonate monoester particles to phosphonic acid 
particles under the reaction conditions 
 
 
Figure 5.11: Relative change in the monoester concentration during the course of the 
reaction 
 
 
Figure 5.12: 31P NMR spectra of the particles dissolved in NaOD/D2O showing 
phosphonate monester peak at δ31P 32.3 ppm 
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Figure 5.13: 31P NMR spectra of the particles dissolved in NaOD/D2O showing 
phosphonate monester (sodium salt) peak at δ31P 32.2 ppm and phosphonate diacid 
(sodium salt) at 24.38 
 
5.4.7 Immobilization of C. rugosa lipase (CRL) 
Lipase load versus time 
Time dependent adsorption of lipase was performed. The particles adsorbed a 
large amount of lipase immediately upon exposure to lipase. Some of the adsorbed lipase 
was then released back into the solution and it was re-adsorbed at a slower rate (Figure 
5.14). 
 
Figure 5.14: Lipase adsorption versus time (n= 2 ± std. dev.) 
5.4.8 Adsorption of lipase on nanoparticles 
A lipase adsorption study was performed on 1 mg/mL nanoparticle dispersions. 
The particles adsorbed a large quantity of lipase from solution. The final protein load on 
the particles was 586.6 ± 28.0 mg/g. (Figure 5.15). 
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Figure 5.15: C. rugosa lipase uptake versus concentration study (n= 3 ± std. dev.) 
 
5.4.9 Dynamic Light Scattering of lipase@RNP(2.5)  
The hydrodynamic radius of the RNP_PME(2.5) an lipase@RNP_PME(2.5) 
nanoparticles was measured in sodium phosphate buffer at pH 5.0. Lipase@ 
RNP_PME(2.5) particle size was measured 30 minutes after loading. The 
RNP_PME(2.5) nanoparticles had a monodisperse size distribution of 196.86 ± 2.75 nm 
(n=3), upon loading lipase the hydrodynamic radius increased to 624.10 ± 8.00 nm (n =3) 
(Figure 5.16) 
 
Figure 5.16: Hydrodynamic radius of nanoparticles. 
 
5.4.10 Michaelis Menten kinetics 
The effect of immobilization on the enzyme kinetics of lipase was studied by 
measuring Michaelis Menten kinetics (Equation 1) of the immobilized enzyme. The study 
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was performed by measuring the rate of hydrolysis of esterase substrate 4-nitrophenyl 
acetate. The study showed that there was no difference between the catalytic ability of 
the immobilized and free lipase (Figure 5.17). The qm (maximum velocity, condition 
during which the enzyme is working at full capacity) values were 33.19 ± 8.76, 15.31 ± 
4.31 U/mg (U = µmol/ min) respectively and the Km (Michaelis constant, the substrate 
concentration at which the enzyme is working at half the maximum velocity or ½(qm)) 
values were 0.027 ± 0.004 and 0.007 ± 0.002 mM respectively. The qm and Km values 
were obtained from Lineweaver-Burke plots (Equation 2) (Figure 5.18). The values were 
found to be statistically significant at p < 0.01 using student’s T- test (Two tailed). 
 
Figure 5.17: Rate of catalysis (q) versus substrate concentration (S) (n= 8 ± std. dev.) 
𝑞 =
𝑞𝑚[𝑆]
𝐾𝑚 + [𝑆]
 
Equation 1: Michaelis- Menten equation 
 
1
𝑞
=  
𝐾𝑚
𝑞𝑚
(
1
[𝑆]
) +
1
𝑞𝑚
 
Equation 2: Equation for Linewaver Burke plot 
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Figure 5.18: Lineweaver-Burke plot of free and immobilized lipase 
5.4.11 Effect of urea 
Urea is a protein denaturant, the effect of urea on the activity of the enzyme was 
studied. Upon addition of urea there was a strong reduction in the activity of free lipase. 
At 1M concentration, the relative activity of lipase dropped down to 39.1 ± 20.9 % and 
at 4M concentration, the activity dropped to 26.5 ± 20.5 %. Lipase@RNP_PME(2.5) 
sample did not show severe denaturation in presence of urea. It retained 89.2 ± 6.8 % of 
its original activity at 1M urea concentration and 59.9 ± 7.7 % of its original activity at 
4M urea concentration (Figure 5.19). Statistical analysis was performed on the relative 
changes in the lipase activity on the enzyme before and after immobilization on 
nanoparticles. Statistical analysis was performed using paired t-test on the immobilized 
and free lipase. The study revealed that the increase was statistically significant at p < 
0.01. 
 
Figure 5.19: Effect of urea on enzyme activity (n = 3 ± Std. dev.) 
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5.5. Discussion 
5.5.1 HMF synthesis 
Platform chemicals that are sourced from renewable resources are of great 
importance to the future of the chemical industry. Biomass is the most abundant source 
of carbon and is an ideal platform for producing various industrially relevant compounds. 
One such compound is HMF. It holds great potential as it can be converted into a variety 
of chemicals with applications ranging from energy (2,5-dimethyl-furan) to polymers 
(2,5-furan-dicarboxylic acid).2 The most commonly used method for synthesizing HMF 
involves acid treatment of sugars such as fructose, which undergo acid catalysed 
dehydration to form HMF. However, HMF undergoes acid catalysed degradation to a 
variety of by products such as formic acid, levulenic acid and insoluble polymers called 
humins.7 
Pioneering work by Dumesic et al.7 demonstrated that efficient separation of HMF 
can be achieved by using biphasic reaction systems. These systems take advantage of the 
differences in solubilities of HMF and the by-products. HMF is soluble in both water and 
a variety of water immiscible organic solvents such as MIBK, chloroform, ethyl acetate 
etc.7 The isolated reaction yield was found to increase using phase transfer agents such as 
2-butanol. Here, we used MIBK: 2-butanol as the organic solvent (HMF extraction) 
system, while the reaction was carried out in water. Phosphonic acid based catalysts are 
mildly acidic and have been previously used by the Sullivan group to perform various 
Brönsted acid catalysed reactions (Appendix 5). RNP_PME(2.5) particles were chosen to 
explore the potential of nanoparticle systems in catalysing HMF synthesis. Nanoparticles 
have been shown to have excellent material transfer co-efficient20 and would therefore 
function as excellent catalysts. RNP_PME(2.5) nanoparticles employed in this work 
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displayed unique features such as large pore size (17.8 nm), high surface area (724 m2/g) 
and good organic loading (2.5 mmol/g), this suggested that these particles could 
potentially be used for catalytic applications. 
Nanoparticles have been demonstrated to stabilize emulsions and these particle 
stabilized emulsions are known as Pickering emulsions.38 These emulsions, have 
excellent mass transfer properties and have demonstrated a variety of interesting 
properties such as controlled release and selective uptake. Due to these properties, 
Pickering emulsions have been used for drug delivery applications.39, 40 Recent reports 
demonstrated the potential catalytic applications of these systems. Leclercq et al. used 
polymetalate nanoparticles for oxidation reactions.41 Wu et al. used these emulsions to 
entrap enzymes and perform enzymatic catalysis.42 However, Brönsted acid catalysed 
reactions have not been demonstrated using this system so far. In order to prepare 
Pickering emulsion stabilized by RNP_PME(2.5) particles, the organic phase containing 
MIBK:2-butanol and aqueous phase containing the nanoparticles and fructose were 
sonicated using an ultrasonic probe. The aim was to homogenize the system and form a 
water in oil emulsion. However, following sonication a dual emulsion system formed 
consisting of oil in water phase and a water in oil phase (Scheme 5.6). Inspection by 
optical microscopy revealed that the majority of the particles remained in the O/W phase. 
Few emulsion droplets were observed in the W/O phase. This was probably due to the 
hydrophilic nature of the phosphonate group. Previous studies on silica nanoparticle 
stabilized emulsions revealed that hydrophilic silica nanoparticles resulted in the 
formation of O/W emulsions.43 The above results are in accordance with the published 
results. The small amount of W/O emulsion could have resulted from interactions with 
the hydrophobic interactions between the methoxy group on the phosphonate and the 
organic solvent. 
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Scheme 5.6: Preparation of emulsions 
Cryo-SEM studies of O/W emulsion revealed that the particles formed a network 
on the droplet surface (Figures 5.5 and 5.6). This could have played a role in stabilizing 
the particles. The gaps within the network could have helped facilitate the partition of 
HMF. Additionally, the particles retained their surface charge even in the presence of 
fructose ( zeta potential = -27 mV), this could have further stabilized the emulsions. These 
results explain the stability of the emulsions despite the observed polydispersity in the 
droplet sizes (sizes between 2 to 20 µm). However, the emulsions were sensitive to 
centrifugation and were easily broken by gently centrifuging the reaction tubes at 1000 
rpm. This helped efficiently recover most of the HMF produced during the reaction. 
RNP_PME(2.5) nanoparticle catalysed reaction resulted in an isolated HMF yield of 
87.36 ± 0.83 %. This value was significantly higher than those reported from mineral 
acid7 and heterogeneous (modified silica)15,19 acid catalysed reactions that were carried 
out under similar biphasic reaction conditions. Only the reactions carried out in high 
boiling point solvents such as DMSO and ionic liquids gave yields greater than 90%.8,11,12 
However, extraction of HMF from DMSO on an industrial scale was demonstrated to be 
an energy intensive process and was expected to result in a significant loss of product.7 
Ionic liquids are expensive and therefore these methods do not lend themselves to 
commercial production of HMF. Aqueous synthesis provides an inexpensive platform for 
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HMF synthesis. In order to develop a commercially viable HMF production process, it is 
important to carry out the reaction at concentrations greater than 30 wt% of fructose.7 
Examples of such reactions have not been demonstrated in ionic liquid or DMSO based 
systems. Under aqueous conditions reactions carried out at 50 wt% fructose gave modest 
yields using mineral acid catalysts.7 However, using RNP_PME(2.5) nanoparticle system 
yields up to 80% were obtained at 50 wt% fructose (Figure 5.9). 
The reaction was carried out at 180 °C and the pressure in the reaction tube was 
over 10 bar. During the reaction, convection was observed. Following these observations, 
the mechanism of HMF transfer to the organic phase was postulated as follows. In the 
O/W phase fructose was present in the continuous water phase (since fructose is insoluble 
in the organic solvent phase) which was converted to HMF by the particles present on the 
oil droplet surface (Scheme 5.7). HMF was then rapidly partitioned into the oil droplet 
due to enhanced transport properties of emulsions. The droplet was then transported 
across the tube to the W/O phase where exchange of HMF occurred due to convection. 
Thus, gradually over the course of the reaction, HMF accumulated in the organic phase. 
This could have helped in the efficient exchange of HMF and therefore in the high yield 
observed. 
 
Scheme 5.7: HMF synthesis and phase transfer 
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Additionally, the particles also demonstrated excellent recyclability (Figure 5.8), 
which was probably a consequence of the robust silica framework.44 The turnover 
frequency of the reaction was 6.40 mol-1h-1g-1, which was significantly higher than found 
for solid acid resin based systems such as Amberlyst-15.45 The results presented above 
can be explained by using two unique features of this system. First, RNP_PME(2.5) 
nanoparticles have a unique architecture consisting of large pore size, high surface area 
and high phosphonate loading. High surface area and large pore size enable better mass 
exchange and therefore improve the rate of catalysis.20,46 The phosphonate group 
~P(O)OMe(OH) is a mild acid group. The vast majority of the reports involving solid 
acid catalysed synthesis of HMF used strong acids such as sulphonic acids.18 These acids 
promote HMF degradation and therefore result in loss of catalytic yield.47 Finally, the 
reaction was carried out in a Pickering emulsion like system (Figures 5.3 and 5.4). 
Pickering emulsions are emulsions stabilized by particles.48 Here, the emulsion was 
stabilized by RNP_PME(2.5) nanoparticles. The particles acted both as emulsion 
stabilizers and catalysts. Emulsions have been demonstrated as excellent systems for 
catalysis.49 These results suggested that this nanoparticle based system has potential to be 
used as a catalyst in industrial HMF production. 
 
5.5.2 Lipase catalysis 
Lipase is an industrially relevant enzyme because it can catalyse a wide range of 
reactions. However, it has been demonstrated to undergo denaturation and has also been 
shown to exhibit poor recyclability.25 Immobilization of enzymes has been demonstrated 
to enhance the enzyme activity and also offer protection from denaturation.26 Chemical 
conjugation of lipases to nanoparticle surfaces is the current preferred strategy, however 
this method leads to lower loadings of the enzymes. Physical adsorption of lipases on 
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organofunctionalized mesoporous silica materials helped improve the catalytic properties 
of the enzyme and also protected the enzyme from degradation.26 However, bulk silica 
materials have been shown to exhibit lower mass transport.20 In order to improve the 
catalytic potential of these dispersed nanoparticle materials systems we used large pore 
RNP_PME(2.5) particles to adsorb lipase. Lipase uptake by the particles was measured 
using Bradford assay. Bradford reagent consists of the dye Coomassie Brilliant Blue G-
250. The dye undergoes colour change depending on pH and upon binding the protein 
molecules (Scheme 8). In freshly prepared reagent the dye has red colour due to the 
presence of phosphoric acid. The measurement was performed in the presence a small 
amount of NaOH (1 M), which results in neutral , green coloured dye.  Finally, the dye 
interacts with the cationic amino acids (arginine and lysine) on the protein molecules and 
forms the blue colour.50 A calibration curve was obtained using BSA as it was known to 
give excellent colour response50 and was found to produce similar response as lipase.51 
The particles as expected demonstrated very high protein load (586.5 mg/g) (Figure 5.15) 
and also showed rapid enzyme uptake (45 minutes for complete uptake) (Figure 5.14). 
This is a significant improvement over previous studies.31,34 
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Scheme 5.8: Coomassie blue colour changes 
The effects of the particles on the enzyme lipase was determined by measuring 
the Michaelis-Menten kinetics. Michaelis-Menten kinetics are an excellent tool for 
modelling enzymatic reactions. Michaelis- Menten equation provides a relationship 
between the rate of enzyme catalysis (q) and the substrate concentration [S]. Information 
about the interactions between enzyme and substrate can be obtained by determining the 
maximum velocity of the reaction qm and the Michaelis constant Km. qm represents the 
maximum rate achieved by the system and Km represents the substrate concentration at 
which the rate of the reaction is half of qm. In addition to this, Km also helps determine 
the interactions between the substrate and the enzyme. Higher Km values represent lower 
affinity between the enzyme and the substrate and vice versa. 52 
In this study, immobilization of lipase on the particles resulted in the doubling of 
qm and an increase of about 4 times in the Km values. The increase in the Km values 
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suggest that the immobilized enzyme has reduced affinity towards the substrate. This 
could have been caused by the phosphonate ester group on the particles. Carboxylate 
esters have been demonstrated as potent lipase inhibitors. Due to similarity in the structure 
of phosphonate esters and carboxylate esters, the functional group on the particles could 
have acted as competitive inhibitor to the lipase.53 Further evidence for the competitive 
inhibition was obtained from the Lineweaver-Burke plot (Figure 5.18). The plots for free 
and immobilized lipases show trends that are similar to those observed during competitive 
inhibition.52 However, contrary to many of the previous studies, the qm value of the 
immobilized enzyme lipase@RNP_PME(2.5) also increased. The result suggested that 
despite the competitive inhibition, there was no distortion of the transition state which 
resulted in an increase in the maximum velocity (qm).
54 
The ability of the particles to protect enzymes from denaturing agent urea was 
also studied. Urea is a non-specific protein denaturing agent. Interactions between urea 
and proteins have been shown to reduce hydrophobic effect and increase the solvation of 
the hydrophobic protein residues.55 Free lipase showed a strong reduction in the protein 
activity in presence of urea. Immobilization of lipase protected the enzyme from 
denaturation. The immobilized enzyme retained 59.9 ± 7.7 % of its initial activity, while 
the free enzyme retained only 26.5 ± 20.5 %, in presence of 4 M urea (Figure 5.19). The 
free enzyme sample displayed high standard deviation of 20.5%, this could be due to the 
nature of the commercially sold crude enzyme extract. Commercially sold C. rugosa 
lipase extract has been demonstrated to contain at least three isoforms of lipase56, these 
isoforms differ in their activity and selectivity, which could account for the large standard 
deviation.56 Immobilization of crude lipase extract on the RNP_PME(2.5) particles could 
have resulted in selective immobilization of highly active isoforms, which resulted in a 
low variation in the results. The problem could be addressed by increasing the number of 
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repeats of the experiment to reduce the experimental error. The differences in the lipase 
activity in presence of urea between the free and immobilized lipase samples was most 
likely due to the immobilization of the lipase molecules inside the mesopores of the 
particles, which reduces the degree of freedom of the enzyme molecules and thus reduces 
the protein unfolding.34  
 
5.6 Conclusions 
A high yielding system for Brönsted acid catalysed conversion of fructose to HMF 
has been achieved using RNP_PME(2.5) nanoparticle system. HMF yields up to 87% 
were obtained using 10 wt% fructose. Similar yields were only achieved using high 
boiling point solvents such as DMSO or using ionic liquid based systems. Both these 
strategies have been previously demonstrated as unviable for industrial production of 
HMF. RNP_PME(2.5) nanoparticle based system demonstrated excellent recyclability 
and HMF yields showed almost no reduction after 5 catalytic cycles. The particles also 
demonstrated strong ability in catalysing fructose to HMF at high fructose concentrations. 
Lipase was immobilized on RNP_PME(2.5) nanoparticles. The enzyme-particle 
conjugates exhibited similar activity to the free lipase suggesting that the enzyme 
structure remained unchanged post-immobilization. The particles exhibited very high 
enzyme load, 58 wt%, which is higher than in most of the published reports. In addition 
to this, enzyme uptake took place in under an hour, another improvement over previous 
reports. Finally, immobilization of the protein on the particle surface helped reduce the 
effect of the denaturant urea on the protein structure. The immobilized enzyme retained 
59.9 ± 7.7 % of its original activity compared to the free enzyme which retained only 26.5 
± 20.5 % of its original activity. The RNP_PME(2.5) nanoparticle system, thus represents 
an excellent catalysis and enzyme immobilization system. 
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Chapter 6: Future work 
 
The aim of the work in this thesis was to synthesize phosphonate functionalized 
silica nanoparticles and to explore their potential for drug delivery applications. The 
phosphonate functionalization gave the particles interesting properties such as high pore 
size, raspberry texture and excellent dispersion stability. Additionally, the particles were 
able to adsorb large quantities of BSA and successfully deliver FITC functionalized BSA 
across cell membranes of HeLa cells. The protein loaded particles displayed endosomal 
escape and the particles remained in the cells after endosomal escape. All these results 
suggest excellent biomedical potential for the particles, notably in the area of cell marker 
research and targeted drug delivery. 
Cell markers are very important in cancer research and diagnostics.1 They are used 
to identify cancer cells in biopsies.2 Nanoparticle based cell markers have been used for 
labelling3 and for in vivo tracking of the labelled cells.4 BSA loaded particles displayed 
folic acid mediated uptake. This pathway was found in many different types of cancers 
and is therefore considered an excellent target for identifying cancer cells.5 Future work 
in this area would involve the study of the fate of the particles following prolonged 
incubation (3 to 4 generations) of the particles in various cancer cells expressing folic 
acid receptors (KB, HeLa, CHO cells etc.). Additionally, in vivo uptake of the particles 
could be studied using a mouse model and the particle localization identified using 2–
photon microscopy.  
The second area of focus is targeted drug delivery. As mentioned previously, the 
particles displayed uptake by the folic acid pathway, which is present in many types of 
cancer.5 BSA loaded particles could be potentially conjugated to various drugs and these 
drug loaded protein particle conjugates could be used for drug delivery applications. 
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Various hydrophobic anti–cancer drugs such as doxorubicin bind to BSA via hydrophobic 
interactions.6 Previous studies performed in animal models suggested that such 
conjugation could be useful to address problems such as multi–drug resistant cancer.7 The 
drug loaded protein–particle conjugates could be used to achieve targeted drug delivery. 
The initial studies would involve using HeLa cells as the model cell line and the 
cytotoxicity of the drug loaded protein–particle conjugates versus time measured by 
Alamar blue assay. Following this, animal studies would have to be used to determine in 
vivo efficiency.  
 The thesis also explored the use of the phosphonic acid functionalised particle 
dispersions as catalysts.  The observation of Pickering emulsion formation and very 
efficient catalytic conversion of a tough substrate system is a promising start that can be 
exploited for systems requiring mild acid catalysis.  The system also clearly holds promise 
as a host for enzymes with multiple application possibilities.  
 Finally in terms of modified silica nanoparticle development the phosphonate 
modifier has clearly played several important roles in determining the formation and 
properties of the wide pore nanoparticles described in this work.  It is of course possible 
that these roles could be covered by judicious choices of conditions with other modifiers.  
However while chemistry is key, the mechanical conditions employed for each action are 
also a very important consideration when it comes to gaining more precise control over 
the properties of these fascinating materials and this is an aspect that requires much 
further investigation. 
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Figure 1: 1H NMR spectrum of RNP_PME(2.5) nanoparticles in NaOD/D2O 
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Figure 2: 31P NMR spectrum of RNP_PME(2.5) nanoparticles in NaOD/D2O 
 
29Si NMR spectra– Deconvolution 
 
1.  
RNP_PME(2.5) 
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2.  
NP_PEE(2.1) 
 
3.  
NP_PME(0.2) 
 
4.  
NP_PME(1.0) 
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5.  
CP_PME(1.6) 
 
Zetapotential measurement :  
Zetapotential measurements were performed on a Malvern Zetasizer Nano ZS instrument 
equipped with a 633 nm laser. For analysis 2 mg/mL particle dispersion in a disposable 
capillary cuvette was prepared by sonication for (15 min) in water. 3 measurements were 
performed for each sample.  
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Appendix 2 
Appendix for chapter 3 
Synthesis and characterization of Mesoporous Silica Nanoparticles (MSN) 
MSNs were synthesized according to a previously published report.1 To 480 mL of 
deionized water, NaOH (2 M, 3.5 mL) and CTAB (1 g) were added and stirred at 1000 
rpm. The temperature of the reaction mixture was raised to 80 °C and once all the 
surfactant was dissolved and the temperature settled, TEOS (5 mL) was added dropwise 
to the reaction vessel. About 2 minutes later, the reaction mixture turned cloudy and white 
precipitate began to settle at the bottom of the flask. The reaction was carried out for 2 
hours. After 2 hours the white precipitate was filtered off and dried under ambient 
conditions. The white solid (2.5 g) was then suspended in acidified ethanol (35 mL of 
ethanol and 2 mL of 35 % HCl) and refluxed overnight to remove the surfactant. The 
surfactant free particles were filtered and washed with ethanol and deionized water and 
dried under vacuum. The particles (1 g) were characterized by FTIR, SEM, TEM and 
nitrogen adsorption porosimetry. 
 
Results 
 
 
Figure 1: Nitrogen sorption isotherm of mesoporous silica nanoparticles 
Reference: 
1. I. I. Slowing, B. G.  Trewyn and V. S. Y. Lin, J. Am. Chem. Soc., 2007, 129, 8845-
8849. 
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Figure 2: SEM (Figure A, Scale 2000 nm) and TEM (Figure B, Scale 100 nm) of 
meosporous silica nanoparticles. 
 
BSA Calibration curve 
BSA stock solution was prepared by dissolving BSA in PBS (concentration of 2 mg/mL). 
The stock solution was then serially diluted to produce concentrations between 0.125 to 
2 mg/mL (Figure 3). The absorbance at 280 nm was recorded on UV-Vis 
spectrophotometer (Figure 4). 
 
Figure 3: BSA calibration curve in PBS 
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Figure 4: BSA UV-Vis adsorption spectra 
 
3. Linearized Langmuir plots (Figure 5) were obtained using the data from figure 3.1, the 
data was fitted according to the following equation: 
 
𝐶(𝑒)
𝑄(𝑒)
=  
1
𝑄𝑚𝐾𝐿
+  
𝐶(𝑒)
𝑄(𝑚)
 
Where, C(e) stands for equilibrium concentration (mg/mL) ; Q(e) stands for the amount 
of protein adsorbed at equilibrium (mg/g); KL is the Langmuir constant and Q(m) is the 
maximum protein load. 
C(e) was calculated using the following formula: 
𝐶(𝑒) = 𝐶(0) −
𝑄(𝑒) × 𝑀
𝑉
 
Where C(0) is the initial protein concentration (mg/mL); M is the weight of the particles 
(g) and V is the total volume (mL) 
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Figure 5: Linearized Langmuir plots of BSA adsorption on the nanoparticles. 
 
Figure 6: Kd (distribution co-efficient) vs C(0) (Initial concentration plots). The 
distribution co-efficient was used to determine the affinity between the nanoparticles and 
protein molecules. Higher the Kd the stronger the affinity. Kd value decreases with 
concentration since the particle surface gets coated by the protein molecules and there are 
fewer sites available to adsorb. 
𝐾𝑑 =
(𝐶(0) − 𝐶(𝑒))𝑉
𝐶(0)𝑀
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Appendix 3 
 
Appendix for Chapter 4 
 
1. BSA Bradford assay calibration curve (Figure 1) 
 
 
2. UV-Vis Spectrum of FITC_BSA or BSA# (Figure 2) 
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3. MTT cell viability study using BSA# (n = 3 ± Std. dev.) (Figure 3) 
 
Figure 3: MTT cell viability study using BSA# 
 
4. Spots Analysis using Imaris: 
Spots package in Imaris is used to model point like structures in the image. This package 
was used to represent particles distributed inside the cells as spheres and the total number 
of spots per cell data was used to identify patterns of nanoparticle uptake. In this section 
a brief overview of the method used to detect particles is described. 
1.  
Figure 4: Confocal image 
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2.  
Figure 5: Contour (using surface function) is drawn around individual cells in each image 
in the stack. (Every confocal microscope image is a collection of around 20 to 30 
individual images) 
3.  
Figure 6: Using the surface function in Imaris, a surface (yellow object in the image) is 
created. A surface is an artificial solid object created to visualize the region of interest. 
Following the creation of the surface, channel of choice (red for the RNP*_PME(2.5) 
particles) is selected. 
4.  
Figure 7: Using the surface function a new channel, which exclusively identifies the 
particles in the region of interest is created. 
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5.  
Figure 8: The spots function is used to identify point-objects and represent them as 
spheres. First, the region of interest is identified and the size of the spots in micrometres 
is given. 
6.  
Figure 9: The detection threshold is then manually adjusted to correct the errors in 
automatic spots detection. 
253 
 
7.  
Figure 10: After a suitable threshold value is determined (the value varies from one region 
to another.) the spots function creates spots (white spheres) in the region of interest. 
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Appendix 4 
 
Appendix for chapter 5 
 
1. Bradford assay calibration using BSA 
 
 
2. Calibration 4-nitrophenol in phosphate buffer (pH 7) 
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A  simple  easily  scalable  one-pot  route  to new  phosphonic  acid  polysilsesquioxanes,  PAPSQ,
[(O3/2SiCH2R)x(O3/2SiCHR(CH2)2SiO3/2)y]n where  R =  CH2PO3H2, is  described  in this  paper.  Nuclear  mag-
netic  resonance  (NMR),  electron  microscopy  (SEM),  thermogravimetric  analysis,  nitrogen  sorption
porosimetry,  phosphorus  and available  acid analysis  were  used  to  characterise  the  new  PAPSQ  mate-
rials.  The  materials  were  shown  to be  very  efﬁcient  and  recyclable  mild  solid  acid catalysts  for  organic
transformations  including  those  relevant  to biomass  conversion  such  as  esteriﬁcation,  transesteriﬁcation
and  dehydration  of  fructose  to  the  important  intermediate  5-hydroxymethylfurfural.
© 2013 Elsevier B.V. All rights reserved.
1. Introduction
Molecular cages, resins, glasses and ordered mesoporous
solids derived from precursor organotrialkoxysilanes such as
RSi(OMe)3 or the bridged type precursors (MeO)3SiRSi(OMe)3
are polysilsesquioxanes, PSQ, and are represented as [RSiO3/2]n
or [O3/2SiRSiO3/2]n in the fully condensed forms. The organic
groups R are important in determining the properties and applica-
tions PSQ display. Polysilsesquioxane, PSQ, materials, [RSiO3/2]n or
[O3/2SiRSiO3/2]n where R is a functional organic group are of great
current interest with potential application areas in energy mate-
rials, drug delivery systems and as separation media [1–6]. The
organic–inorganic hybrid composition provides excellent thermal
stability and built-in chemical functionality makes these materials
ideal candidates for heterogeneous catalysis applications. New PSQ
materials and their catalytic applications are frequently reported
[7–13] but the translation of this research to industrial application
is apparently limited by the complexity of synthesis and cost [7,8].
PSQs with phosphonic acid functional groups are a relatively lit-
tle explored class. Compared to stronger Brønsted acid functions
such as sulfonic acid, phosphonic acid is relatively mild and conse-
quently may  be less prone to promotion of side reactions. We  report
here on new phosphonic acid functionalised PSQs which are readily
synthesised on a large scale, along with studies that demonstrate
their use as solid Brønsted acid heterogeneous catalysts.
∗ Corresponding author.
E-mail address: a.c.sullivan@qmul.ac.uk (A. Sullivan).
1 Joint ﬁrst authors.
2. Experimental
Solvents and reagents used were purchased from Aldrich. Pro-
ton, carbon and phosphorus NMR  spectra of PAPSQ materials
dispersed in NaOD/D2O were recorded on Bruker AMX  400 or
600 MHz  instruments. Solid state spectra were obtained using a
Bruker AMX  600 MHz  instrument: 29Si HPDec MAS, frequency
119.2 MHz, spinning speed 12 kHz; 1 min  recycle delay, with 2 s
∼45◦ pulse; 31P CP MAS; frequency 242.9 MHz, spinning speed
12 kHz, 1 ms  contact time, 1.5 s delay, 90◦ pulse for 2.0 s. SEM
was recorded on a JEOL 6300F scanning electron microscope and
TGA on a TA Q500 ramped at 10 ◦C/min under nitrogen. Nitro-
gen adsorption–desorption was  recorded on a Qantachrome Nova
porosimeter. Phosphorus elemental analysis was obtained from
Medac Ltd.
2.1. Preparation PAPSQa and PAPSQb
[(O3/2SiCH2R)1.5(O3/2SiCHR(CH2)2SiO3/2)]n R = CH2PO(OH)2
To dimethyl phosphite (37.2 g, 31 mL,  0.338 mol) was  added
vinyltrimethoxysilane (33 mL,  0.215 mol) and the mixture heated
with stirring at 110 ◦C for 2 h. Di-tert-butyl peroxide (1 drop)
was added every 15 min  for 2 h after which no vinyl resonances
could be detected by 1H NMR. The excess dimethyl phosphite was
removed under reduced pressure and the residual colourless liq-
uid containing, 1, dimethylphosphonatoethyltrimethoxysilane and
2, 2,4-bis(trimethoxysilyl)-1-dimethylphosphonato butane in ratio
1.5:1 (31P NMR  (CDCl3) 1 35.68(s) 2 35.48(s)) was  treated further.
1381-1169/$ – see front matter ©  2013 Elsevier B.V. All rights reserved.
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2.1.1. PAPSQa
HCl (160 mL  of 5 M)  was added to 20 g of the colourless liq-
uid (from Section 2.1) and then stirred under reﬂux for 5 h. On
cooling to room temperature the white solid was ﬁltered and
washed extensively with distilled water and methanol. The solid
was dried under reduced pressure at 120 ◦C for 4 h to afford a white
powder PAPSQa (10.9 g, 89.7%). Surface area: 65 m2 g−1, 29Si MAS
ıSi: −63 (br s) deconvoluted peaks at −53, −58, −63. 31P CPMAS
NMR  ıP 33 (PO(OH)2, 90%) 24 (Si OH–O P(OH)2, 10%). Found P
4.96 mmol  g−1.
2.1.1.1. Accessible acid measurement. In a typical measurement to
determine the phosphonic acid ﬁrst proton exchange capacity, a
sample of PAPSQa 0.2040 g was shaken in 50 mL  of 0.5 M sodium
formate solution for 60 h. The formic acid produced was titrated
with 20 mM NaOH. Accessible acid in PAPSQa: 3.3 mmol g−1.
2.1.1.2. NMR  PAPSQa dispersed in (NaOD/D2O). PAPSQa was dis-
persed in NaOD/D2O wherein the phosphonate is fully ionised
while Si-C bonds remain intact. This is a convenient way to conﬁrm
presence of components (1) and (2) (see below)
(1)
Si
O
O
O
C1
C2
P
O
O
O
Ha
Ha
Hb
Hb
Si
O
O
O C2
C4
P
O
O-
O-
Hc
C3
Hf
Hd
C1
Si
O O
O
He Hg
HbHa
(2)
ıP (PAPSQa) 26.8 (s, P (1)), 25.6 (s, P (2)) intensity ratio 1.5:1.
ıH (1) 0.65 (Ha, m,  2H), 1.36 (Hb, m,  2H); ıC (1) 7.6 (C1), 22.6 (d,
C2) (Assignments conﬁrmed by HSQC [14]), ıH (2) 0.53 (m,  Hb,
J(b,a),15.27 Hz, J(b,e), 3.43 Hz, J(b,g), 8.73 Hz), 0.73 (m,  Ha, J(a,b),
15.27 Hz, J(a,e), 10.45 Hz, J(a,g), 4.2 Hz), 0.99 (m,  Hc, J(c,d), 5.22 Hz,
J(c,e), 9.76 Hz, J(c,f), 9.32 Hz, J(c,g), 4.27 Hz, J(c,P), 14.10 Hz), 1.27 (m,
Hd, J(d,f), 14.90 Hz, J(d,P), 17.62 Hz), 1.55 (m,  He, J(e,g), 13.48 Hz),
1.63(m, Hf, J(f,P), 16.2 Hz), 1.89 (m,  Hg, J(e,g), 13.48 Hz), ıC (2) 11.6
(C1), 21.1 (C2), 26.6 (C3), 31.0 (d, C4) (Assignments conﬁrmed by
HSQC [14]).
Note: the NUMERIT [15] simulated and experimentally
observed 1H NMR  spectrum features of the complex seven pro-
ton spin system in component (2) are shown in Supplementary
Information Fig. A.
Supplementary data associated with this article can be
found, in the online version, at http://dx.doi.org/10.1016/j.molcata.
2013.03.021.
2.1.2. PAPSQb
To 6.0 g of the mixture of 1 and 2 mole ratio 1.5:1 (from
Section 2.1) was  added aqueous hydrochloric acid (1 M,  15 mL)
and methanol (180 mL). The resultant solution was  placed in a
polypropylene plastic bottle and warmed to 90 ◦C for 16 h. The
formed glass was ground to a powder. To this powder, hydrochloric
acid (5 M,  50 mL)  was added slowly and the resultant mixture was
stirred under reﬂux for 12 h. On cooling to room temperature the
solid was  ﬁltered and then washed extensively with distilled water,
methanol and diethyl ether. The solid was  then dried at 120 ◦C for
4 h to yield a white powder PAPSQb (2.9 g, 79%).
Surface area: 80 m2 g−1, 31P NMR  (NaOD/D2O) ıP: 25.2, 26.3 ratio
1:1.5; 31P CPMAS NMR  ıP 32.2 (br s), 29Si MAS  ıSi: −63 (br s) decon-
voluted peaks at −58, −64, found P 5.1 mmol g−1 Accessible acid by
titration 3.3 mmol  g−1.
2.2. Catalysis
Quantity of catalyst used (mol%) was based on the available acid
determined by titration. Percentage conversions were determined
by 1H NMR  spectroscopy or isolated products. Turnover numbers
are based on three cycles in each case. Blank reactions were per-
formed in the absence of catalyst. The catalyst was recycled either
after ﬁltration and washing or after removal of the product solution
and addition of fresh reagent and solvent. Leaching was assessed by
interrupting the reaction (ketalisation, esteriﬁcation and transes-
teriﬁcation) at partial conversion (1 h), separating the liquid phase
from the catalyst using a 0.2 m ﬁlter and measuring conver-
sion again at the speciﬁed reaction time. No evidence of leaching
was detected. The ketalisation, esteriﬁcation and transesteriﬁca-
tion experiments were also run using the equivalent quantity of
phosphoric acid as catalyst.
2.2.1. Protection of ketones (ketalisation)
A mixture of acetophenone (4.8 g, 40.0 mmol, 4.7 mL), ethane-
1,2-diol (6.7 g, 107.6 mmol, 6.0 mL)  catalyst (30 mg,  0.25 mol%) in
toluene (30 mL)  was  reﬂuxed 10 h using a Dean-Stark apparatus.
The reaction was followed by TLC. The reaction mixture was cooled
to room temperature, the catalyst ﬁltered off and washed with
ether (20 mL). The ketal product 2-methyl-2-phenyl-1,3-dioxolane
was obtained as a white solid from the ﬁltrate after washing with
water (3 × 20 mL)  and drying over magnesium sulfate.
1H NMR  (CDCl3): ıH: 1.67 (s, 3H), 3.78 (t, 2H), 4.02 (t, 2H),
7.25–7.56 (m,  5Harom).
2.2.2. Esteriﬁcation of oleic acid
Oleic acid (1 g, 3.54 mmol), catalyst (20 mg,  1.9 mol%) and
ethanol (6 mL)  were combined and the reaction mixture was
reﬂuxed for 8 h then heated to 90 ◦C for 2 h using an air condenser.
The evaporated solvent was  replaced with dry ethanol and the
mixture heated a further 2 h using an air condenser. Ether (30 mL)
was added to the cooled mixture and the catalyst was  ﬁltered off,
washed with diethyl ether and retained for recycling. The organic
solvents were removed from the ﬁltrate. Conversion to the ethyl
oleate was determined by integration of the total alkene proton
signal at ıH 5.33 (m,  2H) against the ester methylene signal at ıH
4.11 (q, 2H, OCH2CH3).
2.2.3. Transesteriﬁcation of ethyl oleate
Ethyl oleate (1.55 g, 5 mmol), catalyst (50 mg,  3.3 mol%) and pen-
tanol (10 mL)  were reﬂuxed for 12 h. The reaction was  followed
by TLC. On cooling, ether (30 mL) was added and the catalyst was
ﬁltered off. The organic solvents were removed. Conversion was
determined by integration of the alkene proton signals at ıH 5.35
and the ester methylene signal at ıH 4.13 (t, 2H, OCH2(CH2)3CH3).
2.2.4. HMF synthesis
Fructose (206 mg,  1.14 mmol) was dissolved in deionized water
(1.8 g) and PAPSQa (209 mg)  was added to this solution. An organic
phase (2 g) containing MIBK and 2-butanol in 7:3 ratio was added to
the reaction vessel to obtain a biphasic mixture. The reaction mix-
ture was  heated to 130 ◦C, while stirring at 600–700 rpm for 12 h.
The reaction mixture was then cooled to 90 ◦C without stirring,
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Scheme 1. Conditions: (i) direct hydrolysis with 5 M HCl gives PAPSQa x/y = 1.5; or
(ii) sol-gel process 1 and 2 (MeOH, aqueous HCl) and hydrolysis of xerogel with 5 M
HCl gives PAPSQb x/y = 1.5.
the organic phase (top layer) removed, another batch of fructose
(200 mg)  and organic phase added and the process repeated. In this
manner three catalytic cycles were assessed. In each case pure HMF
(by NMR) was obtained from the removed organic phase. The iso-
lated yields of HMF  from the organic layers based on d-fructose
taken in each cycle were 51, 57 and 57%.
Repeating this process with PAPSQb (203 mg)  and fructose
(204 mg)  in three catalytic cycles afforded HMF  product yields of
59, 72 and 73%.
2.2.5. Comparative catalytic activity for ketalisation,
esteriﬁcation and transesteriﬁcation
The reactions as described above in Section 2.2.1, Section 2.2.2,
and Section 2.2.3 and identical ones employing phosphoric acid
as catalyst at the same mol% phosphorus were sampled at regular
intervals up to 5 h and the % conversion evaluated.
2.2.6. Comparative catalytic activity for ketalisation
A mixture of acetophenone (4.8 g, 40.0 mmol, 4.7 mL), ethane-
1,2-diol (6.7 g, 107.6 mmol, 6.0 mL)  and catalysts PAPSQa, PAPSQb
or phosphoric acid, adjusted to give 0.2 mol% acid, was reﬂuxed as
in Section 2.2.1 and samples taken for analysis at regular intervals.
3. Results and discussion
3.1. Synthesis
The objective of this work was to explore simple routes for the
synthesis of new phosphonic acid functionalised polysilsesquiox-
anes, PAPSQ and to investigate the solid acid catalytic activity
of these materials. We  have previously reported on the micro-
porous PAPSQ material [3/2OSiCH2CH(PO(OH)2)CH2CH2SiO3/2]n
which has an in-framework phosphonic acid group [16]. The
precursor for this material required the tedious synthesis of 1,4-
bis(triethoxysilyl)but-2-ene and subsequent radical addition of
HPO(OEt)2 to the ene fragment making this a relatively long and
costly method. Others have reported [17] on the 2-component
PAPSQ system [(O3/2SiCH2CH2(PO(OH)2))x(O3/2Si(CH2)2SiO3/2)y]n
obtained by co-hydrolysis and condensation of the precursors
[(EtO)3SiCH2CH2PO(OEt)2] and [(MeO)3Si(CH2)2Si(OMe)3].
New phosphonic acid polysilsesquioxanes, PAPSQ,
[(O3/2SiCH2R)x(O3/2SiCHR(CH2)2SiO3/2)y]n where R = CH2PO3H2,
were synthesised starting from the mono and bis-
trialkoxysilylalkylphosphonate esters (Scheme 1). The known
phosphonate ester compounds, 1, dimethylphosphona-
toethyl trimethoxysilane [18] and 2, 2,4-bis(trimethoxysilyl)
-1-dimethylphosphonatobutane [19], were formed in this work
as a two-component mixture in a simple radical addition reac-
tion between dimethylphosphite and vinyltrimethoxysilane in
the presence of di-tert-butylperoxide. Both compounds were
produced even when excess dimethylphosphite was  employed.
For dimethylphosphite:vinyltrimethoxysilane 1.6:1, compounds
1 and 2 were formed in 1.5:1 ratio as evidenced by the relative
integration of 31P NMR  resonances at ı 35.68 for 1 and ı 35.48
for 2. The percentage of 2 in the mixture may  be increased by
increasing the proportion of vinyltrimethoxysilane in the reac-
tion. For example, at dimethylphosphite:vinyltrimethoxysilane
ratio of 0.5 the ratio of 1–2 formed was  0.9:1. This simple
reaction allowed for easy one-pot formation of precur-
sors to bridged polysilsesquioxane materials PAPSQ with
very high phosphonic acid loading. In contrast the multi-
step routes to [3/2OSiCH2CH(PO(OH)2)CH2CH2SiO3/2]n and
[(O3/2SiCH2CH2(PO(OH)2))x(O3/2Si(CH2)2SiO3/2)y]n mean that
these are signiﬁcantly more demanding to synthesise.
The phosphonate ester mixture was converted to two-
component amorphous phosphonic acid polysilsesquioxane mate-
rials, PAPSQ. This was achieved either by a one-pot hydrolytic
co-polycondensation of the mixture of 1 and 2, using 5 M HCl
to give directly the phosphonic acid polysilsesquioxane desig-
nated PAPSQa or by sol-gel processing to an isolated intermediate
ethylphosphonate ester xerogel followed by hydrolysis of the
crushed xerogel with 5 M HCl to give the material PAPSQb (see
Scheme 1). The materials obtained were washed extensively with
distilled water, methanol and diethyl ether. Of the two  routes,
the one pot direct hydrolysis route had the advantage of avoiding
any need to form, isolate and grind an intermediate ethylphos-
phonate ester xerogel [(O3/2SiCH2R)x(O3/2SiCHR(CH2)2SiO3/2)y]n
where R = CH2PO(OEt)2. It avoided the need for large quantities of
methanol and facilitated the synthesis of much larger batches of
material in ∼10 h compared to ∼30 h. In addition the direct hydrol-
ysis route also afforded a 10% higher overall yield of product.
3.2. NMR features
Materials PAPSQa and PAPSQb had similar NMR  spectroscopic
features. The ratio x/y of phosphorus components in the PAPSQs
shown in Scheme 1 was determined from the 31P NMR  of materials
dispersed in NaOD/D2O solution (Fig. 1). The 31P CPMAS NMR of the
solid PAPSQ appeared as broad peaks around ı 33 ppm (Fig. 1). A
small peak was also present at ı 24 ppm indicative of some Si OH–
O P(OH)2 interaction [20,21].
When the materials were dispersed in NaOD/D2O the 31P reso-
nances of the two  fully ionized phosphonic acid components were
clearly distinguished and shifted to higher ﬁeld compared to the
phosphonic acid (Fig. 1(b) and (f)). Under these conditions the bulk
material Si O Si framework was sufﬁciently hydrolysed to facil-
itate dissolution while Si C bonds remained intact and this was
a convenient way  to observe the different phosphorus containing
components. Solid state 29Si NMR  on PAPSQa and PAPSQb gave
broad resonances centred at ı −63 ppm, Fig. 1(c) and (g) which after
deconvolution, Fig. 1(d) and (h) were found to have the silicon envi-
ronments in (PAPSQa)PAPSQb T1(12.7%)0%,T2(27.8%)49.8%, and
T3(59.5%)50.2%, with overall condensation (82%)83% respectively.
Tn denotes the number of Si O Si bonds at the trifunctional silicon.
The silicon–carbon–phosphorus skeletons of the two phospho-
rus components in PAPSQa were observed in the 1H and 13C
NMR  spectra of a sample dispersed in NaOD/D2O (see experimen-
tal). Spectral assignments of the different proton environments in
dispersed PAPSQa were made after simulation using HSQC (Hetero
Single Quantum Coherence) [14] and NUMERIT [15] experiments
(see supplementary information Fig. A).
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Fig. 1. 31P CPMAS NMR  (a) PAPSQa (e) PAPSQb 31P NMR  in NaOD/D2O (b) PAPSQa (f) PAPSQb 29Si MAS  NMR  (c) PAPSQa (g) PAPSQb and Deconvoluted 29Si MAS  NMR  (d)
PAPSQa (h) PAPSQb.
3.3. Texture
The as synthesised PAPSQa and PAPSQb were ground to ﬁne
powders. The ground powders were non porous and had sur-
face areas and pore volumes of 65 m2/g, 0.09 cm3/g (PAPSQa) and
200 m2/g, 0 cm3/g PAPSQb. A fused nanoparticle surface texture
was seen for both materials as shown in Fig. 2 where PAPSQb dis-
plays a ﬁner texture.
3.4. Thermal properties
The TGA proﬁles of as-formed PAPSQa and PAPSQb materials
pre-dried at 120 ◦C were recorded under nitrogen and are shown
in Fig. 3. Weight loss from PAPSQa(PAPSQb) of 1.3%(5%) due to
retained solvent or water was  observed below 150 ◦C. Further grad-
ual weight loss ∼8%(5%) was  observed between 150 and 475 ◦C.
This may  reﬂect further condensation of silanol. The weight loss
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Fig. 2. SEM of (a) PAPSQa (b) PAPSQb.
Fig. 3. TGA of (a) PAPSQa (b) PAPSQb.
12%(10%) above 475 ◦C could represent condensation due to P O P
bond formation and/or elimination of small hydrocarbon frag-
ments. Overall weight loss at 600 ◦C was less than 23% in both
cases.
3.5. Catalytic studies
To assess stability and activity the PAPSQ materials were initially
assessed as catalysts in organic transformations including protec-
tion of ketones and esteriﬁcation/transesteriﬁcation of acids and
esters respectively. This was followed by a more complex transfor-
mation involving dehydration of fructose where there are several
potential products. All results are summarised in the Table 1.
The % conversions (92–98%) for ketalisation of actetophenone
(Scheme 2) measured after 10–12 h from catalysts PAPSQa and
PAPSQb were high.
Both catalysts were easily separated from reaction media by
ﬁltration and were recycled further without loss of activity. To
achieve a comparison between the catalysts PAPSQa, PAPSQb and
a homogeneous analogue, the initial progress of reaction was  fol-
lowed for the ketalisation of acetophenone using the solid acids
and phosphoric acid under identical conditions and with 0.2 mol%
of the acid in each case. The results (Fig. 4) showed steady rates of
conversion in all three cases with 94% conversion for PAPSQa after
4.5 h, while phosphoric acid had 85% and PAPSQb 73% conversion in
O
HO
OH
+
O
Ocatalyst
Scheme 2. Ketalisation of acetophenone.
the same time period. The apparent differences in conversion pro-
ﬁles for the solid acids may  in part be due to minor differences in
mechanical mixing during the process (powder PAPSQb was  con-
siderably ﬁner than powder PAPSQa which affected its distribution
Table 1
PAPSQ solid acid catalytic data.
Entry Catalyst (%) Conversion or yielde for
cycles 1,2,3 (TON)f
1a PAPSQa 97,97,97 (1175)
2a PAPSQb 98,97,97 (1175)
3a Phosphoric acid 90
4b PAPSQa 97,95,97 (154)
5b PAPSQb 96,99,99 (154)
6b Phosphoric acid 50
7c PAPSQa 92,93,93 (84)
8c PAPSQb 92,92,92 (84)
9c Phosphoric acid 93
7d PAPSQa 51, 57, 57 (2.7)
8d PAPSQb 59, 72, 73 (3.5)
a Ketalisation of acetophenone. Conditions: 40 mmol acetophenone and ethane-
1,2-diol (6 mL)  in toluene (30 mL)  and 30 mg  phosphonic acid 0.25 mol% based on
titrated acid (or 0.25 mol% phosphoric acid). Blank reactions (no catalyst) gave zero
conversion.
b Esteriﬁcation of oleic acid. Conditions: 3.5 mmol oleic acid, 20 mg catalyst
corresponding to phosphonic acid, 1.9 mol% based on titrated acid (or 1.9 mol%
phosphoric acid); ethanol (6 mL), at 90 ◦C for 12 h.
c Transesteriﬁcation ethyloleate conditions: 5 mmol ethyl oleate, 50 mg catalyst
corresponding to phosphonic acid 3.3 mol% based on titrated acid and pentanol
(10 mL); reﬂuxed 12 h.
d 10 wt%  aqueous fructose in 1:1 w/w aqueous/organic phases (organic phase 7:3
MIBK:2-butanol) and 1:1 w/w fructose and PAPSQa.
e Conversion determined by NMR  for entries 1–6 and yield of HMF  isolated from
organic phase only and conﬁrmed by NMR  for entry 7 and 8.
f TON = mole product mol−1 available acid after the 3 cycles.
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CH3(CH2)7CH=CH(CH2)7CO2H + EtOH CH3(CH2)7CH=CH(CH2)7CO2Et + H2O
catalyst
CH3(CH2)7CH=CH(CH2)7CO2Et + C5H11OH CH3(CH2)7CH=CH(CH2)7CO2C5H11 + EtOH
catalyst
Scheme 3. Esteriﬁcation of oleic acid and transesteriﬁcation of ethyloleate.
HO
OH
O
OH
OH
OH
Fructose
catalyst
O
OHO
5-Hydroxymethylfurfural (HMF)
+ rehydration/condensationproducts
Scheme 4. Dehydration of fructose to HMF.
in this two phase toluene–ethanediol mixture). The PAPSQa pro-
ﬁle indicates a slightly faster rate of conversion compared to the
homogeneous phosphoric acid catalyst in this reaction.
Both catalysts PAPSQa and PAPSQb gave high conversions for
esteriﬁcation of oleic acid and trans-esteriﬁcation of ethyl to pentyl
oleate (Scheme 3).
These experiments showed that the solid catalysts could be
recycled and continued to be active after several runs when
held at temperatures in the range 90 ◦C (ketalisation) to 140 ◦C
(transesteriﬁcation). Turnover numbers (TON) which reﬂect the
mol% of available acid used (see Table 1) were calculated for
the speciﬁc conditions employed in each case but it should be
noted that experiments to optimise these were only carried out
for the ketalisation transformation where the conversion contin-
ued to be high as the mol% catalyst was reduced to 0.25 mol%
resulting in TON of 1175 mol  ketal mol−1 available acid after three
cycles without loss of activity. With an equivalent quantity of
phosphoric acid as catalyst and the timescales employed, the
conversions were found to be much lower for the esteriﬁcation
and comparable for transesteriﬁcation reactions. This was consid-
ered reasonable since the transesteriﬁcation reaction was carried
out at higher temperatures and water was not a by-product.
Compared to organic transformations catalysed by sulfonic acid
supported on silica or polysilsesquioxane [8,22–27], reports on
catalysis using corresponding phosphonic acid systems are scant.
Sulfonic acid has the advantage of signiﬁcantly greater acid strength
with pKa = −1 compared to di-protic phosphonic acid with pKa
values typically ∼2.3–2.9 and 7.7–9 for the ﬁrst and second ion-
izations [28]. A milder acid catalyst might however sometimes be
Fig. 4. Reaction proﬁles for ketalisation of acetophenone with PAPSQa (), PAPSQb
()  and phosphoric acid () Conditions: 40 mmol acetophenone and ethane-1,2-diol
(6  mL)  in toluene (30 mL); catalyst at 0.2 mol% P in each case.
preferable particularly where a number of products can be formed
and selectivity for a particular product is required. In this con-
text there is great interest in the conversion of fructose to
5-hydroxymethylfurfural, HMF, where rehydration and conden-
sation by-products are a complicating factor in the synthesis
(Scheme 4).
HMF  is an important intermediate for 2,5-disubstituted furans
such as the dicarboxylic acid derivative which has been suggested
as an alternative for terephthalic acid and hence a source of biomass
derived polymers. The industrial use of HMF  is limited by high
production costs [29,30]. Some efﬁcient biphasic catalytic sys-
tems were recently reported. Dumesic et al. published in-depth
studies employing mineral acids including phosphoric acid, the
sulfonic acid polystyrene ion-exchange resin catalysts PK-216 and
Amberlyst 70 and various silica supported sulfonic acids in biphasic
media [31]. We  followed conditions reported by Dumesic for a
sulfonic acid resin catalyst, consisting of 10 wt% aqueous fructose
in 1:1 w/w aqueous/organic phases (organic phase 7:3 MIBK:2-
butanol) and 1:1 w/w fructose and catalyst. The reaction with
PAPSQa or PAPSQb as catalyst was run at several temperatures up
to 130 ◦C where the highest yield of HMF  was isolated. Three cycles
were incorporated in the present experiment wherein between
cycles the organic MIBK-2-butanol phase (upper layer) contain-
ing the product HMF  was separated and fresh fructose and organic
phase added to the residual hot aqueous phase containing the cata-
lyst. Our analysis was based on isolated HMF  from the organic phase
only and thus represents the minimum yield since the HMF  formed
is distributed between aqueous and organic layers. This analysis
allowed us to determine whether a constant ﬂow of HMF  would
result with addition of fresh substrate and organic phase. Rehy-
dration or condensation reaction by-products if formed remain in
the aqueous layer. The HMF  isolated yields increased after the ﬁrst
cycle for both PAPSQa and PAPSQb catalysts. Thus while leaving the
aqueous phase and catalyst unperturbed except for the addition of
fresh fructose, the catalysts remained active and the yield of HMF
increased during the three cycles of HMF  production. Both solid
acids resided completely in the aqueous phase of the two-phase
mixture and dispersed well in this phase in the stirred mixture.
The surface area of catalyst PAPSQb being roughly three times that
of PAPSQa may  account for the higher 5-HMF yield from PAPSQb.
For the identical biphasic system employing the sulfonic acid ion-
exchange resin catalyst PK-216, at 90 ◦C for 8–16 h, or phosphoric
acid at 90 ◦C -180 ◦C for 8 min  the HPLC determined yields of HMF
from the organic phase after a single cycle were 23 and 28% respec-
tively [30]. Catalyst stability due to leaching of functional groups
was identiﬁed as an issue for some silica supported sulphonic acid
catalysts when employed in a continuous ﬂow reactor for HMF  pro-
duction [32] but hybrid sulfonic acid catalysts had greater stability
in this respect.
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4. Conclusion
New phosphonic acid polysilsesquioxane materials, PAPSQs,
were readily formed from an easily prepared two-component pre-
cursor mixture. Direct hydrolysis of the precursor mixture afforded
a simple and fast route to the target material (PAPSQa) that avoids
isolating the intermediate phosphonate ester modiﬁed material
which is an inevitable step of the alternative sol-gel route (to PAP-
SQb). The mildly acidic glassy particulate materials PAPSQa and
PAPSQb displayed effective solid Brønsted acid catalytic activity.
Ketalisation proceeded at a faster rate for PAPSQa than with dis-
solved phosphoric acid or PAPSQb as catalyst. PAPSQs hold much
promise as catalysts for transformations that would beneﬁt from
a mild acid catalyst such as those where more than one prod-
uct is routinely formed. In this context the solid acids were used
to demonstrate a constant ﬂow of the important intermediate 5-
hydroxymethylfurfural, HMF, as the substrate fructose and organic
solvent were replenished in this important example of a biomass
conversion reaction.
Overall phosphonic acid polysilsesquioxane PAPSQa is a new
low cost easy to synthesise organic-inorganic hybrid with good
thermal stability and viable catalytic applications can be envisaged
for this material. In future work different compositional variations
including metal derivatives will be investigated.
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